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Abstract
Statistical Methods for Gene-Environment Interactions
Yaqing Xu
2021
Despite significant main effects of genetic and environmental risk factors have been found,
the interactions between them can play critical roles and demonstrate important implica-
tions in medical genetics and epidemiology. Although many important gene-environment
(G-E) interactions have been identified, the existing findings are still insufficient and there
exists a strong need to develop statistical methods for analyzing G-E interactions. In this
dissertation, we propose four statistical methodologies and computational algorithms for
detecting G-E interactions and one application to imaging data. Extensive simulation stud-
ies are conducted in comparison with multiple advanced alternatives. In the analyses of
The Cancer Genome Atlas datasets on multiple cancers, biologically meaningful findings
are obtained.
First, we develop two robust interaction analysis methods for prognostic outcomes.
Compared to continuous and categorical outcomes, prognosis has been less investigated,
with additional challenges brought by the unique characteristics of survival times. Most of
the existing G-E interaction approaches for prognosis data share the limitation that they
cannot accommodate long-tailed or contaminated outcomes. In the first method, we adopt
the censored quantile regression and partial correlation for survival outcomes. Under a
marginal modeling framework, this proposed approach is robust to long-tailed prognosis
and is computationally straightforward to apply. Furthermore, outliers and contaminations
among predictors are observed in real data. In the second method, we propose a joint model
using the penalized trimmed regression that is robust to leverage points and vertical outliers.
The proposed method respects the hierarchical structure of main effects and interactions
and has an effective computational algorithm based on coordinate descent optimization and
stability selection.
Second, we propose a penalized approach to incorporate additional information for iden-
tifying important hierarchical interactions. Due to the high dimensionality and low signal
levels, it is challenging to analyze interactions so that incorporating additional information
is desired. We adopt the minimax concave penalty for regularized estimation and the Lapla-
cian quadratic penalty for additional information. Under a unified formulation, multiple
types of additional information and genetic measurements can be effectively utilized and
improved identification accuracy can be achieved.
Third, we develop a three-step procedure using multidimensional molecular data to
identify G-E interactions. Recent studies have shown that collectively analyzing multiple
types of molecular changes is not only biologically sensible but also leads to improved
estimation and prediction. In this proposed method, we first estimate the relationship
between gene expressions and their regulators by a multivariate penalized regression, and
then identify regulatory modules via sparse biclustering. Next, we establish integrative
covariates by principal components extracted from the identified regulatory modules. Last
but not least, we construct a joint model for disease outcomes and employ Lasso-based
penalization to select important main effects and hierarchical interactions. The proposed
method expands the scope of interaction analysis to multidimensional molecular data.
Last, we present an application using both marginal and joint models to analyze histopatho-
logical imaging-environment interactions. In cancer diagnosis, histopathological imaging has
been routinely conducted and can be processed to generate high-dimensional features. To
explore potential interactions, we conduct marginal and joint analyses, which have been
extensively examined in the context of G-E interactions. This application extends the prac-
tical applicability of interaction analysis to imaging data and provides an alternative venue
that combines histopathological imaging and environmental data in cancer modeling.
Motivated by the important implications of G-E interactions and to overcome the limi-
tations of the existing methods, the goal of this dissertation is to advance in methodological
development for G-E interaction analysis and to provide practically useful tools for identify-
ing important interactions. The proposed methods emerge from practical issues observed in
real data and have solid statistical properties. With a balance between theory, computation,
and data analysis, this dissertation provide four novel approaches for analyzing interactions
to achieve more robust and accurate identification of biologically meaningful interactions.
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1.1 Importance of G-E interactions
Gene-environment (G-E) interactions can contribute to the development of complex dis-
eases, together with the significant main effects of genetic and environmental risk factors
(Hunter, 2005). Identifying G-E interactions has important implications for understanding
etiology and for describing prognosis and response to treatment (Thomas, 2010). One exten-
sively studied G-E interaction is between smoking and gene NAT2 for bladder cancer. In the
Spanish Bladder Cancer Study of 1150 cases and 1149 controls, Garćıa-Closas et al. (2005)
showed an increased risk of bladder cancer among smokers with NAT2 slow acetylation
genotype than that for never smokers, compared to those with NAT2 rapid/intermediate
acetylators. Other environmental exposures of the chemical arylamines, which are widely
used in hair dyes and other consumer products, were also found to be interacting with
NAT2 in multiple studies of cancer risk (Skipper et al., 2003). Substantial evidence of the
existence of NAT2-arylamine exposure interaction associated with bladder cancer risk has
been extensively investigated and supported by the fact that this gene encodes an enzyme
that functions to both activate and deactivate arylamine and hydrazine drugs. These in-
teractions were also confirmed to be biologically reasonable because aromatic amines can
be detoxified by NAT2 and are one of the most important bladder carcinogens in tobacco
smoke (Green et al., 2000; Hein, 2002).
Beyond the better understanding of complex diseases, G-E interactions can also be infor-
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mative for predicting disease risk before diagnosis and for providing personalized preventive
advice based on the genetic profiles of patients. In this sense, we consider the interaction to
be both the effect of genotypes on disease modified by the environmental exposures, and the
environmental exposures on disease risk interacting with different genotypes. For example,
red meat consumption is associated with the risk of colorectal cancer, and studies have
shown the effect of red meat intake was modified by NAT2 polymorphisms (Chen et al.,
1998). Specifically, among carriers of the rapid NAT2 alleles, the association between red
meat intake and the risk of colorectal cancer was stronger (Nöthlings et al., 2009). This G-E
interaction shows that the polymorphisms in gene NAT2 convey differential susceptibilities
to the effect of red meat intake on colorectal cancer risk, providing valuable information for
individualized prevention and risk prediction.
Identifying G-E interactions can help to discover important genes that are associated
with the disease through interacting effects with no significant marginal effects (McAllister
et al., 2017). Similarly, searching for G-E interactions can also reveal the environmental risk
factors that influence the etiology of disease among genetically susceptible populations. In
addition, when we consider a drug as the environmental exposure of interest, pharmacoge-
netics is a special case of G-E interactions. It has demonstrated significant applications and
potential impact on public health and clinical care (Dempfle et al., 2008). For instance, war-
farin is commonly used in anticoagulation therapy, but Higashi et al. (2002) demonstrated
patients possessing CYP2C9 polymorphisms have an increased risk of over anticoagulation
and of bleeding complications so that a lower dose of warfarin is required. Hence, the exis-
tence of such interactions can be applied to personalized treatment in clinical practice, by
tailoring the therapy for patients who are at risk of adverse side effects or treatment failure.
From simple dichotomous genotypes and environmental exposures in the examples, both
genetic and environmental risk factors can take other forms. For genetic measurements,
SNPs, genotypes as categorical, and gene expression levels as continuous are available.
Similar to environmental exposures, a variety of measurements are of interest given the
category of potential risk factors, which include the chemical environment as in aforemen-
tioned NAT2 interactions, physical environment such as sun exposure and air pollution,
and clinical risk factors described as physiological attributes related to certain diseases.
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For instance, clinically relevant factors such as weight and height are usually measured as
continuous ones. The response associated with G-E interactions can be disease status such
as diagnosis, continuous disease outcomes such as surrogate biomarker measurements, and
survival time with censorship.
1.2 Current methods
Though the importance of G-E interactions has been recognized, existing studies barely
scratch the surface of the massive data that have been collected and are readily available
for analysis and research. Current findings remain insufficient considering the sophisti-
cated mechanisms of complex diseases (Khoury and Wacholder, 2009). Many statistical
approaches have been proposed for detecting G-E interactions, especially for categorical
responses such as disease status. Consider the disease outcome or phenotype as Y , and
p single nucleotide polymorphisms (SNPs) as G = [G1, G2, . . . , Gp] with a single binary
environmental risk factor as E.
1.2.1 Hypothesis testing-based approaches
The simplest approach employs a 3× 2 contingency table to test if the relative risk for each
SNP is significantly different comparing the exposed to the unexposed subjects. Chi-square
tests can be conducted as well as Fisher’s exact tests. The importance of potential G-E
interactions is evaluated by p-values with multiple testing correction. For example, Travis
et al. (2010) studied the effects of 12 polymorphisms among 7610 women with breast cancer
and 10196 controls. The per-allele relative risk was calculated using logistic regressions to
describe the main effect of each of the 12 SNPs, and then compared across two levels of
each of the ten environmental risk factors, including age at menarche, height, and others.
ANOVA was applied for comparing the means of continuous variables and conventional
chi-square tests were used for the proportions of categorical variables. Given a total of 120
tests, the threshold of p-values for statistical significance was corrected to be 0.0004 and no
significant evidence of any G-E interaction was concluded in this analysis. Other examples
of hypothesis testing-based analysis include Higashi et al. (2002), Lake and Laird (2004),
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and many others. Among the existing hypothesis testing analysis methods, the majority
have been designed for case-control data. We omit further discussions and refer Garćıa-
Closas and Lubin (1999), Albert et al. (2001), and Gauderman (2002) for comprehensive
discussions about sample size and power calculation in specific study designs for detecting
G-E interactions.
One obvious drawback is that the hypothesis testing-based approaches evaluate the
relative risks or odds ratios across different levels of genetic and environmental factors
(Chatterjee and Wacholder, 2009). When it comes to continuous genetic measurements
such as gene expression data, categorizing expression levels would cause a considerable loss
of information. Dependent upon the strength of the association and the magnitude of the
interaction, statistical methods with increased power are desired. With low-dimensional co-
variates, robust methods have demonstrated to be powerful and efficient (Wilcox, 2011). For
example, Ritchie et al. (2001) developed the multifactor dimensionality reduction (MDR)
method based on hypothesis testing and Ritchie et al. (2003) showed the MDR method
retains high power in the presence of genotyping error. Yet, these methods usually have
limited applicability and demand certain study designs.
1.2.2 Marginal modeling framework
As a result, the most commonly used marginal model when testing for the existence of G-E
interactions between certain genes and environmental risk factors is defined as
Y ∼ φ(βkGk + γE + θkGk × E), for k = 1, 2, . . . , p,
where βk and γ are the main effects of Gk and E respectively, θk is the interaction effect
between Gk and E, and φ(·) is a known link function. Gk×E represents a two-way product
interaction where × is element-wise multiplication. Note that we omit other covariates to
avoid unnecessary notation but they may be added to the above model. Standard estima-
tion, especially likelihood-based techniques, is conducted. Under such a marginal modeling
framework, this model fitting is cycled through all genes and environmental factors. Impor-
tant interactions are selected based on p-values. For instance, we can use the logit link for
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a binary Y such as disease diagnosis. The example of gene NAT2 and smoking interaction
discussed in Garćıa-Closas et al. (2005) was examined by logistic regression with adjustment
for relevant covariates, and the odds ratios were assessed for the effect on bladder cancer
risk.
Many methods have been proposed to enhance the power and can be broadly summarized
into two categories. One is adding a preliminary screening process to reduce the number of
tests. For example, Murcray et al. (2009) proposed to screen the associations between SNPs
and the environmental exposures using likelihood ratio tests based on the logistic model.
Alternatively, Kooperberg and LeBlanc (2008) suggested screening on marginal genetic
effects. In both methods, only for SNPs that were selected by a pre-specified significance
level, their corresponding G-E interactions were tested for association of disease status in the
second step. Combining these two screening approaches, Murcray et al. (2011) developed
a hybrid method and Hsu et al. (2012) introduced a cocktail method. The other category
for improving the power aims to combine a group of genetic variants and then to perform a
set-based test to reduce the multiple-testing burden. Tzeng et al. (2011) proposed a marker-
set approach to detect G-E interactions where the genetic similarity and interaction were
regressed on the trait similarity between individuals, and the genetic similarity was used to
integrate information from multiple polymorphic sites so that the power was increased by
reducing the total number of tests.
In fact, marginal models for identifying G-E interactions discussed above are also based
on hypothesis testing. The candidate interactions are described by two-way products and
the estimates of their coefficients are obtained. With the null hypotheses that the effect of
each interaction equals zero, p-values are produced. Meanwhile, hypothesis testing-based
approaches summarized in Section 1.2.1 are built under the marginal analysis category,
where one interaction is considered at a time and marginal effects on the outcomes are
investigated. We separate hypothesis testing-based methods from Section 1.2.2 for those
that do not explicitly denote G-E interactions by element-wise multiplication of genetic and
environmental risk factors.
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1.2.3 Joint modeling framework
Besides marginal effect modeling for identifying G-E interactions, other approaches assume








Joint modeling framework for analyzing G-E interaction is more challenging mainly for two
reasons. First, high dimensionality is problematic due to the number of genetic factors and
interactions. For instance, given 1000 genes and 5 environmental risk factors, the number of
potential interactions is 5000 and the total number of the covariates in joint analysis adds to
6005. To handle such high-dimensional data, regularized estimation is often adopted and in-
creased computational cost is required (Wu and Ma, 2015). For instance, Lasso (Tibshirani,
1996) and the minimax concave penalty (Zhang et al., 2010), two popular penalization tech-
niques, both demand developed computational algorithms for model fitting. More details
about coordinate descent algorithms are discussed in Friedman et al. (2010) and Breheny
and Huang (2011). Second, the hierarchical structure of main effects and interactions needs
to be accommodated under joint modeling. That is, when an interaction is identified, the
corresponding main effect of genetic factor should be simultaneously included in the model.
The need to respect the “main effects, interactions” hierarchy has been widely recognized to
deliver biologically meaningful findings in the literature (Bien et al., 2013; Hao et al., 2018).
Yet, directly imposing regular penalization in the joint analysis that does not guarantee the
hierarchical structure, important interactions may be identified without their corresponding
main effects. Such identification of G-E interactions can lead to false discovery and difficult
interpretation.
Several published studies address these challenges by statistical approaches. For exam-
ple, Liu et al. (2013) proposed a joint model and adopted the group MCP for penalized
estimation and hierarchical structure. Simulation study showed that it outperforms alterna-
tives by identifying more true positives and fewer false positives. Zhu et al. (2014) developed
a stagewise strategy and employed `1 penalization to identify G-E interactions. A coordi-
nate descent method was utilized in computation to produce regularized estimation. Given
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the massive amount of data collected and the sophisticated mechanisms of interactions, the
existing findings remain insufficient and there is a lack of methodology development for G-E
interaction analysis.
We note that other analysis frameworks exist (Cordell, 2009; McKinney et al., 2006).
One example category arises from a Bayesian standpoint for selecting G-E interactions.
For instance, Mukherjee and Chatterjee (2008) proposed an empirical Bayes-type estimator
for case-control data, Mukherjee et al. (2010) introduced a proper full Bayesian approach
with sample size determination criteria for both estimation and hypothesis testing for G-E
interactions, and Yu et al. (2012) developed a resampling-based test derived from a Bayesian
model. We refer Simonds et al. (2016) and Wu and Ma (2019) for further reviews.
1.3 Application
We conduct data analysis on publicly available data collected by The Cancer Genome Atlas
(TCGA), which provides comprehensive profiling on more than 30 cancer types with high
quality for cancer studies. It serves as benchmark data for conducting and comparing
different statistical approaches and is ideal for demonstrating the practical applicability of
our proposed methods. More information about TCGA can be found online at http://
cancergenome.nih.gov/. Here, we use lung adenocarcinoma (LUAD) data as an example
to introduce the characteristics of the TCGA data and several performance assessments for
comparing different methods.
Lung cancer is the leading cause of cancer death globally, and adenocarcinoma of the
lung is its most common histological type. From molecular profiling, many genetic muta-
tions have been identified as the driver in certain tumors, for example, ALK (Kwak et al.,
2010) and EGFR (Paez et al., 2004). However, the additional unexplained mechanisms of
pathway activation, suggesting potential G-E interactions may exist (Network et al., 2014).
For data analysis, we download the level 3 data from TCGA Provisional using the R package
cgdsr (Jacobsen, 2017). There is a total of 544 tumor samples, 230 of which have mRNA,
copy number variation (CNV) and sequencing data. For example, mRNA gene expression
data is collected using the IlluminaHiseq RNAseq V2 platform, containing a total of 20189
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measurements. CNV data is obtained using the Genome-Wide Human SNP Array 6.0 plat-
form with 18342 measurements. DNA methylation is obtained using the Illumina Infinium
Human DNA Methylation 450 platform with 21231 measurements. For clinical information,
67 measurements about the participants are available and can be regarded as environmen-
tal risk factors. For instance, smoking status is recorded for 353 subjects, which is known
as a major cause of lung cancer. Age of 516 participants is included, ranging from 33 to
88 with a mean of 65. In this dissertation, we select environmental factors based on the
existing findings in biomedical literature and include them in the model for data analysis.
For example, age, gender, tumor pathological stage, and smoking status have been found
to be associated with lung cancer prognosis (Westcott et al., 2015), and can be used as
environmental risk factors for data analysis. In addition, survival times and censoring in-
dicators, as the prognosis outcomes for the proposed methods, are also reported as clinical
information with 262 complete cases. It ranges from 0.13 to 238.11 months with 93 deaths
during the follow-up period.
Using the proposed methods, identified interactions are confirmed and validated by
searching the current literature for biological implications. We expect that some, if not all,
of the selected G-E interactions have already been detected and explained in the existing
studies, which can be found by their main genetic effects, as well as interactive effects with
other environmental risk factors. We also apply the alternative approaches to analyze the
TCGA data. Though analytical methods are different, the actual effects contained in the
data should produce similar discoveries, which means the identified G-E interactions may
be distinct but the information of those identifications can largely overlap. In this sense, we
assess how much the identifications from different methods are overlapped by the modified
matrix correlation coefficient (RV-coefficient), which describes the common information of
two high-dimensional matrices (Smilde et al., 2009). Moreover, we evaluate and compare
the stability performance by the observed occurrence index (OOI), which examines the
probability of an interaction being identified in random samples and with a larger value
indicating higher stability (Huang and Ma, 2010).
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1.4 Summary
Motivated by the importance of G-E interactions and the limitations of the existing interac-
tion analysis methods, in this dissertation, we propose two marginal and two joint modeling
approaches for analyzing G-E interactions and extend the applicability to histopathological
imaging data. For each proposed method, we investigate numerical results using simulated
data under various settings in comparison with multiple alternative approaches. We also
conduct analysis on publicly available data collected by The Cancer Genome Atlas (TCGA).
The proposed methods are intertwined in serval aspects. All of the proposed methods,
except Chapter 2.2, assumes a linear relationship to model the association between the
interactions and outcomes. This modeling strategy of using linear regressions is in accor-
dance with the current statistical theories and applications for analyzing main genetic and
interaction effects on disease outcomes. Several benefits of using linear regressions that
describe the additive effects on disease outcomes are carried out and magnified in the pro-
posed methods. First, the regression coefficients of main genetic and interactions directly
represent their effects on the outcomes. We hence enforce the hierarchical structure of main
effects and interactions in this dissertation by decomposing the coefficients. In this way, an
interaction can be included in the model only if the corresponding main genetic effect is also
included, leading to reasonable interpretability and accurate identification. Consequently,
the unified modeling scheme also brings advantages to the estimation and selection process.
To fit the regression models, the objective functions proposed in this dissertation consist of
the loss function and penalty terms. Since the coefficients of interactions are decomposed
as multiplications, it is intuitive to apply separate penalty terms for the main effects and
interaction respectively. Without further complication in calculating the regularized solu-
tion, we adopt the coordinate descent algorithms that are computationally efficient with
well-established convergence properties.
The rest of the dissertation is organized as follows. In Chapter 2, we develop two G-E
interaction analysis methods with robustness properties to accommodate outlying observa-
tions. In Chapter 3, we propose to incorporate additional information into G-E interaction
analysis using penalization. In Chapter 4, we extend to multidimensional molecular data
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and develop a three-step strategy for analyzing molecular changes-environment interac-
tions. In Chapter 5, we present an application of interaction analysis using histopathologi-
cal imaging features for cancer modeling. In the following studies, we demonstrate that the
methodological advancement of the proposed methods can effectively overcome the limita-
tions of the existing methods and expand the current scope of interaction analysis. Multiple
recently collected data are analyzed using the proposed methods and compared with bench-
mark alternative approaches, which can provide biologically meaningful identifications and
potentially reveal important G-E interactions missed by existing studies. In Chapter 6, we
summarize the achievements and limitations of this dissertation and discuss potential future




Methods for Prognostic Outcomes
2.1 Overview
In practical biomedical studies, the presence of irregular noise caused by various sources
is commonly observed. For example, in cancer research, observed survival data is often
heterogeneous with many possible reasons (Aalen, 1988). The natural course of a disease can
be distinct from person to person, which could be affected by the clinical treatment and the
influence of risk factors. Also, individual frailty varies and patients who are more frail will
die sooner. Even with strict patient selection as in clinical trials, the natural heterogeneity in
study populations requires robust methods to deliver accurate identifications. Additionally,
complex diseases like cancer and diabetes may have various subtypes and mechanisms,
which can result in heterogeneity in survival times as well. The Cancer Genome Atlas
Research Network (2014) stated The Cancer Genome Atlas data on lung adenocarcinoma
demonstrated diverse patterns of survival outcomes under different molecular subtypes.
Finally, potential data contamination such as human error may contribute to the presence
of noise. Relevant discussions can be found in Osborne and Overbay (2004) and Shieh
and Hung (2009). For example, medical records are vulnerable to entry errors during data
collection, and even diagnostic errors may happen: 10-30% of breast cancers are missed on
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mammography and 1-2% of cancers are misread on biopsy samples (Graber, 2013). Together
with biological variation among the population over time, the heterogeneity and possible
contamination in the observed data is not simply a nuisance, but an important characteristic
of the data itself, demonstrating the necessity of developing robust methods for identifying
G-E interactions.
Given the biological variation and potential contamination in real data, the popular
procedures using non-robust methods for identifying G-E interactions have the following is-
sues. (1) The specified model may not be consistent for all subjects due to the heterogeneity
among patients. It is possible that the subgroups of patients demonstrate distinct associ-
ations so that robust methods are necessary to retain accurate estimates across dissimilar
patterns. Considering the large number of genes, chances are that the estimated signifi-
cance level will be invalid because the strict model assumptions may not be met for every
marginal model. For example, some genes exhibit distinctive expression signatures, and
the corresponding residuals do not satisfy the strict assumption of the error distribution.
Consequently, the regression coefficients can be misleading, resulting in false positive de-
tections of interactions. (2) Different sets of covariates may correlate with different disease
subtypes. In this case, since the traditional methods assume that the same set of covariates
in the model, the estimated coefficients may not describe the association properly. Including
irrelevant variables or omitting significant ones can result in misleading identifications of
interactions. Thus, robustness is required given potentially ambiguous disease subtypes. (3)
With insufficient prior knowledge, the regression model can even be misspecified, especially
when the biological findings are too limited to validate the specified model across subtypes.
In contrast, robust models are less sensitive to model misspecification, and accommodate
the complexity of the disease by using weaker model assumptions. (4) Additionally, ex-
treme values could easily disturb the non-robust model, leading to biased estimates and
misleading inference. A small proportion of data contamination can skew regression esti-
mates dramatically even with the prescreening step combined with non-robust methods,
whereas the robust models remain stable and can still provide accurate identifications.
Considering the common presence of noise introduced by the nature of complex diseases,
heterogeneous populations, and even human errors, we propose two robust methods for iden-
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tifying G-E interactions to discover new interaction effects and to advance in methodological
development. In Chapter 2.2, we propose a robust censored quantile partial correlation ap-
proach to identify important interactions while properly controlling for the main genetic and
environmental effects under a marginal modeling framework. In Chapter 2.3, we develop a
robust penalization approach using the trimmed regression technique under joint modeling.
Both of the proposed robust methods can accommodate prognostic response.
2.2 Censored Quantile Partial Correlation for Cancer Prog-
nosis
2.2.1 Introduction
Recent studies have shown that G-E interactions play a critical role for the prognosis of
many diseases. For instance, it has been suggested that the interaction between gene TP53
and age affects the prognosis of glioblastoma (Batchelor et al., 2004). Literature review
suggests that there is less research on G-E interactions for prognosis, which may be caused
by the challenging characteristics of prognosis data (non-negative distributions, censoring,
etc.). Recent methodological developments for identifying G-E interactions for prognosis
include Shi et al. (2014), Sharafeldin et al. (2015), and a few others.
In practical genetic studies, the long-tailed distributions and contaminations in prog-
nostic response are not uncommon. These studies usually cannot afford conducting strict
subject selection, and as such, the subjects are less homogeneous than in for example clin-
ical trials. Sometimes there are some extremely good or bad survivals, which has been
observed in quite a few studies. In addition, human errors (for example, mistakes in death
records) can also cause long-tailed distributions and contaminations. As the demonstrative
examples, consider the LUAD and SKCM (cutaneous melanoma) data collected by TCGA.
More information on these data can be found in the data analysis section of this article as
well as the TCGA website. For the 262 LUAD subjects analyzed in this section, one has
survival time 238.11 months, while the rest 261 have survival times ranging from 0.13 to
129.43 months. In addition, for the 225 SKCM subjects, three have survival times 241.20,
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Figure 2.1: Analysis of the LUAD and SKCM data: the empirical distribution of log(survival
time) (solid line) and best-fitted normal distribution (dashed line).
268.53, and 339.88 months, while the rest 222 have survival times ranging from 2.04 to
228.42 months. In Figure 2.1, we present the empirical density function of the log survival
time as well as the best-fitted Normal density for both datasets. Compared to Normal, we
observe the longer left tails (p-values for LUAD and SKCM from the Kolmogorov-Smirnov
test are 0.001 and 0.002, suggesting a significant difference from Normal). In “classic”
statistical analysis, it has been noted that data with long-tails/contamination cannot be
appropriately accommodated by non-robust estimations: even a single extreme value can
lead to biased estimation and misleading inference.
For low-dimensional biomedical studies, robust methods have been extensively developed
and implemented. For example, Wang and Wang (2009) have proposed the robust censored
quantile regression (CQR) approach which is a recursive weighting approach and generalizes
the Kaplan-Merier (KM) estimator introduced in published studies. Huang et al. (2007)
have developed the robust least absolute deviation estimation based on the AFT model and
KM weights (KMW-LAD). Other examples include the rank-based regression (Wang and
Zhu, 2006), S-estimation (Tharmaratnam et al., 2010), and others. However, development
and implementation in G-E interaction analysis with prognosis data are still much limited.
In this Section, we conduct G-E interaction analysis for data with prognosis responses.
To accommodate long-tailed distributions/contamination in the response, we develop a ro-
bust censored quantile partial correlation (CQPCorr) approach, which can be applied to
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analyze both continuous and categorical variables. This study advances from the existing
literature in the following aspects. First, we specifically consider the scenario with long-
tailed distributions/contamination in the prognosis response, which is not uncommon but
has been little investigated. Second, the proposed approach is built on the quantile regres-
sion technique and may have a more solid statistical basis than some alternatives. Quantile
regression has been first developed for low-dimensional data (Koenker and Bassett Jr, 1978)
and its joint asymptotic distribution, robustness, and statistical inference have been well
established (Koenker and Machado, 1999). Compared to least squares regression, quantile
regression has been demonstrated to have comparable efficiency for Normal error distribu-
tion and perform much better for a wide class of non-Normal error distributions. It has
been more recently developed for high-dimensional main effect analysis, and also shown
to have good properties, including the consistency and asymptotic normality (Lee et al.,
2018; Wang et al., 2012a).Although quantile regression has been a popular tool in statisti-
cal analysis, its applications to genetic interaction analysis are still limited. Different from
the standard quantile regression technique, the proposed approach adopts data-dependent
weights to accommodate censoring. In addition, tailored to interaction analysis, the partial
correlation technique is adopted. Third, compared to some alternative robust techniques,
the quantile-based is computationally more feasible, making the proposed approach suit-
able for high-dimensional analysis. It is noted that although components of the proposed
approach have roots in existing techniques, development and implementation in the present
context are new and innovative. In addition, our extensive numerical study shows that the
proposed approach can outperform multiple direct competitors. Overall, this study provides
a useful new venue for identifying G-E interactions with prognosis responses.
2.2.2 Methods
Consider a dataset with n independent subjects. For subject i, let Ti be the transformed
(e.g., log) survival time of interest, and Xi = (Xi1, · · · , Xiq)′ and Zi = (Zi1, · · · , Zip)′ be
the q- and p-vectors of E and G variables, respectively. To study the interaction between
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the kth E factor and jth gene, consider the model
Ti = akj + αkjXik + βkjZij + θkjXikZij + εi, (2.1)
where akj is the intercept, αkj , βkj , and θkj are unknown coefficients, and εi is the random
error with P (εi < 0|Xik, Zij) = τ . Note that here a very weak assumption is made on the
error distribution, whereas with non-robust estimations, usually very stringent assumptions
(for example, normal distribution) are needed. In the above model, one E factor and
one G factor are considered. This strategy has been commonly adopted in the literature.
See for example Frost et al. (2016) and Zhang et al. (2016). The proposed approach can
straightforwardly accommodate multiple E factors and one G factor in a single model. In
practice, right censoring is usually present. For subject i, denote Ci as the censoring time
which is transferred as the survival time, then we observe Yi = min(Ti, Ci) and δi = I(Ti ≤
Ci).
The CQPCorr approach
Denote Xk, Zj and T as the random variables corresponding to the kth E factor, jth gene
and transformed survival time. In most of the existing studies, the importance of interaction
XkZj on T is quantified by the magnitude or p-value of θkj (Shi et al., 2014). Significantly
different from the existing studies, we propose quantifying the importance of interaction
XkZj using the quantile partial correlation defined as
qpcorrτ (k, j) =
cov{ψτ (T − η00 − η01Xk − η02Zj), XkZj − γ00 − γ01Xk − γ02Zj}√
var{ψτ (T − η00 − η01Xk − η02Zj)}var(XkZj − γ00 − γ01Xk − γ02Zj)
. (2.2)
Here for a quantile 0 < τ < 1, ψτ (u) = τ − 1(u < 0) and ρτ (u) = uψτ (u). (η00, η01, η02) =
argmin E[ρτ (T−η0−η1Xk−η2Zj)] and (γ00 , γ01 , γ02) = argmin E[(XkZj−γ0−γ1Xk−γ2Zj)2].
E is the expectation function with respect to the random variables Xk, Zj and T . Note
that η0, η1, η2, γ0, γ1 and γ2 take possibly different values for different k and j. We omit the
dependence on (k, j) to simplify notations.
The adopted quantile partial correlation measure has multiple desirable properties. The
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same as the classic Pearson correlation coefficient, it lies between -1 and 1, and is scale-free
and easy to compare across variables. Unlike the simple correlation coefficient, it is defined
based on quantile and hence is robust to long-tailed distributions/contamination. In the
definition, the main effects of G and E variables are first removed from T and XkZj , and
then the correlation is computed. Thus, the main effects are removed in a more explicit
manner. In the literature, the quantile partial correlation has been used for screening
predictors under high-dimensional settings (Ma et al., 2017). However, there is a lack of
application in the context of G-E interaction analysis. In our analysis, there is one additional
significant complication: T is subject to right censoring and not always observable. To tackle
this problem, we propose the censored quantile partial correlation (CQPCorr) technique,
which advances from the quantile partial correlation by adopting weights to accommodate
censoring. Overall, the proposed approach consists of the following steps.
Step I Conduct the censored quantile regression of the prognosis response on the main






(η̂0, η̂1, η̂2) = argmin
n∑
i=1
wiρτ (Yi − η0 − η1Xik − η2Zij)
+ (1− wi)ρτ (Y +∞ − η0 − η1Xik − η2Zij). (2.3)
Y +∞ is a fixed value that is large enough.
Here we adopt the weights wi’s to accommodate censoring. The basic strategy is to
redistribute the mass of a censored observation to the non-censored observations to the
right. This is achieved by creating pseudo-observations with weights wi’s for censored
observations and complementary weights 1 − wi’s at a point large enough. Motivated by
the literature (Wang and Wang, 2009), wi is defined for a censored observations as
wi =
τ − F (Ci|Xik, Zij)
1− F (Ci|Xik, Zij)
(2.4)
if F (Ci|Xik, Zij) < τ , where F (·|Xik, Zij) is the conditional cumulative distribution func-
tion of the survival time given the covariates. For better computational feasibility, we ap-
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proximate F (t|Xik, Zij) using the Kaplan-Meier (KM) estimator and calculate the weight





, if δi = 0 and F̂ (Ci) < τ,
1, otherwise,
for i = 1, . . . , n. Here F̂ (t) = 1−
∏
i:t(i)≤t[1−(n−i+1)
−1]δ(i) , where the subscript “(i)” refers
to the ith subject in the sorted data (according to the observed times, from the smallest to
the largest).
Step II Remove the main G and E effects from the interaction, and obtain the “net” G-E




2) using the simple least squared approach,
where
(γ̂0, γ̂1, γ̂2) = argmin
n∑
i=1
(XikZij − γ0 − γ1Xik − γ2Zij)2.
Step III Results from the above two steps are combined to assess whether the interaction
has an effect on prognosis after accounting for the main effects. Specifically, for interaction
XkZj , the censored quantile partial correlation is defined as




























i (k, j) = Yi − η̂0 − η̂1Xik − η̂2Zij , r
(2)









As in Step I, the weights are introduced to accommodate censoring.
Remarks Advancing from the existing quantile partial correlation studies, the proposed
approach introduces weights to accommodate censoring. In survival analysis, there are many
ways to estimate F (t|Xik, Zij) in (2.4) to accommodate censoring. Popular examples include
the semi-parametric Cox model, accelerated failure time model and transformation model,
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nonparametric KM estimator, and others. We adopt KM estimator as it is computationally
simpler and has been a common choice in the literature. It also has the advantage of
making no assumption on the underlying data distributions and models, leading to more
robust results. It is noted that, although may seem “straightforward”, coupling the KM
weights with quantile partial correlation to achieve robustness with censored data has not
been pursued in the literature. Examining the procedures described above suggests that the
proposed approach can be directly applied to analysis with multiple E factors. Setting all
weights equal to one, the proposed approach can directly accommodate continuous responses
without censoring.
2.2.3 Simulation
Simulation is conducted to gauge performance of the proposed method and compare with
direct competitors. For all simulated data, we set n = 200, p = 1000, and q = 5. There are
thus a total of 5,000 candidate interactions and 1,005 candidate main effects. Other settings
are as follows. (a) The G factors are generated from a multivariate Normal distribution
with marginal mean 0 and variance 1. The continuous distribution mimics gene expression
data analyzed below. The Normal distribution, although somewhat simpler than practi-
cally encountered, has been extensively adopted in published studies. Following published
literature, we consider the AR (auto-regressive) structure with different parameters, where
the jth and lth G variables have correlation coefficient ρ|j−l|. We consider two levels of
correlation with ρ = 0.5 and 0.3. (b) There are five continuous E factors (E1) that are gen-
erated from a multivariate Normal distribution with marginal mean 0, marginal variance
1, and AR correlation (ρ = 0.5). (c) The log event time Y is computed from the following












θkjXkZj + ε, (2.6)
where ε is the random error. Note that this is a joint model, under which prognosis is deter-
mined by the joint effects of multiple main effects and interactions. We choose this model as
it may better describe “biological reality”. Thus, it is sensible to conduct marginal analysis
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and compare results to the data generating mechanisms described above. Additionally, the
log censoring times are generated from uniform distributions and conditionally independent
of the event times (conditional on covariates). The parameters are adjusted so that the
censoring rates are around 20%. (d) Consider three error distributions: N(0, 1) (Error 1),
90%N(0, 1) + 10%N(±50, 1) (Error 2) and 80%N(0, 1) + 20%N(0, 50) (Error 3). The last
two scenarios represent different types/levels of long-tailed distributions/contamination. (e)
There are 16 G-E interactions together with two main E effects and five main G effects.
Although the proposed method focuses on interaction identification, the main effects are
assumed to make the simulated dataset closer to practical data. Five different coefficient
settings are considered.
C1 has θkj = 2 for k = 1, 2 and j = 1, · · · , 5, and α1 = α2 = β1 = · · · = β5 = 1.
Under this setting, the main effects are weaker than the corresponding interactions.
In addition, θkj = 1 for k = 3, 4, 5 and j = 6, 7. All other coefficients are 0.
C2 has θkj = 1.5 for k = 1, 2 and j = 1, · · · , 5, and α1 = α2 = β1 = · · · = β5 = 1.5.
Under this setting, the main effects and interactions have the same level. In addition,
θkj = 1 for k = 3, 4, 5 and j = 6, 7. All other coefficients are 0.
C3 is the same as C1 except that the magnitudes of the main effects are larger, that is
α1 = α2 = β1 = · · · = β5 = 3.
C4 is the same as C1 except that the magnitudes of the interactions are smaller, that is
θkj = 0.5 for k = 1, 2 and j = 1, · · · , 5, and θkj = 0.5 for k = 3, 4, 5 and j = 6, 7.
C5 is the same as C1 except that the interactions with main effects have negative coeffi-
cients, that is θkj = −2 for k = 1, 2 and j = 1, · · · , 5.
Under all five settings, there are two types of interactions. The first one includes ten
interactions (θkj , k = 1, 2 and j = 1, · · · , 5) with main effects and the second one includes
six interactions (θkj , k = 3, 4, 5 and j = 6, 7) without main effects. Thus, the hierarchy of
the second type is violated. There are a total of 21 simulation scenarios, covering a wide
spectrum of settings.
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Comparison with the alternative methods
Besides the proposed approach, we also consider four alternatives with the same covariate
effects as in (2.1), including the AFT model, Cox model, censored quantile regression ap-
proach (CQR), the least absolute deviation estimation with KM weights (KMW-LAD). As
introduced in Section 1, AFT and Cox models are perhaps the most popular methods for
analyzing prognosis data, but without the property of accommodating long-tailed distri-
butions and contamination. Note that under our simulation settings which are based on
AFT model, the Cox model is mis-specified. However, due to its popularity, it has been
also adopted as the alternative method in many published studies without sufficient model
diagnostics (Liang et al., 2016; Song et al., 2014) and is a suitable benchmark for compar-
ison. The CQR and KMW-LAD approaches are also robust. Different from the proposed
approach, they consider one interaction and its corresponding main effects in one regres-
sion model. For all the proposed method and four alternatives, p-values are computed and
used to rank/identify interactions. We note that there are other G-E interaction analysis
methods that are potentially applicable to the simulated data. The above four methods are
chosen because their analysis frameworks are the closest to the proposed and also because of
their popularity and competitive performance demonstrated in published studies. With the
proposed approach and CQR, we set the quantile τ = 0.5. Choosing this specific quantile
makes the proposed approach more comparable to KMW-LAD (which is a special case of
quantile regression with τ = 0.5).
The main goal of our analysis is to accurately identify important interactions. Identi-
fication accuracy is evaluated using multiple measures, including: (a) TP20, which is the
number of true positives when 20 interactions are selected; (b) TP40, which is defined in a
similar way as TP20; (c) pAUC, which is the standardized partial area under the ROC curve
when the number of false positives are restricted to 150 (Robin et al., 2011); (d) TP.FDR,
which is the number of true positives when the number of important interactions is selected
using the FDR (false discovery rate) approach with target FDR 0.1; (e) FP.FDR, which
is the corresponding number of false positives; and (f) E.FDR, which is the corresponding
estimated FDR. All five measures have been adopted in multiple publications.
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Under each setting, we simulate 200 replicates. Summary results for scenarios C1 and
C2 are presented in Tables 2.1 and 2.2, respectively. It is observed that the proposed
approach has similar or better performance than the alternatives. When there is no con-
tamination (Error 1), the proposed approach may be slightly inferior to the non-robust
alternatives. This is reasonable as the non-robust alternatives can be more efficient for
data with no contamination. Although the true model is not Cox, the Cox-model-based
approach is observed to have satisfactory performance. Both the Cox and AFT models are
transformation models. The “robustness” of the Cox model (to model mis-specification) has
also been observed in the literature. The proposed approach can more accurately identify
important interactions than the robust alternatives. For example in Table 2.2 with ρ = 0.3
and Error 1, the proposed approach selects on average 10.3 true nonzero interactions when
the model size is 40, while CQR and KMW-LAD select 4.9 and 8.8 on average, respectively.
When there is a stronger correlation which is common in practice, the advantage of the
proposed approach over the alternatives gets more prominent, even over AFT and Cox for
data without contamination. For example in Table 2.1 with ρ = 0.5 and Error 1, the pro-
posed approach has pAUC=0.94, compared to 0.84 (AFT), 0.90 (Cox), 0.74 (CQR), and
0.90 (KMW-LAD). When data have contamination, the proposed approach has significant
advantages. For example in Table 2.1 with ρ = 0.3 and Error 3, the proposed approach has
pAUC=0.77, compared to 0.65 (AFT), 0.72 (Cox), 0.62 (CQR), and 0.71 (KMW-LAD).
Across all settings, the proposed approach performs moderately or slightly better than the
KMW-LAD approach. It is reasonable that the improvement over the KMW-LAD is not
dramatic: this approach has a strategy similar to the proposed, with the loss function being
a special case of quantile regression, and using the KM weights to accommodate censor-
ing. However, we can still observe improvement which supports the proposed three-steps
strategy. We also examine an example of the partial ROC curves in Figure A.1 (Appendix)
under setting C1 with ρ = 0.3 and Error 3. It is shown that the solid line representing the
proposed approach is superior to the others.
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Table 2.1: Simulation results for setting C1 with the AR correlation structure. In each cell,
mean (sd) based on 200 replicates.
Error Method TP20 TP40 pAUC TP.FDR FP.FDR E.FDR
ρ = 0.3 1 AFT 9.8(1.2) 10.7(0.9) 0.79(0.05) 10.9(1.2) 69.0(57.0) 0.78(0.17)
Cox 9.6(1.6) 10.5(1.7) 0.83(0.05) 9.0(2.0) 16.2(27.8) 0.49(0.22)
CQR 3.1(1.4) 4.9(1.8) 0.67(0.04) 7.9(2.0) 116.1(31.3) 0.93(0.02)
KMW-LAD 7.1(2.3) 8.8(2.4) 0.81(0.06) 3.2(2.3) 0.8(1.3) 0.12(0.16)
CQPCorr 8.6(1.8) 10.2(2.0) 0.84(0.06) 4.8(2.2) 0.8(0.9) 0.11(0.11)
2 AFT 4.8(1.8) 5.8(1.7) 0.71(0.05) 3.2(2.3) 4.9(6.0) 0.38(0.34)
Cox 6.9(2.0) 8.3(2.1) 0.78(0.06) 4.1(2.4) 2.2(2.6) 0.32(0.24)
CQR 2.9(1.3) 4.1(1.8) 0.65(0.05) 6.3(2.5) 94.4(36.4) 0.94(0.02)
KMW-LAD 6.4(1.7) 8.3(1.7) 0.79(0.05) 1.2(1.1) 0.3(0.6) 0.08(0.17)
CQPCorr 7.7(1.9) 8.8(2.1) 0.81(0.05) 3.3(1.7) 0.4(0.6) 0.07(0.11)
3 AFT 3.2(2.4) 4.3(2.8) 0.65(0.08) 1.8(2.3) 5.7(9.0) 0.43(0.41)
Cox 5.0(2.9) 6.4(2.9) 0.72(0.09) 2.3(2.5) 1.7(1.8) 0.30(0.30)
CQR 1.8(1.4) 3.0(1.7) 0.62(0.06) 5.8(2.5) 105.0(39.2) 0.94(0.02)
KMW-LAD 4.0(1.3) 5.4(1.6) 0.71(0.05) 0.9(1.0) 0.2(0.4) 0.11(0.21)
CQPCorr 6.0(2.4) 7.7(2.6) 0.77(0.07) 2.4(1.9) 0.5(0.8) 0.09(0.15)
ρ = 0.5 1 AFT 11.2(1.4) 12.5(1.7) 0.84(0.06) 14.1(1.3) 142.9(165.7) 0.84(0.11)
Cox 11.6(1.2) 13.2(1.2) 0.90(0.04) 12.9(1.7) 29.8(29.6) 0.60(0.17)
CQR 4.7(1.6) 6.9(1.8) 0.74(0.06) 11.5(2.0) 133.0(33.1) 0.92(0.02)
KMW-LAD 10.6(1.8) 12.3(1.7) 0.90(0.05) 7.9(2.3) 2.3(1.6) 0.21(0.13)
CQPCorr 12.2(1.6) 13.8(1.5) 0.94(0.03) 10.9(2.0) 3.3(2.5) 0.21(0.12)
2 AFT 9.3(1.7) 10.2(1.5) 0.81(0.04) 9.4(2.7) 22.1(29.6) 0.50(0.29)
Cox 10.4(1.3) 11.4(1.7) 0.86(0.04) 9.9(1.9) 6.3(4.1) 0.35(0.13)
CQR 5.2(1.4) 7.1(1.5) 0.73(0.04) 9.6(2.1) 108.4(23.8) 0.91(0.02)
KMW-LAD 9.0(2.0) 9.9(1.8) 0.84(0.05) 5.6(2.5) 1.2(1.3) 0.17(0.17)
CQPCorr 10.4(1.7) 12.0(2.0) 0.89(0.05) 8.0(2.4) 1.6(1.2) 0.16(0.09)
3 AFT 7.0(2.1) 8.1(2.1) 0.77(0.06) 5.9(2.9) 17.1(20.7) 0.56(0.28)
Cox 9.3(1.5) 10.2(1.6) 0.84(0.05) 8.4(2.1) 8.0(13.2) 0.35(0.22)
CQR 4.5(1.6) 6.3(1.7) 0.70(0.05) 9.0(1.9) 105.8(44.7) 0.92(0.03)
KMW-LAD 8.7(1.9) 10.7(1.9) 0.86(0.06) 4.0(2.0) 0.8(1.0) 0.13(0.16)
CQPCorr 10.7(1.7) 12.2(1.9) 0.90(0.06) 7.5(2.4) 1.3(1.4) 0.14(0.11)
23
Table 2.2: Simulation results for setting C2 with the AR correlation structure. In each cell,
mean (sd) based on 200 replicates.
Error Method TP20 TP40 pAUC TP.FDR FP.FDR E.FDR
ρ = 0.3 1 AFT 9.5(1.6) 11.1(2.0) 0.82(0.06) 11.3(3.1) 67.6(64.0) 0.73(0.21)
Cox 8.8(1.6) 10.5(2.0) 0.85(0.05) 7.2(2.6) 5.1(7.6) 0.29(0.20)
CQR 3.0(1.6) 4.4(1.9) 0.67(0.05) 8.4(2.3) 122.4(44.7) 0.93(0.02)
KMW-LAD 6.2(1.8) 8.2(2.0) 0.80(0.06) 2.0(1.5) 1.0(1.2) 0.26(0.30)
CQPCorr 8.1(2.0) 9.8(2.0) 0.84(0.06) 3.9(2.3) 1.2(1.3) 0.17(0.19)
2 AFT 3.2(1.8) 4.8(2.4) 0.66(0.07) 1.4(1.9) 4.3(6.6) 0.45(0.43)
Cox 5.4(2.2) 6.9(2.5) 0.73(0.07) 2.3(2.3) 2.8(4.8) 0.36(0.38)
CQR 2.3(1.3) 3.5(1.6) 0.63(0.04) 6.1(2.1) 111.3(32.9) 0.94(0.02)
KMW-LAD 5.7(2.0) 7.4(2.4) 0.77(0.06) 1.5(2.3) 0.2(0.5) 0.04(0.12)
CQPCorr 7.2(2.4) 9.0(2.2) 0.81(0.06) 2.4(1.9) 0.1(0.4) 0.03(0.07)
3 AFT 1.5(1.4) 2.2(1.4) 0.58(0.06) 0.4(1.0) 2.7(6.2) 0.47(0.48)
Cox 3.9(2.3) 4.9(2.8) 0.69(0.09) 1.0(1.6) 1.5(2.6) 0.26(0.39)
CQR 2.2(1.2) 3.2(1.5) 0.62(0.04) 5.4(2.1) 105.2(38.0) 0.95(0.02)
KMW-LAD 4.2(1.4) 5.7(1.8) 0.73(0.06) 0.3(0.5) 0.1(0.2) 0.03(0.12)
CQPCorr 5.4(2.2) 7.2(2.3) 0.76(0.07) 1.2(1.4) 0.1(0.2) 0.01(0.06)
ρ = 0.5 1 AFT 11.9(1.4) 13.4(1.4) 0.88(0.05) 14.1(1.5) 86.6(100.4) 0.75(0.14)
Cox 12.4(1.5) 13.6(1.8) 0.92(0.04) 12.6(2.0) 11.6(13.6) 0.38(0.20)
CQR 5.0(2.0) 7.0(2.1) 0.73(0.06) 11.0(2.0) 138.2(40.5) 0.92(0.03)
KMW-LAD 10.9(1.8) 12.5(1.8) 0.91(0.05) 7.4(2.4) 1.9(1.8) 0.18(0.15)
CQPCorr 12.0(1.5) 13.8(1.5) 0.95(0.03) 10.1(2.5) 2.5(2.0) 0.17(0.12)
2 AFT 7.7(1.9) 9.1(2.0) 0.79(0.06) 7.3(3.4) 27.8(49.0) 0.53(0.27)
Cox 10.1(2.1) 11.3(2.1) 0.86(0.06) 8.1(3.4) 3.2(4.8) 0.20(0.20)
CQR 4.8(1.5) 6.4(2.0) 0.72(0.05) 9.9(2.0) 112.1(39.1) 0.91(0.03)
KMW-LAD 9.5(2.1) 11.6(2.1) 0.88(0.06) 5.8(2.3) 1.1(1.2) 0.14(0.15)
CQPCorr 11.2(2.0) 12.8(2.0) 0.91(0.05) 8.2(2.5) 1.4(1.3) 0.13(0.10)
3 AFT 5.0(3.1) 6.3(3.3) 0.72(0.10) 4.3(4.4) 12.1(17.4) 0.56(0.38)
Cox 6.9(2.7) 8.7(3.0) 0.80(0.08) 5.0(4.0) 5.0(11.3) 0.26(0.28)
CQR 3.9(1.5) 5.5(1.5) 0.70(0.04) 8.8(2.0) 110.5(36.4) 0.92(0.02)
KMW-LAD 8.5(2.0) 10.7(1.9) 0.85(0.05) 4.0(2.5) 1.0(1.3) 0.15(0.18)
CQPCorr 9.6(1.8) 11.2(2.3) 0.87(0.06) 5.8(3.0) 1.4(1.5) 0.15(0.13)
With target FDR 0.1, it can be seen that the proposed method performs better in
achieving the nominal FDR control and has the smallest estimated FDR under most settings.
Except KMW-LAD, the alternatives cannot control the FDR. For example, in Table 2.1
with ρ = 0.3 and Error 1, the proposed method has the estimated FDR 0.11, compared
to 0.78 (AFT), 0.49 (Cox), 0.93 (CQR), and 0.12 (KMW-LAD). Under the settings with a
weak correlation, the values of TP.FDR with the proposed method are relatively small due
to the limited sample size. We further examine the results for scenario C1 with ρ = 0.3
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and various values of sample size in Tables A.1-A.3 (Appendix). With a large enough
sample size, the proposed method is able to identify majority of the true positives with the
estimated FDR approximately being 0.1. The improvement of TP.FDR is also observed
when there is a stronger correlation (ρ = 0.5) even with a small sample size.
In addition, we conduct analysis on the simulated datasets under coefficient scenarios
C3-C5 with ρ = 0.5. Summary results are provided in A.4-A.6 (Appendix). It it can be seen
that all methods perform slightly worse under these three scenarios compared to scenario
C1. This may due to that the relative magnitudes of the interactions to main effects under
scenarios C3 and C4 are smaller, and the interaction and its corresponding main effects have
different directions under scenario C5. Similar to under the previous simulation scenarios,
the proposed method performs better than or comparable to the alternatives. For example
in Table A5 with Error 2 (Scenarios C4), the proposed method has TP20=7.6, compared
to 1.2 (AFT), 4.2 (Cox), 3.4 (CQR), and 7.2 (KMW-LAD). For settings C1 and C2, we
also examine other scenarios with G factors with banded correlation structure, E factors
with binary measurements, and higher censoring rate (35%). Detailed results are provided
in Appendix. Similar conclusions can be drawn for the G factors with banded correlation
structure. The performance of all methods decay when the datasets are with binary E
factors or a higher censoring rate, which is as expected. However, the proposed CQPCorr
still has superior or comparable performance. An advantage of quantile-based approaches
is that multiple quantiles can be potentially examined to generate a more comprehensive
picture. We analyze the simulated datasets under coefficient scenarios C1 with ρ = 0.5
using the proposed method and CQR with various values of τ , and present the summary
results in Table A.15 (Appendix). Slight differences across the results are observed. The
proposed method can achieve favorable performance with multiple quantiles.
Computational cost Simulation suggests that the proposed analysis is computationally
feasible. The analysis of 5000 interactions (along with the corresponding main effects) can
be accomplished within ten seconds using a laptop with standard configurations. Although
a large number of permutations may need to be computed, as they can be analyzed in a
highly parallel manner, the overall computational cost is still much affordable. For example,
for the 10,000 permutations, the analysis can be accomplished within 10 minutes using 100
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parallel jobs on our cluster. More parallel jobs can be conducted if less computational time
is desirable.
2.2.4 Data analysis
In the following, we analyze the TCGA data on lung adenocarcinoma (LUAD) and cuta-
neous melanoma (SKCM). With a high quality, TCGA provides an ideal testbed for new
analysis approaches. Although TCGA data have been analyzed in multiple published stud-
ies, as described in the first section, it is worthwhile re-examining data using the new robust
approach. We refer to the TCGA website for more information on the study design. Data
analyzed are downloaded from TCGA Provisional using the R package cgdsr.
Analysis of LUAD data
Lung cancer is the leading cause of cancer death globally, and adenocarcinoma of lung is
its most common histological type. In analysis, we focus on primary tumor samples of the
Whites. The prognosis response of interest is overall survival. Data are available for 262
subjects, among whom 93 died during followup. The survival times range from 0.13 to
238.11 months with median 20.65 months. The E factors analyzed include smoking pack
years (smoking), age, American Joint Committee on Cancer (AJCC) tumor pathologic stage
(stage), and gender, all of which have been suggested as potentially associated with lung
cancer prognosis (Westcott et al., 2015). Following the literature, here we take a loose
definition of E factors to also include clinical variables. For G factors, we analyze mRNA
gene expressions, which have been collected using the IlluminaHiseq RNAseq V2 platform.
A total of 20,189 measurements are available. As the number of relevant genes is not
expected to be large, we conduct a simple prescreening and select the top 2,000 genes with
the largest variances across all the samples for downstream analyses.
When applying the proposed approach, we compute p-values based on 10,000 permuta-
tions and use the FDR (false discovery rate) approach to identify important interactions.
With a target FDR of 0.1, 48 G-E interactions are identified, and the CQPCorr values are
shown in Table 2.3. Literature search suggests that the identified genes and interactions
may have important biological implications. For example, a negative correlation between
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survival and the AP3D1-Gender interaction is observed. Gene AP3D1 has been reported as
involved in fusions in lung cancer and overexpressed in lung adenocarcinoma in women com-
pared with men. Gene BPIFB1 (LPLUNC1) is a secretory protein that is predominantly
present in lung tissues and has been shown to be potentially relevant to lung carcinogenesis.
Gene CHEK2 is a cell cycle-control gene encoding a pluripotent kinase that can cause arrest
or apoptosis in response to DNA damage, and its mutations have been shown to be associ-
ated with an increased risk of lung cancer. CPSF4 has been found to play an important role
in regulating lung cancer cell proliferation and survival, and has been suggested as a po-
tential prognostic biomarker and therapeutic target for lung adenocarcinoma. Gene DKK1
has been observed to increase the migratory activity of mammalian cells and suggested as
a novel serologic and histochemical biomarker for lung adenocarcinoma. Published analysis
has also suggested that inhibition of gene PCSK9 induces apoptosis and inhibits prolif-
eration of lung adenocarcinoma cells via endoplasmic reticulum stress and mitochondrial
signaling pathways. WFS1 protein is expressed in various tissues but at higher levels in the
lung and has been found to probably contribute to the relationship of cigarette smoking
and lung cancer.
Data are also analyzed using the alternatives. The summary of comparison is presented
in the upper sub-table of Table A.16 (Appendix). When evaluating the differences in find-
ings, we use both the simple numbers of findings as well as the RV-coefficients (Smilde et al.,
2009), which measure the common information of two matrices of interactions, with a larger
value indicating a higher degree of similarity. The RV-coefficient can effectively account for
correlations of different genes and is a more objective and rigorous measure of overlap. More
detailed identification results of the alternative approaches are available from the authors.
Table A16 suggests that although there are overlapping identifications, the proposed ap-
proach identifies a different set of interactions. As the numbers of identifications identified
by different approaches are quite different, we also consider the top 40 interactions and
evaluate overlap. Note that because of ties, the numbers can be slightly off. The results are
shown in the lower sub-table of Table A.16 (Appendix). Again it is observed that although
there are overlaps, the proposed approach makes different findings. With practical data, it
is difficult to objectively evaluate identification accuracy. Here we evaluate the stability of
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findings, which may provide some insight into the analysis. Specifically, we compute the
observed occurrence index (OOI) (Huang and Ma, 2010), which lies between 0 and 1 and
can be roughly interpreted as the probability of an interaction being identified in random
samples and with a larger value indicating higher stability. For the interactions identified
using the FDR controlling procedure, we compute the OOI values. The proposed approach
has mean OOI (across the identified interactions) 0.41, compared to 0.26 (AFT), 0.34 (Cox),
0.18 (CQR), and 0.14 (KMW-LAD). The OOI values with proposed and alternative meth-
ods are all moderate, which has been also observed in the literature. This may due to the
more complex correlation structures, lower signal-to-noise ratios, higher censoring rates,
small sample size, and other factors in real datasets. However, the proposed method still
has slightly better stability, which provide support to a large extent to the superiority of
the proposed approach. More results and discussions on stability with simulated datasets
are provided in Appendix.
Analysis of SKCM data
The occurrence of skin cancer is rapidly increasing over the last decade, and cutaneous
melanoma is responsible for approximately 75% of all deaths from skin cancer. In anal-
ysis, we focus on metastatic samples of the Whites. Data are available for 225 subjects.
The prognosis response of interest is overall survival. Among the subjects, 93 died during
followup, with survival times ranging from 2.04 to 339.88 months (median 56.31 months).
For E variables, we consider Breslow thickness at diagnosis, Clark level, age, AJCC tumor
pathologic stage, and gender, all of which have been suggested in the literature. For G
variables, we consider gene expressions, for which 20,189 measurements are available. With
the same processing as above, 2,000 gene expressions are selected for downstream analysis.
The proposed approach identifies 80 G-E interactions with the FDR control. Details are
presented in Table 2.4. Most of the identified interactions are with Breslow thickness and
Clark level, which are the most important prognostic parameters in evaluating the primary
tumors (Dickson and Gershenwald, 2011). Published studies suggest potentially important
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Table 2.3: Analysis of the LUAD data using CQPCorr: identified G-E interactions.


















































implications of the findings. For example, gene GSN has been shown to be crucial for mi-
gration and invasion of melanoma cell lines, indicating its potential effects on cutaneous
melanoma. Gene NFKBIE has been suggested as a candidate oncogene in melanomas,
of which recurrent mutations have been found at several nearby hotspots in melanomas.
The expression levels of gene PEBP1 (RKIP) in melanoma cancer cell lines have been
found to be low relative to primary melanocytes, indicating its important role in melanoma
turmorgenesis. Gene PLD1 has been observed to be strongly expressed in primary and
metastatic melanomas, enhancing the activity of basal phospholipase D enzyme in a pro-
tein phosphorylation-independent manner in melanoma cells. Gene RNF144A has been
found to be specifically upregulated in melanocytes, which function to avoid uncontrolled
proliferation and to be a part of embryonic development, acting as cancer development mod-
ulators. Gene SSR2 exerts a prosurvival functionality in human melanoma cells, and high
expression levels of SSR2 have been observed to be associated with an unfavorable disease
outcome in primary melanoma patients. Gene TRPM2 is capable of inducing melanoma
apoptosis and necrosis and has been suggested as an important diagnostic and prognostic
marker for primary cutaneous melanoma.
Data are also analyzed using the alternatives. The summary comparison results are
shown in Table A.16 (Appendix). Both the FDR control results and (roughly) top forty lists
suggests that the proposed approach identifies interactions different from the alternatives.
Stability is also evaluated. For the proposed approach, the average OOI is 0.37, compared
to 0.26 (AFT), 0.28 (Cox), 0.19 (CQR), and 0.22 (KMW-LAD).
2.2.5 Discussion
The identification of G-E interactions is an important task in genetic epidemiology studies.
In this article, we focus on prognosis data. Prognosis is an essential endpoint in the study
of cancer, cardiovascular diseases, and many others. Different from most of the existing
studies, we have developed a novel approach which can accommodate long-tailed distribu-
tions/contamination in the prognosis response. The proposed approach has an intuitive
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Table 2.4: Analysis of the SKCM data using CQPCorr: identified G-E interactions.
















































































formulation and solid statistical basis and can more explicitly remove main G and E effects
so as to facilitate the analysis of interactions. By examining a wide spectrum of simulation
settings, we have shown that the proposed approach can outperform direct competitors. It
is interesting to note that it has more accurate identification than two robust approaches.
In the analysis of TCGA lung and skin cancer data, interactions different from using the
alternatives are identified. Literature search shows that the identified genes and interactions
have sound biological interpretations. In addition, the proposed approach has more stable
identifications.
The proposed approach conducts marginal analysis, which is more popular than joint
analysis in the current literature. The proposed approach can be potentially extended to
joint analysis. The formulations in the three steps may directly hold. However, with the
high dimensionality of joint analysis, the estimation demands regularization. This extension
is expected to be highly nontrivial and warrants a separate investigation. The proposed
method may not respect the “main effects, interactions” hierarchical constraint, which is
often explored in recent G-E interaction analysis (Liu et al., 2013; Wu et al., 2018). Under
this constraint, an interaction can be selected only if the corresponding main effects are also
selected. In (2.5), when the main E and G factors are not associated with the response,
the estimated η0, η1 and η2 in r
(1)
i can be approximately zero. Then no information is
removed from the response and the proposed CQPCorr can still work. Thus the identified
interactions are not necessary to have corresponding main effects. As our main interest is
to identify interactions, no specific attention is paid to the selection of main effects. More
studies on the identification of main effects and “main effects, interactions” hierarchy are
deferred to future investigation. In Step II, we adopt least square as it is computational
simpler. Data analysis demonstrates that the proposed method identifies biological sensi-
ble interactions with better stability. If needed, robust regression, such as quantile-based
method, can be adopted as in Step I. Besides KM estimator, it can be of interest to estimate
the conditional cumulative distribution function F (t|Xik, Zij) using other approaches, for
example the Cox model or AFT model. The weights so estimated may generate differ-
ent results. The details will be studied in the future. The proposed method can be also
extended to accommodate non-linear or nonparametric gene-environment interactions. In
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Steps I and II, the nonparametric models, such as the varying coefficients model, can be
adopted. In Step III, the censored quantile partial correlation can be developed based on
some correlations measuring nonlinear dependence, for example distance correlation. In
the study, we have focused on methodological development and numerical examination.
Theoretical study for robust methods under high-dimensional settings is still much limited
and will be postponed to future research.n numerical study, we set τ = 0.5 which is one of
the most popular choices in the literature, and generate satisfactory results. More exten-
sive numerical analysis with multiple τ may be of interest. For example, we can compare
the identified interactions across different τ to explore some interesting findings, such as
that some interactions are important across all τ , while some variables may be important
only for certain τ . In data analysis, significant differences across approaches are observed.
High-dimensional interaction identification can be more challenging than the identification
of main effects. Even in simulation (which has simpler settings), a few false positives are
observed. The significant differences observed in Table A.16 (Appendix) are at least partly
attributable to the potential false positives. In the literature, G-E interaction analysis for
lung and skin cancers is still limited. The sound biological implications of the identified
genes provides at least partial support to the validity of our analysis. This is further sup-
ported by the improved stability measured using OOI. More functional studies are needed
to confirm the findings.
2.3 Penalized Trimmed Estimation and Selection for Joint
Interaction Analysis
2.3.1 Introduction
Among successful approaches developed for detecting important G-E interactions associated
with the etiology, diagnosis and prognosis of many complex diseases, joint analysis has
attracted increasing interest. It can accommodate all genetic and environmental risk factors,
and their interactions in a single model, given that the biological processes are usually
dominated by the joint effects of multiple genetic changes. To facilitate the estimation and
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interpretation, the “main effects, interactions” hierarchical constraint is often imposed (Bien
et al., 2013; Wu et al., 2018), where an interaction can be identified only if its corresponding
main effects are also identified. Compared to marginal analysis, there are more challenges
in joint analysis due to the high dimensionality of genomic measurements and hierarchical
constraint (Chai et al., 2017).
Despite many advantages, most of the existing interaction analysis approaches have the
limitation of nonrobustness. They usually assume that data have no outliers/contaminations.
However, in practice, outliers/data contaminations are not uncommon in both predictor
and response spaces (Osborne and Overbay, 2004), which are known as leverage points and
vertical outliers. More specifically, for some types of G factors, such as gene expression,
outliers/contaminations may occur because of technical problems in profiling, human errors
and genetic abnormalities (Li and Wong, 2001). For the disease-related clinical response
(for example, Breslow’s depth for skin cutaneous melanoma), outliers/contaminations can
be caused by errors in data collection and recording and inadvertently incorrect sampling.
In addition, sometimes there are extremely long or short survivals in prognosis studies due
to the mistakes in death records as well as misclassification in the cause of death. In Figure
2.2, we show the distributions of some G factors and Breslow’s depth for the SKCM (skin
cutaneous melanoma) data collected by TCGA (The Cancer Genome Atlas), where both
leverage points and vertical outliers are clearly observed. More information on this data is
available in the data analysis section of this article. For nonrobust approaches, it has been
shown that these outliers can lead to biased estimation and false marker identification. Re-
cently, a few approaches have been developed for robust G-E interaction analysis, including
those based on quantile regression (Wang et al., 2017) or correlation (Xu et al., 2019), least
absolute deviation (LAD) loss (Wu et al., 2018), rank-based loss function (Wu et al., 2015),
and others. However, these approaches are only robust to outliers in response but cannot
accommodate leverage points in predictor space. The interaction studies on both vertical
outliers and leverage points are still much limited (Wu and Ma, 2019).
In this Section, we develop a joint model respecting the “main effects, interactions”
hierarchical structure for G-E interaction analysis. The unique characteristic of this study
is accommodating outliers/contaminations in both predictor and response spaces. The
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Figure 2.2: Analysis of SKCM data: the distributions of some G factors and the Breslow’s
depth.
proposed approach is built on the robust trimmed regression technique, which can accom-
modate many types of data, such as continuous biomarkers and censored survival times.
It significantly differs from least absolute deviation regression and other robust approaches
which only have robustness property towards vertical outliers. Our study extends the
traditional trimmed regression to interaction analysis and develops the “coefficient decom-
position+penalization” framework for hierarchical selection, which may have independent
methodological value. Advanced from the existing trimmed regression approaches which
are usually built with the predefined size of trimmed set, we propose a more flexible data-
driven process to determine the number of outliers, leading to satisfactory efficiency and
robustness. In addition, a stability selection strategy is adopted to more accurately select
the trimmed subject set. Overall, this study provides a practically useful new venue for
G-E interaction analysis.
2.3.2 Methods
For a subject, let y be the response of interest, which can be a continuous marker, categor-
ical disease status, or survival time. Let z = (z1, · · · , zq) be the q environmental/clinical
variables and x = (x1, · · · , xp) be the p genetic variables. We consider the joint regression
35
model with all G and E effects and their interactions,
E(y; z,x) = φ
(






where φ is the known link function, E(·) denotes expectation, α0 is the intercept, α =
(α1, · · · , αq)′, β = (β1, · · · , βp)′ and ηk = (ηk1, · · · , ηkp)′ , k = 1, · · · , q are the regression
coefficients for main E factors, main G factors and their interactions, respectively, and
w(k) = (zkx1, · · · , zkxp).
We assume n independent subjects and use the subscript “i” to denote the ith subject.
Denote the design matrices of E and G variables as Zn×q andXn×p, and the response vector
as yn×1. Under model (2.7), the unknown parameters θ =
(
α0,α
′,β′,η′1, · · · ,η′q
)′
can be







with the deviance li (θ), which are usually not robust to vertical outliers or leverage points.
Robust trimmed estimation and selection
Instead of using the negative log-likelihood function directly, we propose the following robust





li (θ) , (2.8)
where S is an outlier-free subset of {1, 2, · · · , n} and |S| denotes the cardinality of set S.
We first consider the most popular linear regression model,


















where εi is the random error.
Let r = (r1, · · · , rn)′, then S is defined as
S = {1 ≤ i ≤ n : |ri −median(r)| < µ MAD(r)}, (2.10)
where median(r) and MAD(r) are the median and median absolute deviation of vector r
adjusted by a factor 1.4826, and µ > 0 is a tuning parameter.
The penalization is adopted for regularized estimation and variable selection, which has
been a popular choice in several recent studies. For respecting “main effects, interactions”
hierarchy, the coefficient for the interaction term ηk is decomposed as ηk = β  γk, where
 represents the component-wise multiplication. Then, the following robust penalized ob-






















ρ(|γkj |;λ2, ξ), (2.11)







dx is the minimax concave penalty (MCP) (Zhang
et al., 2010), λ1 and λ2 are data-dependent tuning parameters, and ξ is the regularization
parameter. The proposed estimate θ̂ is defined as the minimizer of (2.11) with the optimal
subset Ŝ. The nonzero components of β̂ and β̂  γ̂k(k = 1, · · · q) are regarded as the
important main G effects and interactions that are associated with the response.
The proposed approach is motivated by the following considerations. As opposed to the
nonrobust squared loss, the robust trimmed squared loss is adopted in (2.11) based on a
subset S of subjects. The definition of S in (2.10) can exclude those subjects with extreme
absolute residuals due to the deviated values in the spaces of predictors and/or response.
It significantly advances from the existing robust G-E interaction analyses (Wang et al.,
2017; Wu et al., 2018, 2015) which can only accommodate outliers in response but not in
predictors. Besides, the robust measures of central location (median) and scale (MAD) are
adopted in S, leading to more accurate detection of the number of outliers. Different from
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the existing studies on the least trimmed squares estimator (Alfons et al., 2013; Kurnaz
et al., 2018) where the size of S is predefined, the proposed approach determines the value
of |S| based on the residuals themselves and data-driven parameter µ. The identification of
S becomes more flexible to achieve sufficiently high efficiency for the dataset without out-
liers and satisfactory robustness against data contamination. When µ is large enough, the
proposed approach is reduced to the squared loss. In addition, motivated by the pairwise
interaction analysis with strong hierarchal constraint developed in Choi et al. (2010), we
adopt the decomposition ηk = β γk so that if an interaction term is selected (βjγkj 6= 0),
the corresponding main genetic effect must also be selected (βj 6= 0). The MCP penalty is
then imposed on βj and γkj for variable selection given its satisfactory statistical and numer-
ical properties. Here, E factors are not subject to penalized selection and always included in
the model as they are usually pre-selected by clinical evidences and with low dimensionality.
This decomposition framework for respecting hierarchical G-E interaction structure has the
advantage of lucid interpretation and a less complex computational algorithm.
We also modify li (θ) to accommodate other types of response variables. For example, for
the right-censored survival response with observed logarithm survival time y and censoring
indicator δ, we consider the weighted squared loss under the accelerated failure time (AFT)
model,
li (θ) = wi
(














where the data {(xi, zi, yi, δi), i = 1, . . . , n} have been sorted by yi in ascending order, and
the weight wi is the Kaplan-Meier (KM) estimator defined as w1 =
δ1










i = 2, · · · , n. This weighted approach has been adopted in many published studies due
to its considerably low computational cost and good statistical properties (Huang et al.,
2006). Using the subjects with nonzero weights and their corresponding r
(w)
i , the proposed
approach can then proceed in the same manner. For categorical and count data under
generalized linear model, a similar weighted squared loss can be conducted based on the
Taylor series expansion. In numerical study, we examine both continuous data under the
linear regression model and survival data under the AFT model.
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Algorithm
A modified C-steps algorithm is developed to obtain the optimal subset Ŝ and corresponding
estimation θ̂, which is motivated by the stability selection (Meinshausen and Bühlmann,
2010). We present the proposed algorithm in Algorithm 1. In this algorithm, the most
challenging step is the optimization of the objective function (2.11) given the outlier-free
subset S. In Algorithm 2, we adopt an iterative coordinate descent (CD) algorithm, which
optimizes Lp (θ;Z,X,y,S) with respect to one parameter at a time and iteratively cycles
through all parameters until convergence. Denote yS as the components of y indexed by S
and XS as the rows of X indexed by S.
Algorithm 1: Robust trimmed estimation and selection
Step 1: For t = 1, · · · , T ,
Step 1.1 Set m = 0. Draw q + 10 observations from the dataset at random as the





Step 1.2 Set m = m+ 1. Compute











1 ≤ i ≤ n :
























Step 1.4 Return the subset S(t,mstop) of the subjects selected at the stopping iteration
mstop.















where I(·) is the indicator function and τ ∈ (0, 1) is a tuning parameter.






Algorithm 2: Iterative coordinate descent (CD) algorithm













k = 0, where we denote b as the index of iteration.























ρ(|βj |;λ1, ξ). (2.12)



































































where ST(ν, λ1) = sgn(ν)(|ν| − λ1)+ is the soft-thresholding operator.
Step 3 With α0, α and β fixed at α
(b−1)
0 , α
(b−1) and β(b), optimize (2.11) with respect



















































































Different from the original C-steps algorithm which conducts a sufficiently large number
of initial subsampling (500 adopted in Alfons et al. (2013); Kurnaz et al. (2018)) and
returns the results with the smallest objective function, the proposed algorithm identifies the
optimal outlier-free subset based on the stability selection. With stability selection, we do
not simply select one model which may not be optimal with insufficient initializations. The
subset selection depends on the whole process where the outliers have smaller probability to
be included, leading to more accurate detection and the lower requirement for a large number
of initializations. In our numerical study, we set T = 50, which generates satisfactory result.
Another advantage of the proposed algorithm is in Step 3 of Algorithm 2. Due to the
decomposition ηkj = βjγkj , we only need to update γkj when βj 6= 0, dramatically reducing
the searching space and computational cost. Both algorithms are guaranteed to converge
as the value of the objective function (2.11) decreases at each step. It is observed that
convergence is achieved in a small to moderate number of iterations in both simulation and
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case study. For a simulated dataset with q = 5, p = 1000 and n = 250, the analysis with
T = 50 takes about five minutes using a laptop with standard configurations.
Tuning parameters We set µ = 2.5 in our numerical studies based on the 99.5% quantile
of the standard normal distribution, motivated by that 1% of the observations are expected
to be outliers for the normal distribution. For simulation scenarios with continuous G
factors and AR structure under linear model (see the next section for details), we further
examine the outlier detection results (as a function of µ) to better comprehend the effects
of µ. In Table A.17, two specific measures are considered, including true positive (TP) and
false positive outliers (FP). For the five different error distributions, a larger µ detects fewer
false positives but also fewer true positives. On the other hand, a smaller µ produces more
true positives as well as more false positives. When µ = 2.5, it is observed to be able to
effectively control the false positives and have satisfactory performance on the detection of
true positives. As suggested by Meinshausen and Bühlmann (2010), the stability selection
results are not sensitive to the threshold value τ in a range of (0.6, 0.9). In our numerical
studies, we set τ = 0.6. For the regularization parameter ξ in the MCP penalties, we
follow the published studies (Shi et al., 2014) and set ξ = 6. A grid search is conducted to
choose the values of (λ1, λ2) of the MCP penalties using BIC criterion with model size as
the degrees of freedom.
2.3.3 Simulation
We assess the performance of the proposed analysis with extensive simulations. A total of
forty simulation scenarios are considered. Under all scenarios, we set q = 5 and p = 1, 000.
There are thus a total of 1,005 main effects and 5,000 interactions. (a) Two types of G
factors are considered, mimicking continuous gene expression and categorical SNP data,
respectively. The continuous G variables are generated from a multivariate normal dis-
tribution with marginal means 0 and marginal variances 1. We consider two correlation
structures. The first is an AR (auto-regressive) structure where the correlation between
the jth and kth G variables is 0.3|j−k|. The second is a Band (banded) structure where
the correlation between jth and kth G variables is 0.33 if |j − k| = 1 and 0 otherwise.
For the discrete G variables, we further dichotomize the above continuous variables at the
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1st and 3rd quartiles and generate 3-level measurements (0, 1, 2). (b) There are three con-
tinuous and two binary E factors, where the three continuous ones are simulated from a
multivariate normal distribution with marginal means 0 and the AR structure as mentioned
above, and the two binary ones are simulated from a binomial distribution with a success
probability of 0.6. (c) All E factors, eight main G factors and fourteen G-E interactions are
assumed to have nonzero coefficients randomly generated from Uniform(0.6, 1), where the
strong hierarchy is satisfied. The rest coefficients are zero. (d) We consider two types of
response variables and models. The first is a continuous response under the linear model
(2.9). The second is the censored survival data under the AFT model, where the observed
logarithm survival times are generated based on model (2.9), and the censoring times gen-
erated from an exponential distribution with the parameter adjusted so that the censoring
rate is around 20%. (e) Five types of data contaminations are considered. The first three
ones have no outliers in predictors. The first one (D1) has error distribution N(0, 1) which
is also without outliers in response. The second (D2) and third (D3) ones have error distri-
bution 90%N(0, 1) + 10%Cauchy(0, 5) and 90%N(0, 1) + 10%N(20, 1), where outliers exist
in response. The fourth (D4) and fifth (D5) ones are assumed to contain leverage points.
Specifically, for dataset with continuous G factors, 2% and 8% of the subjects have G fac-
tor measurements added by 20 and N(0, 2), respectively. For dataset with categorical G
factors, 10% of the subjects are re-generated from a multinomial distribution with prob-
ability (0.5, 0.3, 0.2) for (0, 1, 2). The error distributions for D4 and D5 are N(0, 1) and
90%N(0, 1) + 10%Cauchy(0, 5). Thus, D4 only has outliers in predictors, while D5 has
outliers in both predictor and response spaces. (f) We set the sample size n = 250 and
n = 300 for the continuous and survival responses, respectively.
Besides the proposed approach (referred to as “LTS-MCP-Hier”), the following alter-
natives for joint analysis are also considered. The first four approaches conduct variable
selection on all G factors and G-E interactions directly, without considering the hierarchical
structure. LS-MCP is based on the nonrobust squared loss function and MCP penalty,
implemented by the R package ncvreg. LAD-LASSO consists of the robust least absolute
deviations and LASSO penalty which has robustness property towards vertical outliers. It
is realized using the R package quantreg. RLARS is the robust least angle regression with
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robust correlation measure for variable selection (Khan et al., 2007) and is realized using
the R package robustHD. It has been demonstrated to be robust to both vertical outliers
and leverage points. LTS-MCP is similar to the proposed, except that the hierarchical
structure is not reinforced and the original C-steps algorithm is used instead of stability
selection. The last one is LS-MCP-Hier, which has the same modeling framework as the
proposed, except that the nonrobust squared loss function is adopted. The above alterna-
tive approaches cover different types of G-E interaction analyses and can comprehensively
evaluate the merits of the proposed approach. They are chosen due to their popularity and
competitive performance among the existing approaches.
For each approach, we evaluate the identification performance for main effects (M) and
interactions (I) separately, by the number of true positives M:TP and I:TP and the number
of false positives M:FP and I:FP. In addition, the root of the sum squared error ||θ̂ − θ0||2
(RSSE) is used to assess the estimation accuracy, where θ̂ and θ0 are the estimated and
true values of θ. We also examine the prediction performance using an independent testing
set with 100 subjects under the same simulation scenarios. We adopt the prediction mean
squared error (PMSE) for continuous outcome and C-statistic (Cstat) for survival outcome.
The C-statistic quantifies the overall adequacy of risk prediction for censored survival data
based on the time-integrated AUC (area under curve), where a larger value indicates better
prediction (Uno et al., 2011).
For each scenario, 200 replicates are simulated, and summary statistics (mean and stan-
dard deviation) are computed. Summary results for the scenarios with continuous G factors
and AR structure under linear and AFT models are shown in Tables 2.5 and 2.6, respec-
tively. The rest of the results are provided in Appendix. The proposed LTS-MCP-Hier is
observed to have competitive performance under all simulation scenarios. For the dataset
without contamination (D1), the proposed approach can achieve satisfactory efficiency that
is comparable to the nonrobust LS-MCP-Hier, and outperforms the robust alternatives and
even nonrobust LS-MCP. The majority of true positives are identified by the proposed
approach while with a small number of false positives. The advantage of the proposed
approach over the alternatives becomes prominent for the datasets with different types of
contaminations. For example, for the scenario with outliers in predictors (D4) under lin-
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ear model (Table 2.5), the proposed approach has (M:TP, M:FP, I:TP, I:FP)=(7.4, 3.8,
11.1, 2.7), compared to (1.4, 22.6, 3.1, 68.0), (4.1, 4.0, 4.2, 13.4), (7.2, 0.7, 6.9, 11.6), (6.2,
7.9, 10.0, 30.1), and (5.4, 54.5, 3.9, 5.4) for LS-MCP, LAD-LASSO, RLARS, LTS-MCP
and LS-MCP-Hier, respectively. The superior identification performance of the proposed
approach over LAD-LASSO and RLARS provides a strong support to the proposed trim-
ming strategy for accommodating outliers. In addition, it performs better than LTS-MCP,
which suggests that the “coefficient decomposition” and stability selection framework can
improve the identification of both main effects and interactions. The proposed approach
also behaves better in terms of estimation and prediction. For example, for the scenario
with contamination type D2 under AFT model (Table 2.6), the proposed approach has
(ESSE, Cstat)=(2.71, 0.89), compared to (46.11, 0.55), (4.11, 0.74), (4.83,0.73), (3.71,0.82),
and (59.00,0.58) for LS-MCP, LAD-LASSO, RLARS, LTS-MCP and LS-MCP-Hier, respec-
tively. For the datasets with categorical G variables, the similar pattern is observed that
the proposed approach demonstrates superior or comparable performance compared to five
alternatives in identification, estimation and prediction accuracy.
In practical genetic interaction analyses, the important interactions may have different
magnitude of signals, including those with weak but nonzero effects (Gao et al., 2017). To
be thorough, we also examine the scenarios with both moderately large and weak effects.
Specifically, we consider data with continuously distributed G factors and AR correlation
structure, and with a continuous outcome under the linear regression model. The simulation
settings for coefficients are similar to those in (c) as mentioned above. One different is that
seven of the fourteen important interactions are with weaker signals equal to 0.2. Results
with five types of data contaminations are shown in Table A.24. It can be seen that the
performance of all approaches decay compared to those in Table 2.5. However, the proposed
approach is again observed to have favorable performance. For example, under the scenario
with D4, the values of (I:TP, I:FP) for interactions are (7.7, 1.4) (proposed), (2.3, 69.4)
(LS-MCP), (3.2, 14.2) (LAD-LASSO), (5.0, 10.1) (RLARS), (7.2, 27.0) (LTS-MCP), and
(3.7, 5.1) (LS-MCP-Hier).
In the interaction analysis literature, it has been suggested that there may exist im-
portant interactions in the absence of the corresponding main effects (Thomas, 2010). For
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Table 2.5: Summary results under simulation scenarios with continuous G factors and AR
structure under linear model. In each cell, mean (sd) based on 200 replicates.
M:TP M:FP I:TP I:FP RSSE PMSE
D1: N(0, 1)
LTS-MCP-Hier 7.8(0.4) 0.6(1.6) 12.7(1.9) 0.7(0.8) 2.15(0.49) 0.99(0.43)
LS-MCP 5.7(0.9) 3.0(3.5) 10.8(0.9) 10.7(10.7) 2.80(0.41) 1.29(0.56)
LAD-Lasso 8.0(0.0) 10.6(5.6) 13.3(1.2) 28.0(11.4) 1.68(0.33) 1.35(0.45)
RLARS 7.5(0.6) 0.5(0.8) 7.3(1.9) 12.5(8.2) 3.27(0.42) 2.51(0.91)
LTS-MCP 6.4(0.9) 6.9(2.8) 11.0(1.1) 26.4(7.4) 2.39(0.53) 1.23(0.28)
LS-MCP-Hier 8.0(0.0) 0.3(1.2) 13.0(1.0) 0.4(0.6) 1.70(0.30) 0.80(0.18)
D2: 0.9N(0, 1) + 0.1Cauchy(0, 5)
LTS-MCP-Hier 7.9(0.3) 0.6(1.8) 12.0(1.5) 0.9(0.9) 2.12(0.38) 1.12(0.34)
LS-MCP 2.2(1.8) 18.0(8.0) 2.7(2.6) 71.0(10.6) 30.42(40.46) 555.38(1853.39)
LAD-Lasso 7.8(0.5) 2.2(1.5) 7.6(2.3) 7.0(3.3) 3.01(0.36) 3.85(1.23)
RLARS 7.2(0.7) 0.7(1.0) 5.7(1.8) 11.0(5.7) 3.68(0.41) 3.55(1.24)
LTS-MCP 6.2(1.1) 7.8(3.3) 10.6(1.3) 30.9(9.7) 2.55(0.55) 1.18(0.32)
LS-MCP-Hier 5.8(1.5) 151.3(125.9) 2.6(3.4) 25.6(59.8) 28.80(42.28) 1351.47(5973.38)
D3: 0.9N(0, 1) + 0.1N(20, 1)
LTS-MCP-Hier 7.9(0.3) 0.6(1.8) 12.0(1.6) 0.9(0.8) 2.01(0.41) 1.03(0.40)
LS-MCP 2.9(1.2) 24.3(4.7) 3.1(1.4) 66.2(5.5) 9.82(0.68) 32.66(6.95)
LAD-Lasso 7.5(0.7) 2.6(1.7) 6.1(2.3) 8.2(3.2) 3.29(0.33) 4.68(1.46)
RLARS 6.3(1.0) 1.4(1.5) 3.8(1.7) 11.7(5.8) 4.25(0.48) 5.23(1.79)
LTS-MCP 6.4(1.0) 7.6(3.0) 10.9(1.1) 28.3(6.2) 2.44(0.53) 1.09(0.27)
LS-MCP-Hier 6.5(0.9) 94.1(5.9) 2.4(1.5) 5.8(5.6) 8.81(0.64) 33.23(7.21)
D4: N(0, 1) and with leverage points
LTS-MCP-Hier 7.4(1.0) 3.8(8.0) 11.1(3.1) 2.7(2.1) 2.12(0.79) 1.08(2.02)
LS-MCP 1.4(0.9) 22.6(5.1) 3.1(2.0) 68.0(6.4) 7.38(1.03) 19.15(6.64)
LAD-Lasso 4.1(1.3) 4.0(2.4) 4.2(2.2) 13.4(3.6) 3.99(0.35) 9.27(2.47)
RLARS 7.2(0.8) 0.7(1.2) 6.9(2.0) 11.6(7.1) 3.42(0.34) 2.92(0.91)
LTS-MCP 6.2(1.2) 7.9(3.6) 10.0(1.3) 30.1(9.2) 2.47(0.60) 2.43(0.40)
LS-MCP-Hier 5.4(1.5) 54.5(37.3) 3.9(3.2) 5.4(3.1) 5.52(1.39) 14.61(9.16)
D5: 0.9N(0, 1) + 0.1Cauchy(0, 5) and with leverage points
LTS-MCP-Hier 7.7(0.7) 3.4(8.4) 10.6(2.6) 2.3(2.3) 2.20(0.75) 1.02(1.77)
LS-MCP 0.7(0.7) 18.0(8.9) 1.5(1.4) 69.3(17.5) 25.80(32.38) 271.98(796.53)
LAD-Lasso 3.8(1.4) 4.0(1.9) 4.0(2.0) 12.5(3.5) 4.02(0.36) 9.20(2.59)
RLARS 6.8(0.9) 0.9(1.2) 5.6(2.0) 11.4(6.8) 3.79(0.42) 3.77(1.04)
LTS-MCP 6.3(1.1) 8.6(3.9) 10.8(1.2) 31.9(10.1) 2.47(0.57) 2.05(0.32)
LS-MCP-Hier 4.5(1.5) 152.6(99.4) 1.0(1.6) 24.6(62.0) 27.97(39.71) 1088.91(4898.79)
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Table 2.6: Summary results under simulation scenarios with continuous G factors and AR
structure under AFT model. In each cell, mean (sd) based on 200 replicates.
M:TP M:FP I:TP I:FP RSSE Cstat
D1: N(0, 1)
LTS-MCP-Hier 7.8(0.5) 5.6(9.6) 11.0(2.7) 0.9(1.1) 2.48(0.52) 0.90(0.03)
LS-MCP 6.3(1.1) 12.3(4.8) 11.3(1.2) 38.3(9.6) 2.39(0.66) 0.92(0.02)
LAD-Lasso 7.5(0.8) 15.5(8.1) 8.4(3.9) 36.5(15.7) 3.06(0.59) 0.85(0.05)
RLARS 7.3(0.7) 10.3(3.8) 3.2(1.6) 21.8(4.3) 4.22(0.35) 0.78(0.04)
LTS-MCP 6.0(1.0) 14.8(4.9) 6.4(1.8) 57.4(10.4) 3.37(0.34) 0.85(0.04)
LS-MCP-Hier 8.0(0.2) 1.0(1.9) 12.1(1.5) 0.6(0.8) 1.94(0.34) 0.92(0.02)
D2: 0.9N(0, 1) + 0.1Cauchy(0, 5)
LTS-MCP-Hier 7.7(0.5) 5.5(4.1) 9.1(2.8) 1.3(1.1) 2.71(0.58) 0.89(0.03)
LS-MCP 1.2(1.4) 13.9(8.6) 1.1(1.4) 59.6(10.7) 46.11(87.78) 0.55(0.07)
LAD-Lasso 5.8(1.7) 4.6(2.1) 1.7(1.3) 12.0(3.4) 4.11(0.40) 0.74(0.07)
RLARS 6.3(1.6) 7.6(4.9) 1.6(1.3) 22.9(6.3) 4.83(0.68) 0.73(0.06)
LTS-MCP 6.0(1.0) 15.4(4.0) 5.5(1.8) 59.7(5.5) 3.71(0.33) 0.82(0.03)
LS-MCP-Hier 5.4(1.5) 196.6(162.2) 2.0(2.4) 70.9(223.4) 59.00(119.77) 0.58(0.07)
D3: 0.9N(0, 1) + 0.1N(20, 1)
LTS-MCP-Hier 8.0(0.2) 2.2(4.8) 11.9(1.6) 0.9(0.9) 2.01(0.38) 0.92(0.01)
LS-MCP 2.5(1.1) 24.6(4.9) 2.4(1.4) 72.2(6.1) 10.72(0.71) 0.64(0.04)
LAD-Lasso 6.6(1.2) 3.9(2.2) 2.7(1.6) 11.1(3.3) 3.79(0.28) 0.78(0.04)
RLARS 6.4(1.0) 4.2(3.2) 1.4(1.1) 12.4(6.3) 4.41(0.42) 0.78(0.04)
LTS-MCP 6.1(1.0) 11.4(4.1) 9.0(1.7) 48.9(10.3) 2.95(0.49) 0.89(0.02)
LS-MCP-Hier 5.8(1.1) 100.5(7.8) 2.5(1.5) 8.3(7.2) 9.75(0.56) 0.66(0.03)
D4: N(0, 1) and with leverage points
LTS-MCP-Hier 7.1(1.0) 10.9(14.7) 9.0(4.0) 1.2(1.2) 3.18(0.83) 0.84(0.07)
LS-MCP 3.4(1.1) 14.7(4.5) 4.9(2.1) 52.7(6.5) 4.89(0.60) 0.75(0.05)
LAD-Lasso 6.1(1.2) 7.2(5.0) 3.4(2.0) 17.8(11.8) 3.88(0.31) 0.77(0.04)
RLARS 7.0(0.8) 11.9(3.6) 2.6(1.4) 21.5(4.5) 4.37(0.36) 0.77(0.04)
LTS-MCP 5.5(1.3) 17.0(4.0) 5.2(1.8) 61.4(6.0) 3.77(0.42) 0.81(0.04)
LS-MCP-Hier 6.4(1.0) 42.4(24.3) 4.6(2.5) 2.9(2.1) 4.08(0.66) 0.78(0.05)
D5: 0.9N(0, 1) + 0.1Cauchy(0, 5) and with leverage points
LTS-MCP-Hier 7.1(1.1) 12.9(14.1) 9.3(3.9) 1.5(1.4) 3.08(0.81) 0.85(0.07)
LS-MCP 1.1(1.1) 12.6(7.8) 1.3(1.3) 56.3(9.8) 35.96(69.84) 0.56(0.06)
LAD-Lasso 5.7(1.5) 4.3(2.3) 2.0(1.5) 12.2(3.4) 4.12(0.36) 0.74(0.06)
RLARS 6.5(1.4) 8.8(4.6) 2.2(1.5) 21.6(6.4) 4.79(1.30) 0.74(0.06)
LTS-MCP 5.7(1.1) 16.1(4.2) 5.1(2.0) 60.4(4.6) 3.77(0.37) 0.81(0.04)
LS-MCP-Hier 5.1(1.6) 174.4(158.2) 2.4(2.6) 67.4(229.7) 54.36(131.61) 0.57(0.07)
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comprehensive consideration, we conduct another analysis on scenarios where the “main
effects, interactions” hierarchy is violated for some interactions. Specifically, data with
continuous G factors, AR correlation structure, and a continuous response are generated.
Besides the fourteen nonzero G-E interactions as described above, six additional nonzero
interactions are considered without the corresponding main G effects. As shown in Table
A.25, the proposed approach performs slightly worse than LTS-MCP which is similar to
the proposed but does not reinforce the hierarchy. However, it still outperforms other alter-
natives, including two nonrobust approaches LS-MCP and LS-MCP-Hier, and two robust
ones LAD-Lasso and RLARS which do not respect the hierarchy and may be favored here.
2.3.4 Data Analysis
The Cancer Genome Altas provides comprehensive profiling data in various cancer types.
With high quality and public availability, the TCGA data have contributed to thousands of
genetic studies and serve us as an ideal testbed. In this section, we analyze TCGA data on
skin cutaneous melanoma (SKCM) and breast invasive carcinoma (BRCA). The processed
level 3 data are considered which can be downloaded from TCGA Provisional using the R
package cgdsr.
Skin Cutaneous Melanoma (SKCM) Data
Cutaneous melanoma, the most dangerous type of skin cancer, has been demonstrated to
account for approximately 75% of all deaths from skin cancer. The response of interest is
the continuous (log2-transformed) Breslow’s depth, which is analyzed using a linear model.
It describes the thickness of the tumor, which is considered as one of the most significant
factors in predicting progression of melanoma (Breslow, 1970). For E variables, we include
age, American Joint Committee on Cancer (AJCC) tumor pathologic stage, gender, and
Clark level. For G variables, we consider mRNA gene expressions, which are collected using
the IlluminaHiseq RNAseq V2 platform and have been lowess-normalized, log-transformed,
and median centered. There are 298 subjects available with 18,355 measurements of gene
expressions. We conduct a simple prescreening as the number of cancer-related genes is not
expected to be large, which selects the top 2,000 genes with the largest variances across all
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the samples for downstream analyses.
The estimated coefficients with the proposed approach are listed in Table 2.7. Compared
to age and gender, stage and Clark level are more relevant to the Breslow’s depth, which
is consistent with the literature. The proposed approach identifies a total of 43 important
genes and 26 G-E interactions associated with Breslow’s depth. Existing literature shows
potentially useful implications of our findings. For instance, gene FGFR3 has been shown
to deactivate the malignant transformation as a tumor suppressor in melanoma cancer
cells. An increased expression of antigen from gene FMR1NB has been found in melanoma
stem cells, which may be a cause of treatment failure. Gene LAMP1 has been observed to
express on the surface of metastatic melanoma cells, and its downregulation could reduce
lung metastasis. Gene SPRR1A has been found to express dramatically higher levels in thin
melanomas. In addition, gene SPRR2G has been characterized as keratinocyte-associated
and has been found to have decreased expression in the primary melanoma. Gene S100A7,
known as psoriasin, has been observed to significantly over-express in human epithelial skin
tumors, as well as in breast and bladder cancer.
We also analyze the data using the alternatives, and the comparison results are sum-
marized in Table A.26. The numbers of overlapping identifications of main effects and in-
teractions are presented, respectively, along with the corresponding RV-coefficients (Smilde
et al., 2009). The RV-coefficient evaluates the similarity of two data matrices with a larger
value indicating a higher degree of similarity. It is observed that significantly different
sets of main effects and interactions are found by different approaches with moderate RV-
coefficients. LS-MCP, LAD-LASSO, RLARS and LTS-MCP, which do not reinforce the
hierarchical structure, identify much smaller number of main effects compared to that of
interactions. Both LTS-MCP-Hier and LS-MCP-Hier identify a moderate number of main
effects and interactions.
To provide an indirect support to the identification analysis, we evaluate the prediction
accuracy using PMSE based on 200 times resampling (9/10 training subjects and 1/10
testing subjects), which has also been adopted in the literature. The proposed approach
is observed to have the best prediction performance with PMSE=0.26, compared to 1.01
(LS-MCP), 0.32 (LAD-LASSO), 0.49 (RLARS), 0.87 (LTS-MCP) and 0.58 (LS-MCP-Hier).
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We also examine the selection stability by calculating the observed occurrence index (OOI)
(Huang et al., 2006). Using the same resampling strategy, the OOI measures the identified
probability for each main effect or interaction, where a larger value indicates better stability
in identification among random samples. The mean OOI of the identified main effect and
interactions using the proposed approach is 0.85, compared to 0.32 (LS-MCP), 0.81 (LAD-
LASSO), 0.50 (RLARS), 0.10 (LTS-MCP) and 0.81 (LS-MCP-Hier), suggesting satisfactory
stability of the proposed approach.
Breast Invasive Carcinoma (BRCA) Data
Breast cancer is the second cause of cancer death among female, which can be influenced
by a number of environmental and genetic factors (Shipitsin et al., 2007). The response
of interest is the censored survival time, which is analyzed based on AFT model. In this
section, we focus on the female Whites with primary tumor. Data are available on 353
subjects, with 60 deaths during the follow-up period. For E variables, we include age,
AJCC tumor pathologic stage, ER status (positive/negative) and weight. For G variables,
there are 16,277 measurements of mRNA expressions and the top 2,000 genes are selected for
the downstream analyses using the same prescreening as described in the previous section.
The coefficients estimated from the proposed approach are provided in Table 2.8. The
three E variables age, stage and weight have negative coefficients, indicating that higher
levels are associated with shorter survival, and the positive coefficient of ER status suggests
that the subjects with negative ER status tend to have better prognosis. In addition, there
are 32 important main effects along with 43 interactions. These findings are validated
by the literature search. For example, gene ASH2L has been shown to be over-expressed
in human breast cancer among other candidate oncogenes. Gene ATAD1 has been found
to be down-regulated in different subtypes of breast tumors in gene expression profiling,
whose interactions with age, tumor stage and ER status are identified using the proposed
approach. Abnormal expression of gene FGF4 has been found in human breast cancer cells,
and the up-regulation of endogenous FGF4 expression indicates its biological significance
in tumorigenesis. Gene KAT6A has been suggested to be a novel oncogene in breast cancer
as a chromatin modifier. Gene MED1 has been demonstrated a key role in tamoxifen
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Table 2.7: Analysis of SKCM data using the proposed approach: coefficients of identified
main effects and interactions
Main:G Age Stage Gender Clark level








CALCA 0.0029 0.0010 0.0008




































resistance of human breast cancer cells, suggesting its potential as a therapeutic target
in cancer treatment. Over-expression of gene MTBP has been observed to be strongly
correlated with reduced breast cancer patient survival. Gene NSD3 has been showed to
be amplification in primary breast carcinomas, suggesting a possible involvement in human
tumorigenesis. Gene PHB2 has been demonstrated to play a crucial role in modulation of
ER status in breast cancer cells.
Data are also analyzed using the alternatives. The summary results of comparison are
shown in Table A.27. Small numbers of overlapping main effects and interactions are found
across different approaches, whereas moderate common information is contained among
different identifications given the values of RV-coefficients. We also compute C-statistics to
evaluate the prediction accuracy of survival response using the same resampling process.
The proposed approach demonstrates improved prediction ability with a C-statistic value
of 0.55, compared to 0.49 (LS-MCP), 0.49 (LAD-LASSO), 0.47 (RLARS), 0.51 (LTS-MCP)
and 0.47 (LS-MCP-Hier). In addition, the proposed approach has better stability with the
average OOI as 0.49, compared to 0.09 (LS-MCP), 0.43 (LAD-LASSO), 0.27 (RLARS),
0.08 (LTS-MCP) and 0.4 (LS-MCP-Hier). The improved prediction and stability confirm
the validity of the proposed analysis.
2.3.5 Discussion
Identifying important G-E interactions associated with complex multifactorial human dis-
eases is an important goal of high-dimensional cancer studies. In this Chapter, we propose
a novel effective interaction analysis approach based on the least trimmed regression. The
proposed approach can accommodate the vertical outliers as well as the leverage points,
which are not uncommon in practice but have not been well studied. It differs significantly
from the existing robust interaction analyses that usually focus on model mis-specification
or outliers/contaminations in response. A robust criterion based on the (weighted) resid-
uals is developed for choosing the optimal number of outliers, which can accommodate
multiple types of responses, such as continuous biomarkers and censored survival time. The
coefficient of each interaction is decomposed as the product of the corresponding main ef-
fect and interaction-specific coefficient, which has an intuitive formulation to automatically
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Table 2.8: Analysis of BRCA data using the proposed approach: coefficients of identified
main effects and interactions
Main:G Age Stage ER status Weight
Main:E -0.1594 -0.1089 0.2705 -0.1219
AASDHPPT 0.0885 0.0347 -0.0069
ASH2L 0.0006






ITLN2 -0.1221 -0.0113 0.0069
KAT6A 0.0123
MAEA 0.0453






PHB 0.0984 0.0015 0.0008 0.0005
PHB2 0.0832 -0.0032 0.0025
PMVK 0.1227 0.0064 -0.0016 -0.0216 -0.0564
RAD21 -0.0555 -0.0311
SEZ6 -0.1450 -0.0320 -0.0017
SMIM19 0.0950 0.0379 0.0127 0.0022 -0.0136




TRIM11 -0.1352 -0.0314 0.0071
UBE2Z 0.0895 -0.0003 -0.0031 0.0002
UBE4A -0.0055
ZNF572 0.0053
ZNF597 0.0932 0.0065 0.0205
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respect the strong hierarchical structure. The modified stability selection-based C-steps
algorithm and iterative coordinate descent algorithm are adopted to optimize the objective
function, which leads to the estimation of main effects and interactions as well as the optimal
outlier-free subject set. Extensive simulations are conducted, including various scenarios
without data contamination, with vertical outliers, and with leverage points. The results
demonstrate the competitive performance of the proposed analysis in terms of identifica-
tion, estimation and prediction. In the data analysis of cutaneous melanoma and breast
invasive carcinoma with gene expression measurements, the proposed approach identifies
biologically sensible markers with better prediction performance and stability.
In this Section, we have considered a continuous response under the linear model and
a censored survival time under the AFT model. For the categorical and count data un-
der generalized linear models, the iterated weighted squared loss can be adopted as an
approximation to the negative log-likelihood. Thus, with minor modifications, the pro-
posed approach can be extended to accommodate other types of responses. The proposed
approach is built on the trimmed regression which has been demonstrated to have solid
statistical properties for the analysis of low-dimensional data and high-dimensional main
effects. Thus it may be reasonable to conjecture that the proposed approach also has good
theoretical properties. The detailed study is postponed to future research. In simulation,
we focus on the leverage points in G factors, more extensive numerical studies with out-
liers in E factors are deferred to future investigation. In data analysis, more biological and








Many statistical methods have been proposed for identifying G-E interactions, among which
marginal modeling framework becomes more popular due to less computation and simpler
interpretation (Sun et al., 2018b; Xu et al., 2019; Zhang et al., 2019). Though marginal
analysis is computationally simpler, the “main effects, interactions” hierarchy is not auto-
matically guaranteed, leading to difficult interpretation. That is, an interaction term may
be identified due to a significant p-value, but the corresponding main effects are not. Com-
paratively, the joint analysis that models a large number of genetic factors and interactions
in a single model, the importance of respecting such hierarchical structure for producing
statistically and biologically meaningful findings have been demonstrated (Bien et al., 2013;
Hao and Zhang, 2017) and a few approaches have been developed such as Shi et al. (2014)
and Zhu et al. (2014). In the current literature, the hierarchy structure in marginal analysis
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shares equal importance yet has been less studied Bien et al. (2015).
Considering the high dimensionality and low signal levels, it becomes more challenging
to identify important G-E interactions beyond the main effects without sufficient infor-
mation. In recent literature, incorporating additional information for main effect analysis
have been adopted to facilitate effective and biologically meaningful discoveries for complex
diseases. For example, consider the adjacency structure of SNPs. Due to linkage disequilib-
rium, SNPs that are physically close can demonstrate similar associations with the disease
outcomes (Ardlie et al., 2002). Multiple statistical methods using penalization have been
proposed that account for high correlations among closely located markers, including fused
lasso (Tibshirani et al., 2005), smooth lasso (Hebiri et al., 2011), spline lasso (Guo et al.,
2016), and so on. Extensive research has shown that combining biological knowledge as
a priori can lead to more accurate and interpretable estimation and identification. Yet,
almost all of the existing G-E interaction analyses omit such biological knowledge. An-
other example of additional information arises from published studies. Literature review
suggests that, for many common problems in the field of biology and biomedicine, multiple
relevant investigations were conducted and published, which may provide valuable and com-
prehensive input for the current study. To incorporate existing studies, meta-analysis or
integrative analysis can be conducted. We refer Zeggini et al. (2008), Guerra and Goldstein
(2009), and Ma et al. (2011) for further discussion. Despite the great achievement, such
analysis procedure requires highly comparable design across available studies and datasets.
Excluding partially relevant ones may cause a waste of information, and it is desired to
include as many related studies as possible to add to G-E interaction analysis.
In this Chapter, our goal is to incorporate additional information for G-E interaction
analysis. Motivated by the lack of information in G-E interaction analysis and the suc-
cess of utilizing available information in the main effect analysis, we propose a new G-E
interaction analysis method under a marginal modeling framework. Using penalized regres-
sion, the proposed method respects the ’main effects, interactions’ hierarchical structure.
That is, when an interaction is identified, the corresponding main effect of the genetic fac-
tor is simultaneously included in the model. In addition, significantly advancing from the
existing G-E interaction analysis, the proposed method can incorporate additional infor-
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mation, especially including the adjacency structure of SNPs and mined data extracted
from relevant literature. We propose using penalization to address the lack of information
problem, which provides a coherent formulation for multiple types of additional informa-
tion and genetic measurements. Different from the meta-analysis and integrative analysis
framework, strict comparability across studies is not required, which allows more compre-
hensive information to be included. This advancement of utilizing additional information
enables improved performance in identification and interpretation for G-E interaction anal-
ysis. Our numerical study shows that the proposed method can outperform multiple direct
alternatives. Overall, this study provides an effective and practically meaningful way to
incorporate additional information for G-E interaction analysis.
3.2 Methods
Assume N iid subjects. Let X = (X1, X2, . . . , Xp) and Z = (Z1, Z2, . . . , Zq) be N × p
and N × q matrix of gene expressions and environmental factors. Denote Y as a length
N vector of continuous disease outcome. We consider the regression model for jth gene,
j = 1, 2, . . . , p, Y =
∑q
k=1 αkjZk + βjXj +
∑q
k=1 ηkjZkXj + ε, where αk, βj , and ηkj are
the coefficients for environmental factors, gene expressions, and their interactions. ε is the
random errors. We decompose ηkj to impose the hierarchical structure of main effects and
interactions by using ηkj = βjγkj . Then, the marginal model for j
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q), β = (β1, β2, . . . , βp)
′, γk = (γk1, γk2, . . . , γkp)
′ for
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minimax concave penalty, λ1, λ2 ≥ 0 are tuning parameters, r > 0 is the regularization
parameter. J is a p×p matrix for Laplacian quadratic penalty, which is tailored for different
types of additional information. More details are discussed below. We obtain the proposed
estimates that minimizes equation (3.1) as θ̂ = arg minQ(θ), and important main genetic
effects and interactions are identified by non-zero estimated coefficients.
The proposed objective function is designed under a marginal analysis framework. For
each genetic measurement, one regression model is assumed. Decomposing the coefficient
of interactions as βjγkj , the ’main effects, interactions’ hierarchical structure is ensured.
Note that environmental factors are pre-selected and have a low dimensionality so that
their coefficients are not subject to penalized selection. The proposed method thus differs
from the pairwise interaction analysis such as (Choi et al., 2010). The first two minimax
concave penalty (MCP) terms in 3.1 is applied, which guarantees that interaction and its
corresponding main effects can be selected simultaneously. Without further computational
burden, we impose the same tuning parameter across different genes using λ1 to ensure
comparability. In the literature, the MCP-based penalty has been extensively adopted
(Kim et al., 2017; Zhang et al., 2010), and many other ways exist for achieving hierarchy,
such as the sparse group MCP (Liu et al., 2013). Our investigation suggests the proposed
method has computational advantages and satisfactory performance.
We adopt the Laplacian quadratic penalty to incorporate additional information as the
last two terms. In this Chapter, we consider two specific examples. (1) Consider the ad-
jacency structure of SNPs as additional information, and assume that SNP measurements
are ordered by their physical locations. We adopt the spline type penalty for main ge-
netic effects and interactions as
∑p−1
j=2[(βj+1 − βj) − (βj − βj−1)]2 and
∑p−1
j=2[(γk(j+1) −
γkj) − (γjk − γk(j−1))]2. Then, for SNP data, we have J = H′(p−2)×pH(p−2)×p where
Hjj = Hj(j+2) = 1, Hj(j+1) = −2, and 0 otherwise. This penalty encourages smooth-
ness and is analogous to penalize second-order derivatives in spline-based nonparametric
estimation. Consequently, the main effects and interactions of physically adjacent SNPs
associated with the response are promoted to be similar. Other alternative penalties, such
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as the fused lasso and smooth lasso are available. We choose the spline type penalty in
this Chapter due to its demonstrated superior performance and computational feasibility
(Guo et al., 2016). (2) Consider text-based literature mining data of PubMed as additional
information. We adopt PubMatrix (https://pubmatrix.irp.nia.nih.gov), which is a
web-based tool that allows simple text-based mining of PubMed and has been used in the
studies of Wang et al. (2019), Minafra et al. (2018), and many others. PubMatrix uses two
lists of keywords and produces a frequency matrix of term co-occurrence as results (Becker
et al., 2003). Consider gene expression data and we utilize gene names as keywords. The
pairwise frequency matrix is generated by PubMatrix, each element of which suggests not
only whether an association exists but also its amount of evidence. Given the fact that the
majority of the frequency counts are zero, we construct the adjacency matrix A = {ajl}p×p
using quantiles at 0.2, 0.4, 0.6, and 0.8 of the nonzero frequencies. In this way, the magni-
tude in A is managed as extreme values are excluded. Then, consider J = I−D−1/2AD−1/2




l=1 a2l, . . . ,
∑p
l=1 apl). This
penalty promotes similar main genetic effects and interactions for those genes that have
demonstrated more co-occurrences as pairs in the existing publications.
We also note that other designs of constructing J can be tailored given the type of data
and additional information. For instance, for gene expression levels, the adjacency matrix
can be calculated based on Pearson correlation coefficients, similarity measure such as the
Euclidean distance, and others alternative approaches. Recent studies have established the
improved performance and effectiveness of the Laplacian quadratic penalty in main effect
analysis. However, limited adoption for analyzing G-E interaction exists. We refer Huang
et al. (2011a), Shi et al. (2015), and Wu et al. (2019b) for further discussion of construction
of Laplacian quadratics.
3.2.1 Computation
To compute the proposed estimates, we adopt an iterative coordinate descent algorithm with
fixed tuning parameters. This algorithm minimizes the objective function with respect to
one coefficient at each step until convergence. We summarize the algorithm as follows.
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∣∣∣φ(t)j − λ2δ(t)j ∣∣∣ > λ1 (χ(t)j + λ2Jjj) (3.2)
where ST (a, b) = sign(a)(|a| − b)+ is the soft-thresholding operator.
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5. Compute the relative difference as ∆(t) = |Q(θ
(t))−Q(θ(t−1))|
|Q(θ(t−1))| . Repeat Step 2-4 until
∆(t) < 10−4.
For model selection, we set r as 3 to reduce computational cost and adopt the extended
Bayesian information criterion to choose the values of (λ1, λ2) (Chen and Chen, 2008). In
the literature, convergence properties of coordinate descent have been well established and
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we observe convergence in all of our numerical studies. The computational cost of the
proposed method is moderate. We have developed R code and made it publicly available
on GitHub.
3.3 Simulation
We set N = 200, p = 1000, and q = 5 for all simulated data. (a) For genetic data, we
consider two types. (S1) We generate SNP data with adjacency structure to mimic densely
positioned SNPs. Two approaches are adopted to simulate SNP data coded as (0, 1, 2) for
genotypes (aa, Aa, AA). For the first approach, we first generate p continuous variables
using a multivariate normal distribution with mean 0 and covariance matrix Σ = {σjl}p×p
and then categorize them at q1 and q2 quantiles. We consider two correlation structures
for Σ. The first one is auto-regressive structure (AR) with ρ = 0.3 and 0.5. The second
is the banded correlation structure where two scenarios are considered. One has σjl = 1
if j = l, 0.3 if |j − l| = 1, and 0 otherwise (Band1). The other one is σjl = 1 if j = l,
0.5 if |j − l| = 1, 0.3 if |j − l| = 2, and 0 otherwise (Band2). We adjust q1 and q2 for
minor allele frequency (MAF) values and conducer two scenarios. The first one (M1) has
MAF = 0.05 with q1 = 0.91 and q2 = 0.99. The second scenario (M2) has MAF = 0.15
with q1 = 0.73 and q2 = 0.97. For the second approach of generating SNP data, we use
pairwise LD structure with pairwise correlation rLD = 0.3 and 0.5. Specifically, denote pA
and pB as the MAFs of alleles A and B for two adjacent SNPs. Four haplotypes ab, aB,
Ab, and AB have frequencies (1 − pA)(1 − pB) − φ, (1 − pA)pB − φ, pA(1 − pB) − φ, and
pApB−φ respectively, with φ = rLD
√
pA(1− pA)pB(1− pB) and two scenarios of MAFs as
in the first approach. (S2) We also simulate gene expression data. Among p expressions, C1
setting has 50 clusters with size 20 and C2 has 10 clusters with size 100. Genes in different
clusters are independent whereas within each cluster, gene expressions are generated from a
multivariate normal distribution using AR and banded correlation structures. We use same
parameter settings for generating covariances. (b) Environmental risk are generated from
a multivariate normal distribution with marginal mean 0, variances 1, and AR correlation
(ρ = 0.3). (c) We set 20 main genetic factors and 40 hierarchical G-E interactions with
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nonzero effects, generated from Uniform (0.75, 1.25). The coefficients of environmental risk
factors are generated from Uniform (0.8, 1.2). (d) To simulate the response, we assume a








j=1 βjγkjZkXj + ε, where ε follows
a standard normal distribution.
We analyze the simulated data using the proposed method. For S1, we consider the
spline type penalty. For S2, two types of additional information are considered with differ-
ent Laplacian quadratics. The first type (J1) is literature mining information. We select top
1000 genes in TCGA SKCM data based on marginal p-values and unitize the pairwise fre-
quency matrix generated by PubMatrix as J. The second type (J2) is the correlation struc-
ture of gene expressions, for which we construct J based Pearson correlation coefficients.
We also consider the following alternative approaches for comparison. (1) HierMCP, which
excludes the Laplacian quadratic penalty from the proposed objective function. (2)MCP-
LP, which uses Y =
∑q
k=1 αkjZk + βjXj +
∑q
k=1 ηkjZkXj + ε without decomposition. To
estimate coefficients, MCP and Laplacian quadratics are applied to βj and ηkj as the same
as the proposed method. (3) Lasso, which imposes the Lasso penalty under a marginal
modeling framework. The tuning parameter is selected by cross-validated mean squared
error. (4) MA, which is the benchmark marginal analysis that analyzes one genetic factor
at a time. P-values are adjusted by the false discovery rate (FDR) approach and important
interactions are selected at FDR=0.1. To assess the identification accuracy of the proposed
method in comparison with alternatives, we evaluate the numbers of true positives and
false positives for main effects (M:TP and M:FP) and G-E interactions (I:TP and I:FP)
respectively. In addition, we report the true positive counts when a total of 60 effects are
identified as TP60. These measurements do not take environmental risk factors into account
since they are not subject to selection.
Under each setting, we produce 200 datasets. The advantage of the proposed method is
obvious in continuous genetic data settings. Summary results for gene expressions are pre-
sented in Table 3.1 and 3.2 that incorporates literature mining information J1. For example
in Table 3.1 with correlation setting C1, the proposed method has (18.5, 9.2, 36.2, 7.6), com-
pared to (14.9, 3.0, 19.0, 29.5) for HierMCP, (5.2, 1.9, 18.3, 39.4) for MCP-LP, (2.3, 0, 7.8, 9.8)
for Lasso, and (1.5, 0.1, 3.0, 4.6) for MA. Compared to HierMCP, the proposed method
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yields superior results in identification, which provides strong and direct support to the
estimation strategy that incorporates additional information using the Laplacian quadratic
penalty. The proposed method also outperforms MCP-LP, which suggests the effectiveness
of respecting the hierarchical structure of main effects and interactions by coefficient de-
composition. Lasso and MA serve as benchmark analysis that both identify much fewer
effects. This indicates that given high-dimensionality and low signal level, traditional ap-
proaches that do not address the“main effect, interaction” hierarchy structure nor addi-
tional information can lead to misleading discovery. In addition, we uses correlation as
additional information and present summary results in Table B.1 and B.2 (Appendix).
When zero and nonzero effects are correlated as C2, we also observe the satisfactory perfor-
mance of the proposed method. Under correlation setting C1, it has TP60= 58.7 compared
to 34.4 for HierMCP, 28.2 for MCP-LP, 8.8 for Lasso, and 4.1 for MA. The proposed
method remains favorable for SNP data compared to alternative approaches. Summary
results for SNP data are presented in Table 3.3 and 3.4. We observe that the proposed
method has better or competitive performance in identification accuracy across different.
For instance in Table 3.3 with MAF = 0.05 (M1) and AR(0.3), the proposed method has
(M:TP, M:FP, I:TP, I:FP)= (18.9, 9.4, 34.1, 40.5), compared to (13.1, 48.5, 3.0, 7.9) for Hi-
erMCP, (10.8, 0.2, 5.4, 30.6) for MCP-LP, (0.1, 0, 3.5, 14.9) for Lasso, and (0.1, 0.5, 1.5, 11.8)
for MA. Across various settings, the superiority in identification performance of the pro-
posed method demonstrates solid evidence that incorporating additional information using
Laplacian quadratics improves accurate selection in the G-E interaction analysis.
3.4 Data analysis
We analyze data on cutaneous melanoma. Data are downloaded from TCGA Provisional
using the R package cgdsr. The response of interest is the Breslow’s depth, which mea-
sures the thickness of the tumor and has been extensively studied for the relationship with
development and prognosis in melanoma patients (Dickson and Gershenwald, 2011). For
environmental risk factors, we include age, sex, Clark level, and American Joint Committee
on Cancer (AJCC) nodes pathologic stage (PN), all of which have been shown to be asso-
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Table 3.1: Simulation results of S2 under correlation setting C1 and additional information
J1. In each cell, mean(sd) based on 200 replicates.
M:TP M:FP I:TP I:FP TP60
AR(0.3)
Proposed 18.5(1.3) 9.2(7.7) 36.2(2.7) 7.6(6.3) 52.7(4.2)
HierMCP 14.9(1.8) 3.0(2.6) 19.0(1.9) 29.5(2.6) 33.7(5.2)
MCP-LP 5.2(4.7) 1.8(1.5) 18.3(5.3) 39.4(9.5) 21.5(3.7)
Lasso 2.3(1.0) 0(0) 7.8(1.7) 9.8(3.9) 6.5(4.0)
MA 1.5(2.0) 0.1(0.3) 3.0(2.7) 4.6(8.3) 5.2(1.7)
Band2
Proposed 19.4(1.0) 2.3(2.6) 37.2(3.1) 5.3(6.3) 57.6(1.3)
HierMCP 15.3(1.6) 0(0) 20.7(2.7) 30.8(4.3) 34.5(1.8)
MCP-LP 5.2(3.9) 0.4(0.8) 22.3(4.3) 21.9(9.7) 38.4(3.9)
Lasso 2(1.0) 0(0) 11.8(2.9) 4.6(2.3) 8.8(4.5)
MA 4.4(3.7) 0.5(0.7) 9.4(4.6) 9.8(8.8) 7.4(1.3)
LD(0.3)
Proposed 19.3(1) 10.9(8.1) 37.8(2.6) 5.7(7.5) 52.3(4.7)
HierMCP 14.7(1.7) 4.6(2.7) 17.6(3.3) 30(2.7) 31.8(3.3)
MCP-LP 2.7(2.4) 1.8(2.2) 13.6(4.4) 49.8(25.2) 21.7(4.8)
Lasso 2.2(1.6) 0.4(0.5) 9.8(6.1) 17.6(13.7) 6.8(8.0)
MA 0.8(0.9) 0.1(0.3) 4.3(3.7) 16(25.8) 4.1(1.6)
LD(0.5)
Proposed 19.2(1.2) 4(6.0) 37.4(2.4) 5.7(6.8) 56.1(1.5)
HierMCP 15.7(1.4) 0.3(0.6) 20.9(2.0) 30.4(2.4) 35.4(4.3)
MCP-LP 4.7(4.2) 0.7(1.3) 19.1(4.5) 30.3(12.3) 30.8(4.1)
Lasso 3.8(1.5) 0.2(0.4) 11.3(3.1) 4.5(1.9) 8.2(4.8)
MA 4.2(3.6) 0.3(0.6) 7.1(3.5) 9.3(11.4) 7.1(2.1)
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Table 3.2: Simulation results of S2 under correlation setting C2 and additional information
J1. In each cell, mean(sd) based on 200 replicates.
M:TP M:FP I:TP I:FP TP60
AR(0.3)
Proposed 19.6(1.0) 7.9(6.5) 37.3(3.1) 5.1(5.7) 53.8(4.0)
HierMCP 15.3(1.8) 1.6(1.8) 19.2(1.9) 30.3(2.3) 35.1(4.9)
MCP-LP 3.1(2.6) 1.4(1.2) 16.6(3.6) 36.7(10.2) 23.2(3.9)
Lasso 1.4(1.1) 0.6(0.5) 12.8(4.0) 19.2(4.1) 7.3(3.7)
MA 1.5(1.6) 0.5(0.8) 5.5(4.9) 14.1(4.2) 4.4(1.8)
Band2
Proposed 19.7(1.1) 2.4(3.2) 38(2.5) 4.2(4.7) 56.5(1.7)
HierMCP 15.3(1.2) 0.2(0.4) 19.9(1.6) 29.5(2.8) 35.5(4.6)
MCP-LP 6.4(4.6) 1.2(1.3) 23.7(3.2) 26.2(14.2) 39.4(7.2)
Lasso 3.4(2.3) 0(0) 11(2.9) 2.6(3.6) 9.3(4.6)
MA 4.3(4.1) 0.4(0.9) 9(3.5) 8.2(7.4) 7.4(1.9)
LD(0.3)
Proposed 19.1(0.9) 10.2(5.9) 36.8(2.8) 4.5(3.4) 52.9(4.0)
HierMCP 14.5(1.8) 7.5(4.6) 16.1(2.7) 29.3(3.6) 30(4.0)
MCP-LP 3.2(2.9) 2.2(2.1) 13.9(4.3) 49.2(27.2) 20.9(4.1)
Lasso 2(1.6) 1.6(1.5) 6.6(1.1) 23.8(15.3) 4.9(3.1)
MA 0.6(1.2) 0.4(0.7) 2.9(2.8) 10(18.4) 3.7(1.7)
LD(0.5)
Proposed 19.6(0.8) 5.9(8.6) 38.6(2.2) 2.6(3.3) 57.7(1.7)
HierMCP 15.6(1.5) 0.2(0.4) 20.7(1.9) 30.7(2.9) 36.3(4.4)
MCP-LP 4.2(3.8) 0.6(1) 20.1(3.2) 30.7(11.4) 31.9(3.2)
Lasso 4(2.9) 0(0) 11.8(3.1) 6.4(3.6) 9.3(4.1)
MA 2.7(3.3) 0.2(0.4) 6.2(5.3) 7.7(10.7) 6.5(2.3)
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Table 3.3: Simulation results of S1 under MAF setting M1. In each cell, mean(sd) based
on 200 replicates.
M:TP M:FP I:TP I:FP TP60
AR(0.3)
Proposed 18.9(1.0) 9.4(9.8) 34.1(1.1) 34.7(11.8) 40.5(5.8)
HierMCP 13.1(2.1) 48.5(19.1) 3.0(2.9) 7.9(13.5) 15.2(2.2)
MCP-LP 10.8(4.4) 0.2(0.7) 5.4(4.0) 30.6(5.4) 21.3(4.5)
Lasso 0.1(0.2) 0(0) 3.5(2.6) 14.9(19.2) 3.5(2.6)
MA 0.1(0.2) 0.5(1.1) 1.5(1.7) 11.8(15.3) 5.8(3)
AR(0.5)
Proposed 19.0(1.2) 3.6(3.6) 34.6(1.5) 32.9(8.5) 41.4(4.4)
HierMCP 13.9(2.5) 34.6(22.7) 12.9(6.9) 46(32.9) 19.3(3.8)
MCP-LP 14.3(4.3) 0.5(0.5) 5.4(3.4) 27.4(3.9) 26.4(3.9)
Lasso 0.5(0.8) 0.1(0.2) 6.0(3.8) 15.4(13) 6.5(4)
MA 0.2(0.4) 1.7(2.9) 2.4(2.1) 18.7(16.5) 5.7(3.1)
Band1
Proposed 18.3(2.1) 6.4(4.9) 32.9(3.5) 30.5(8.6) 39.5(6.6)
HierMCP 12.3(3.3) 51.7(33.3) 8.1(4.1) 30.5(20.8) 17.0(2.8)
MCP-LP 11.7(6.2) 0.4(0.5) 4.5(4.1) 30.8(5.6) 21.9(4)
Lasso 0.1(0.3) 0(0) 2.4(2.3) 7.3(6.4) 2.5(2.3)
MA 0(0) 0.9(1.3) 1.2(1.5) 14.2(15.1) 5.6(2.8)
Band2
Proposed 18.9(1) 3.6(4.1) 35.3(1.7) 30.9(12.3) 39.1(5.3)
HierMCP 14.2(2.1) 39.9(24.7) 4.8(3.8) 12.0(15.7) 19.6(3)
MCP-LP 11.4(5.1) 0.5(0.8) 6.1(4.6) 28.7(5.5) 24.5(5.1)
Lasso 0.4(0.6) 0.1(0.2) 5.5(3.3) 20.9(23.7) 5.7(3.1)
MA 0(0) 0.8(1.5) 2.3(2.5) 18.4(22.1) 5.7(3)
LD(0.3)
Proposed 19.1(1.1) 2.7(5.8) 33.8(2.2) 30.2(12.3) 42.7(7.1)
HierMCP 14.3(2.1) 52.7(31.7) 2.2(2.7) 4.0(5.2) 19.9(2.5)
MCP-LP 12.5(4.6) 0.3(0.6) 9.0(4.4) 26.5(5.6) 27.1(5.2)
Lasso 0.3(0.6) 0(0) 4.9(3.3) 11.4(14.5) 5.1(3.3)
MA 0(0) 0.4(0.7) 2.7(2.6) 11.8(15.8) 5.6(2.8)
LD(0.5)
Proposed 19.2(1.0) 2.6(4.0) 34.0(1.4) 32.8(11.3) 41.2(7.3)
HierMCP 15.4(2.1) 68.8(27.8) 5.3(4.8) 15.9(22) 18.0(1.7)
MCP-LP 13.3(5.7) 0.6(1.1) 7.1(4.4) 25.3(5.7) 27.9(6.6)
Lasso 0.2(0.7) 0(0) 6.7(3.6) 22.3(28.4) 6.6(3.6)
MA 0.3(1.3) 2.4(7.2) 2.9(3) 17.6(22.5) 5.6(2.9)
ciated with melanoma. For genetic factors, we consider the mRNA gene expressions. The
level 3 data in TCGA are collected using the IlluminaHiseq RNAseq V2 platform and have
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Table 3.4: Simulation results of S1 under MAF setting M2. In each cell, mean(sd) based
on 200 replicates.
M:TP M:FP I:TP I:FP TP60
AR(0.3)
Proposed 18.1(2.3) 22.1(10.9) 32.4(4.4) 30.6(9.6) 34.5(6.4)
HierMCP 12.3(2.1) 19(9.3) 1.6(1.5) 2.2(2.2) 16.5(3.0)
MCP-LP 5.7(4.3) 1(1.4) 4.4(3.3) 39.5(8.7) 13.2(4.4)
Lasso 0(0) 0(0) 1.8(1.7) 6.8(5.4) 1.8(1.7)
MA 0.1(0.2) 0.4(0.7) 1.2(1.3) 11.3(17.9) 4.8(2.9)
AR(0.5)
Proposed 18.4(2.3) 13.2(12.9) 33.3(3.5) 31.9(14.1) 37.7(6.8)
HierMCP 13.9(3.0) 16.2(9.1) 4.0(3.0) 7.0(5.4) 20.5(3.3)
MCP-LP 8.7(4.7) 0.4(0.6) 3.3(4.1) 36.8(8) 18.3(6.6)
Lasso 0.4(0.8) 0(0) 5.4(3.2) 20.3(12.8) 5.8(3.2)
MA 0.3(0.7) 2.3(4.9) 1.3(1.7) 11.6(14.2) 4.9(3.1)
Band1
Proposed 17.4(2.3) 22(11.4) 30.8(4.2) 30.8(12.3) 35.8(6.2)
HierMCP 11.2(2.0) 19.4(11.7) 2.4(3.9) 5.2(9.9) 17.3(2.8)
MCP-LP 3.8(3.3) 1.9(2.8) 4.7(3.7) 51.2(25.2) 13.9(4.2)
Lasso 0(0) 0(0) 0.8(1.4) 2.8(4.7) 0.8(1.4)
MA 0(0) 0.2(0.4) 1.8(2.5) 13.8(18.6) 5.2(3.0)
Band2
Proposed 18.1(1.3) 10.3(7.8) 33.7(2.9) 29.7(14.1) 41.1(6.6)
HierMCP 13.9(1.9) 18.5(11.6) 5.4(4.5) 12.7(16.3) 21.6(4)
MCP-LP 8.5(5.6) 0.9(1.6) 2.3(2.6) 40.3(9.3) 18(4.2)
Lasso 0.1(0.2) 0(0) 2.7(3.0) 9.5(13.4) 2.7(3.1)
MA 0.1(0.2) 1.1(2.9) 2.7(3.2) 19.2(27.3) 4.9(3.0)
LD(0.3)
Proposed 18.2(1.2) 12.8(10.8) 33.2(2.2) 29.3(13.5) 42.3(7.4)
HierMCP 14(1.8) 19.1(10.8) 5.9(4.9) 12.9(15.4) 22.8(3.8)
MCP-LP 8.9(5.5) 1.2(2.5) 3.2(3.3) 38.7(9.9) 16.0(4.3)
Lasso 0.1(0.2) 0(0) 2.5(3.1) 9.2(14.2) 2.6(3.1)
MA 0.1(0.2) 0.5(0.9) 2.6(2.7) 17.8(24.1) 4.9(3.0)
LD(0.5)
Proposed 18.2(1.2) 12.8(10.8) 32.7(2.1) 29.8(13.4) 41.9(8.1)
HierMCP 13.8(1.7) 18.3(11.2) 6.2(5.0) 13.8(16.0) 23.1(3.8)
MCP-LP 8.9(5.5) 1.2(2.5) 3.2(3.3) 38.7(9.9) 16.1(4.3)
Lasso 0.1(0.2) 0(0) 2.7(3.1) 10.0(14.8) 2.5(3.1)
MA 0.1(0.2) 0.5(0.9) 2.8(2.7) 19.7(24.7) 4.7(3.0)
been lowest-normalized, log-transformed, and median centered. A total of 361 subjects are
available with 18,355 measurements of gene expressions. We conduct a prescreening proce-
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dure using marginal regression and select the top 1000 genes with the smallest p-values for
downstream analysis.
The proposed method identifies 33 main genetic effects and 12 G-E interactions. Details
are presented in Table 3.5. Published studies suggest potentially important implications
of the findings. For instance, the proposed method identifies the interaction between the
pathologic stage with gene TCTEX1D1, and it has been found as one of the differently
methylated genes among metastatic melanoma patients. Gene MS4A14 has been found
to be consistently altered in expression in cutaneous malignant melanoma patients with
multiple in-transit metastases on the limbs. Expressions of LAMP2 cell-surface have been
found in different human tumor cell lines. were correlated with better overall survival
among gastric cancer patients, Gene MS4A14 has been showed positive expression in gastric
cancer and correlated with better overall survival. Gene PLCB4 has been considered to be
one of the plausible candidate driver genes of uveal melanoma and a tumor suppressor
in cutaneous melanoma. A recurrent mutation in gene PLCB4 has been found to promote
uveal melanoma tumorigenesis. We also confirm the identified genes are biologically sensible
by enrichment analysis. The selected genes by main effects and interactions are used for
enrichment analysis of pathways and diseases by DAVID version 6.8 (Sherman et al., 2009).
We entered the identified genes from Table 3.5 into the web application david.ncifcrf.gov,
with “OFFICIAL GENE SYMBOL” as gene identifier and Homo sapiens as species. The
identified genes using the proposed approach are also significantly enriched into several GO
terms. For example, seven identified genes (ISL1, SFI1, TAF9B, WWC2, CREG1, LPA,
PON1) are enriched into negative regulation of cellular metabolic process (GO:0031324,
p-value=0.0083). This has been selected to be one of the optimal features of the final
characterization of skin cancer-related genes.
3.5 Discussion
In this Chapter, we have developed a new marginal G-E interaction analysis, which adopts a
combination of penalization to respect the “main effects, interaction” hierarchical structure
and to incorporate additional information. The advantage of the proposed method that
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Table 3.5: Analysis of the SKCM data using the proposed method: identified G-E interac-
tions.

























REXO1L1P -0.1557 -0.2845 -0.3137 0.3015
SFI1 -0.0061
TAF9B 0.0014
TCTEX1D1 -0.2992 0.1487 0.6563
USHBP1 -0.0163




utilizes the additional Laplacian quadratic penalty leads to more accurate identification
and efficient computational algorithm. With the goal of improving the identification of
G-E interaction, we have transformed the additional information by the adjacency matrix
and then Laplacian quadratics. In main effect analysis, the sparse Laplacian shrinkage
estimator has been comprehensively investigated and its theoretical properties including
statistical inference are well established. Our proposed method adapts this penalization to
conduct G-E interaction analysis. We have demonstrated considerable superiority can be
achieved over multiple closely related alternatives using simulation under various settings.
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In data analysis, biologically sensible findings are made.
Through penalization is more coherent under a joint modeling framework, it is still
worth exploring and extending its applicability and performance to marginal models in the
interaction analysis. We have witnessed great success in the joint analysis of G-E interaction.
It can be of interest to migrate and to advance some of these analysis strategies to marginal
models. It can also be of interest to extend our simulation to other types of responses, for
example, survival outcomes. In the example of using texted-based mining data, we adopted
PubMatrix and other software tools are also available including VxInsight, MedMiner, and
others. Although bioinformatics and statistical evaluations have been conducted with the





Molecular Data Into Interaction
Analysis Using Sparse Biclustering
and Lasso-Based Penalization
4.1 Introduction
For the outcomes and phenotypes of cancer, cardiovascular diseases, asthma, mental disor-
ders, and other complex diseases, accumulating evidences have shown that multiple types of
molecular changes, environmental risk factors, and their interactions play important roles.
For example, the expression of gene IL9 is found to interact with environmental dust mite
to increase severe asthma exacerbations in children (Sordillo et al., 2015). In the study of
lung cancer genetics, it has been suggested that smoking can act through increasing the
CNV (copy number variation) of gene IGF1 to induce its oncogenesis (Huang et al., 2011b).
Epigenetic changes have also been investigated. For example, Teschendorff et al. (2015)
finds that smoking-associated DNA methylation changes in buccal cells are associated with
epithelial cancers. It is observed that in each of the aforementioned and other published
studies, only the interactions between a single type of molecular changes and environmental
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risk factors have been analyzed.
In recent biomedical studies, multidimensional profiling is becoming popular. In such
studies, data on multiple types of molecular changes is collected on the same subjects.
Such studies make it possible to not only more deeply understand disease biology but also
construct more effective models for disease outcomes and phenotypes. A myriad of novel
statistical methods has been developed. For example, Wang et al. (2012b) proposes an
integrative Bayesian analysis to identify gene expression and methylation measurements
that are associated with clinical outcomes such as survival. Gross and Tibshirani (2015)
develops collaborative regression which applies penalization to explicitly accommodate the
correlations (overlapping information) as well as independent information between gene
expressions and CNVs for marker identification. Zhu et al. (2016a) develops a linear reg-
ulatory module-based method using the sparse SVD (singular value decomposition) and
penalization techniques to integrate gene expressions and their regulators for cancer out-
comes. We refer to Kristensen et al. (2014) and Wu et al. (2019a) for more discussions.
The aforementioned and other published studies have convincingly shown that integrating
multidimensional molecular data not only is biologically sensible but also improves estima-
tion, marker identification, and prediction. It is noted that these studies have focused on
the main effects of molecular changes.
Analyzing multidimensional molecular data as the main effects have provided rich and
valuable information in cancer research. However, G-E interaction analysis of multidi-
mensional molecular changes is lacking and relevant statistical methodologies are much
underdeveloped (McAllister et al., 2017). In fact, incorporating distinct molecular levels of
measurements to select important interactions is not trivial. Rather than immediately ap-
pending additional measurements to the existing methods for identifying G-E interactions,
genomic regulations among different types of measurements need to be properly accom-
modated to the model of disease outcomes. Various frameworks have been proposed for
analyzing genomic regulations, such as correlation analysis (Langfelder and Horvath, 2008)
and network-based analysis (Breitling et al., 2004). Accumulative evidence suggests that it
is limited to include only single type data such as gene expression levels as genetic factors
in the interaction analysis. Those “one-dimensional” cancer-genomic studies may not be
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comprehensive enough in exploiting interactions associated with cancer outcomes.
Motivated by the successes as well as limitations of the existing studies, here we conduct
M-E interaction analysis, where M stands for multidimensional molecular changes and E
stands for environmental risk factors. The objective is to collectively accommodate mul-
tiple types of high-dimensional molecular changes, environmental risk factors, and their
interactions in modeling disease outcomes and phenotypes. This analysis is the natural
next step of the integrated analysis of the main effects of multidimensional molecular data
and studies that conduct the interaction analysis of a single type of molecular changes and
environmental risk factors. Beyond the “ordinary” high dimensionality and noisy nature of
molecular data, the analysis faces other challenges. Specifically, multiple types of molecular
measurements are interconnected, which leads to overlapping information. For example,
gene expression levels are regulated by genetic and epigenetic changes. On the other hand,
they can also have independent information for disease outcomes (Risch and Plass, 2008).
Several techniques, for example built on canonical correlation analysis (Meng et al., 2016)
and matrix factorization (Zhang and Zhang, 2019), have been developed to accommodate
such overlapping and independent information. In addition, interaction analysis demands
respecting the unique “main effects, interactions” hierarchy (Bien et al., 2013; Wu et al.,
2019b), for which multiple regularization techniques have been developed.
This study has the potential to significantly expand the gene-environment interaction
analysis and multidimensional molecular data analysis paradigms. The proposed approach
is designed tailored to the M-E analysis and will significantly advance from the aforemen-
tioned ones. With the growing popularity of multidimensional profiling, this study can open
a new venue for modeling complex diseases.
4.2 Methods
The proposed approach can accommodate multiples types/combinations of molecular mea-
surements. Without loss of generality and to avoid confusion with terminologies, we use
gene expressions and their regulators (for example, genetic and epigenetic changes) as an
example in description. Such a combination has been quite popular in published studies
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(Wang et al., 2012b; Zhu et al., 2016a). Other combinations, for example proteins and
gene expressions, can be analyzed in the same manner. Assume n iid subjects. Denote
G = (G1, · · · ,Gp) and R = (R1, · · · ,Rq) as the n × p and n × q design matrices of p
gene expression and q regulator measurements. Denote E = (E1, · · · ,EM ) as the n ×M
design matrix of environmental risk factors, and Y as the length n vector of outcome. We
first consider continuous outcomes and will discuss accommodating other types of outcomes
later. Assume Y has been properly centered, and E,G, and R have been standardized.
4.2.1 M-E interaction analysis
Our goal is to identify important M-E interactions (as well as main effects) and construct
a comprehensive outcome model. Overall, the proposed approach consists of the following
main steps: (i) identification of the gene expression-regulator regulatory modules, which de-
scribe the regulation relationships (overlapping information), (ii) integration of multidimen-
sional molecular measurements within the regulatory modules, and (iii) joint modeling and
estimation that respect the “main effects, interactions” hierarchy. The analysis flowchart is
provided in Figure 4.1.
Step I We employ a penalized regression to estimate the gene expression-regulator reg-
ulations and then sequentially conduct biclustering to identify the regulatory modules.
Consider the model G = RΘ + ε, where ε is the n × p matrix of random errors and
Θ = (θ1, · · · ,θp) is the q × p unknown coefficient matrix. For estimating Θ, consider








where || · ||F and || · ||1 denote the Frobenius norm of a matrix and L1 norm of a vector, and
λ ≥ 0 is the tuning parameter.
To identify the regulatory modules, we propose conducting biclustering with Θ̂. Here a
regulatory module corresponds to a bicluster, which contains a small number of co-expressed
gene expressions and their regulators. Specifically, for estimation, we adopt the sparse
clustering technique developed in Helgeson et al. (2019), which first introduces weights for
gene expressions and then maximizes the weighted between-cluster distance for regulators.
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Figure 4.1: Flowchart of the proposed M-E interaction analysis.
























subject to ||w||2 ≤ 1, ||w||1 ≤
√
p, and wj ≥ 0 for j = 1, · · · , p,




measures the distance between
the lth and l′th regulators, C and C̄ are the disjoint index sets of regulator clusters, q1 = |C|
and q2 = |C̄| are the cardinalities of C and C̄ with q1 < q2 and q1 + q2 = q, and w =
(w1, · · · , wp)′ is the weight vector for gene expressions, with a larger weight indicating higher
importance for clustering. With the constraints for w, each wj has a nonzero value between
0 and 1. With the estimated weight ŵ, a two-sample permutation-based Kolmogorov-
Smirnov test is conducted to test the significance of the difference between two clusters
and select the gene expression set D with significantly large weights. This process leads to
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one regulatory module {C,D} with regulators in C and gene expressions in D. To obtain
subsequent modules, we update Θ̂ by subtracting the module just identified and repeat the
above procedure. This process is iterated until the Kolmogorov-Smirnov test fails to reject
the null hypothesis of no clusters. With the sparsity of Θ̂, it is expected that only a subset
of gene expressions and regulators can form modules. Suppose that there are S identified
modules {C1,D1} , · · · , {CS ,DS}.
Rationale Linear regression is used to describe the regulations between two types of molec-
ular measurements. Multiple published studies (Shi et al., 2015; Zhu et al., 2016a) have
shown that it is a sensible choice, especially considering the high dimensionality. One gene
expression is regulated by only a few regulators, and one regulator affects the expressions of
only a few genes. As such, Θ is assumed to be sparse, and the Lasso penalization is applied
for estimation and identification of important regulations.
The concept of regulatory module has been developed in Zhu et al. (2016a) and other
studies. A regulatory module consists of a small number of gene expressions and regulators
that behave in a coordinated manner. The construction in Zhu et al. (2016a), which is
based on sparse SVD, limits each regulatory module to have rank one. Here we lift this
inconvenient constraint via biclustering. By construction, each bicluster (regulatory mod-
ule) consists of gene expressions and regulators sharing similar patterns in Θ. We adopt
the sparse biclustering method developed in Helgeson et al. (2019) because of its favorable
numerical performance. Note that here we cluster regulators into two disjoint groups with
weighted gene expressions. It is also possible to reverse the roles of gene expressions and
regulators, and this leads to similar clustering results in our numerical investigations. With
the sequential cluster construction strategy, different regulatory modules may have overlaps.
This is desirable as one gene/regulator can participate in multiple biological processes.
Step II We integrates information within each regulatory module {Cs,Ds} , s = 1, · · · , S,
using the PCA (principal component analysis) technique. Given a matrix A and index set
I, denote AI as the columns of A indexed by I. For the sth module, we apply PCA to the
stacked matrix (GDs ,RCs) and select the top PCs with the cumulative variance contribution
rate ≥ 80%. Denote the resulted matrix composed of the ps PCs asXs = (Xs,1, · · · ,Xs,ps).
In addition, for gene expressions and regulators not involved in any identified modules,
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we collect and combine them as Z = (Z1, · · · ,Zpz) = (GDc ,RCc), where Dc = {j ∈
{1, · · · , p} : j /∈ Ds, s = 1, · · · , S} and Cc = {j ∈ {1, · · · , q} : j /∈ Cs, s = 1, · · · , S}.
X = (X1, · · · ,XS) and Z form input for downstream analysis.
Rationale The previous step of analysis does not directly limit the sizes of the modules.
Thus, it is possible some modules have moderate to large sizes. In addition, with regulations,
measurements within the same modules often times have strong correlations. To reduce
dimensionality, remove collinearity, and simplify computation, we apply PCA, which can
be replaced by other dimension reduction techniques. Overall, the input for the next step
consists of the PCs (representing overlapping information) and the gene expressions and
regulators that do not form patterns (representing independent information).
Step III Here we conduct interaction analysis, that respects the “main effects, interactions”









(E′m X ′s)′(βs ∗ ηsm) +
M∑
m=1
(E′m Z ′)(γ ∗ τm) + ξ,
= g(X,Z,E) + ξ. (4.3)
Here α = (α1, · · · , αM )′, β = (β′1, · · · ,β′S), and γ = (γ1, · · · , γpz)′ correspond to the
main effects of the environmental factors, regulatory modules, and individual molecular
measurements (that do note belong to any module), respectively. For themth environmental
factor, βs ∗ ηsm and γ ∗ τm correspond to the interactions with the sth regulatory module
and all individual molecular measurements, respectively, with ∗ being the component-wise
product.  is the “matching column-wise” Khatri-Rao product. ξ is the random error
vector. Here, following the literature (Choi et al., 2010), we use the products EimXij and
EimZij to describe the interactions for the ith subject. To accommodate the hierarchical
structure of interaction analysis, the interaction effects βsjηsmj and γjτmj are decomposed
into two components, the first for the corresponding main effects (βsj and γj) and the other
for the interaction-specific effects (ηsmj and τmj).
For the estimation and identification of important interactions (and main effects), we
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where Φ = (α′,β′1, · · · ,β′S ,γ ′,η′11, · · · ,η′MS , τ ′1, · · · , τ ′M )′, || · ||2 is the L2 norm of a vector,
and λ1, λ2 ≥ 0 are tuning parameters. Gene expressions and regulators that are involved in
modules with nonzero estimated βs and βs ∗ ηsm are identified as having important main
effects and M-E interactions, respectively. In addition, for individual molecular measure-
ments, the nonzero components of γ and γ ∗ τm correspond to important main effects and
interactions, respectively.
Rationale A joint model is developed to accommodate all molecular and environmental ef-
fects and their interactions. As to be described below, the linear regression model can be
replaced by other models. For estimation and selection, we adopt penalization, which has
been the choice of quite a few recent interaction studies (Bien et al., 2013; Wu et al., 2019b).
For many datasets including those analyzed in this article, the environmental factors are
pre-selected based on existing knowledge and usually considered as important, so that their
coefficients are not subject to penalized selection. As such, the “main effects, interactions”
hierarchy postulates that an identified interaction corresponds to an identified main molec-
ular effect. To achieve this, we decompose the interaction effects into two components and
have that βsjηsmj 6= 0 only if βsj 6= 0 and γjτmj 6= 0 only if γj 6= 0 (Choi et al., 2010).
In (4.4), we employ group Lasso for regulatory modules (where PCs corresponding to the
same module form a group) and Lasso for individual molecular measurements to identify
M-E interactions and main effects. Here, all PCs corresponding to the same module are
in or out simultaneously, which is motivated by the coordinated nature of the molecular
measurements in the same module.
Accommodating other types of outcomes With a different type of outcome variable,
the lack-of-fit in (4.4) can be replaced by the negative log-likelihood function or an estimat-
ing equation-based measure. As an example, consider survival data, which is analyzed be-
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low. Denote T as the length n vector of survival times. Consider the AFT (accelerate failure
time) model log(T ) = g(X,Z,E) + ξ, where notations have similar implications as above.
Denote C as the length n vector of censoring times, then we observe Y = log(min(T ,C))
and δ = I(T ≤ C) with I(·) being the indicator function. Assume that data has been
sorted according to the observed times from the smallest to the largest. Compute the
Kaplan-Meier weights: ρ1 =
δ1








δi′ , i = 2, . . . , n. Then, we have the























The detailed computational algorithms for Steps I and III are provided in Algorithms 1 and
2 (Appendix), respectively. Step II can be realized using existing algorithms and R function
prcomp. In computation, effort has been made to take advantage of the existing algorithms
and software. When not possible, optimization has been based on the CD (coordinate de-
scent) techniques. In the literature, convergence properties of the CD and other techniques
used in computation have been well established. Convergence is observed in all of our numer-
ical studies. The two tuning parameters in (4.4) are selected using the extended Bayesian
information criterion (Chen and Chen, 2008). The proposed algorithm is computationally
feasible. For example, under a standard laptop configuration, it takes less than five min-
utes for a simulated dataset with 250 subjects, 500 gene expression measurements, and 500
regulator measurements. We have developed R code implementing the proposed approach
and made it publicly available at https://github.com/shuanggema/omics_interaction.
4.2.3 Heuristic theoretical justifications
Consider the scenario where the number of molecular factors (gene expressions and their
regulators) increases and the number of environmental factors is finite as the sample size
increases. There are several key estimation procedures and conditions. First, in the step
of identifying regulatory modules, the consistency of Lasso estimator Θ̂ is needed. For
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each gene expression, with probability at least 1 − 2√
π
qu−1n e
−u2n/2, θj can satisfy the weak
oracle property, under mild regularity conditions on the design matrix R, signal strengths,
Gaussian random error, and q = o(une
u2n/2). Here, the order of un can be o(n
a) with
a ∈ (0, 12 ], leading to log(q) = o(n
2a). Thus, with a total of p gene expressions, to ensure
the overall consistency of Θ̂, it is required that 1− 2√
π
qpu−1n e
−u2n/2 → 1 with the Bonferroni
approach. Assume that p and q are of the same order, then we have log(q) = log(p) = o(na).
Second, the adopted biclustering strategy is an “upgrade” of the sparse K-means clustering
with an L2/L1 penalty. For the sparse K-means with an L∞/L0 penalty, it has been shown
in Chang et al. (2018) that under certain regularity conditions, the estimated weight w has
feature selection consistency. Consistency under an L2/L1 penalty is expected to hold with
revised norm assumptions, which will lead to consistency of the estimated gene expression
clusters. Consistency of the estimated cluster centers of K-means has been well established
in Pollard (1981), which can support the consistency of the estimated regulator clusters.
Combining such results is expected to lead to the consistency of biclustering. Third, for
each regulatory module, PCA is conducted to extract integrated information. With the
ratio n/(|Cs| + |Ds|) → 0, Jung et al. (2009) shows that if the first few eigenvalues are
large enough compared to the others, then the corresponding estimated PC directions are
consistent or converge to the appropriate subspace (subspace consistency). Finally, for
estimators in interaction analysis with hierarchy, consistency has been established in Choi
et al. (2010) and Wu et al. (2019b). As shown in Wu et al. (2019b), under mild regularity
conditions on the design matrix, smallest signal, and tuning parameters, the estimator has
consistency properties, where the dimensionality p+ q is allowed to grow up exponentially
faster than the sample size.
4.3 Simulation
We set p = q = 500, M = 5, and n = 250, and generate environmental factors from inde-
pendent standard normal distributions. In addition, (a) we consider two settings for Θ to
represent different regulation patterns. The first (Θ1) contains 15 regulatory modules with
one overlapping. The corresponding elements are independently generated from normal
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distributions with mean ranging from −0.7 to 1.5 and standard deviation 0.1, covering dif-
ferent levels and directions of regulations on average. Each regulatory module contains 12.3
gene expressions and 16.6 regulators. The rest elements of Θ1 are zero. The second (Θ2)
contains 20 nonzero regulatory modules with one overlapping, and the nonzero values are
generated similarly as Θ1. Those modules consist of 6.0 gene expressions and 8.1 regulators
on average. Compared to Θ1, Θ2 contains more modules with smaller sizes, representing
a different type of regulations. (b) The values of regulators R involved in each regulatory
module are generated from a multivariate normal distribution with marginal means 0 and
variances 1. We consider three correlation structures. The first (R1) is an auto-regressive
structure where the correlation between the jth and lth variables is (−0.5)|j−l|. The second
(R2) is a banded structure where the correlation between the jth and lth variables is −0.5
if |j− l| = 1 and 0 otherwise. The third (R3) has a structure where the correlation between
the jth and lth variables is (−1)|j−l|/(|Cs|+ |Ds|). Among them, R1 and R2 are “diagonally
dominant”, while R3 has all correlations at the same level. The individual regulators that
are not involved in any regulatory modules are independently generated from the standard
normal distribution. As such, regulators in different modules are independent of each other
and also independent of the individual regulators. (c) Gene expression measurements are
generated by G = RΘ+ε, where the elements of ε follow independent standard normal dis-
tributions. (d) GivenG, R, and Θ, generate the integrated informationXs for each module
using the top PCs and Z for the individual molecular units. (e) With Xs, s = 1, · · · , S and
Z, consider the continuous response under model (5.2). Two types of nonzero coefficient
settings are considered, leading to a total of 100 (P1) and 70 (P2) important main molec-
ular effects and M-E interactions, respectively. These nonzero coefficients are generated
uniformly from (0.5, 0.8) (B1) or (0.8, 1.2) (B2), representing two signal levels, with the
“main effects, interactions” hierarchical structure satisfied. The molecular factors with im-
portant effects include gene expressions and regulators involved in the regulatory modules
as well as individual molecular measurements. Additional information is provided in the
Appendix. Random errors ξ are generated from independent standard normal distributions.
To better appreciate operating characteristics of the proposed module detection proce-


























































































Figure 4.2: Simulation. Left: true values of regulation under setting Θ1 and R1; Middle:
estimated values; Right: identified regulatory modules.
the true regulation relationships between gene expressions and regulators in Figure 4.2,
together with their estimated values and identified regulatory modules. We observe that
with moderate associations between small sets of molecular measurements, the estimated Θ̂
based on Lasso closely reflects the true regulation relationships. Furthermore, biclustering
is able to properly identify the regulatory modules based on the estimated regulations.
To be more informative, besides the proposed approach, we also consider the following
alternatives which have closely related frameworks. Comparing with these alternatives can
directly establish the necessity of the considerations on gene expression-regulator regula-
tions, correlations within regulatory modules, and hierarchical interactions. Specifically,
Alt.1 excludes Step II of integration and builds the hierarchical interaction model using
gene expressions and regulators directly combined as groups based on the identified reg-
ulatory modules. Alt.2 excludes the decomposition of interaction coefficients in Step III,
and so the “main effects, interactions” hierarchical structure may be violated. Alt.3 builds
the hierarchical joint model directly using the original stacked gene expression and regula-
tor measurements without accounting for the regulations. Alt.4 incorporates the original
stacked gene expression and regulator measurements directly in the interaction model. It
ignores the regulation relationships and interaction hierarchy. For evaluation, we consider
the numbers of true positives (TP) and false positives (FP) for main effects and interactions
together.
For each scenario, 200 replicates are simulated. Summary results under settings P1 and
P2 are presented in Tables 4.1 and 4.2 respectively. We observe that the proposed ap-
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proach achieves better or comparable performance in identification accuracy. For example
in Table 4.1 with weak effects (B1), regulation pattern Θ1, and correlation structure R1,
the proposed approach selects on average 95.94 true positives, compared to 71.90 (Alt.1),
65.20 (Alt.2), 23.15 (Alt.3), and 16.80 (Alt.4). When there are more correlated molecular
measurements, the proposed approach remains superior in identification. For instance in
Table 4.1 with weak effects (B1), regulation pattern Θ1, and correlation structure R3, the
proposed approach selects on average 99.70 true positives with 8.50 false positives. In com-
parison, Alt.1, Alt.2, Alt.3, and Alt.4 select fewer true positives and more false positives
with (TP,FP)=(83.68,12.26), (95.90,54.75), (27.30,14.70), and (20.75,136.65), respectively.
With a higher signal level under setting B2, all approaches behave better, while with more
regulation modules under setting Θ2, performance of all approaches decays. Under both
settings, the proposed approach still has advantage. It is observed that Alt.1 generally
achieves the second best identification performance, and under some scenarios it is compet-
itive in true positive identification compared to the proposed approach, at the cost of larger
numbers of false positives. This is because the integration procedure of the proposed ap-
proach that uses PCs for the joint interaction model can effectively remove collinearity and
reduce false discovery. The proposed approach performs better than Alt.2, suggesting that
the hierarchical interaction modeling can lead to more accurate identification. The superior
performance of the proposed approach over Alt.3 and Alt.4 provides a direct support to the
integrated analysis strategy that accommodating the regulations among multidimensional
molecular data in interaction analysis substantially improves identification performance.
4.4 Data analysis
TCGA is one of the largest data resources with multidimensional profiling. TCGA data
have been analyzed in interaction analysis with one type of molecular measurements as well
as integrated modeling with the main effects of multiple types of molecular measurements.
This study is the first to conduct the integrated M-E interaction analysis. We analyze data
on lung adenocarcinoma (LUAD) and cutaneous melanoma (SKCM). Data are downloaded
from TCGA Provisional using the R package cgdsr.
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Table 4.1: Summary results for simulation under setting P1 with a total of 100 true positives:
mean (sd) from 200 replicates.
Θ1 Θ2
Approach TP FP TP FP
B1 R1 Proposed 95.94(4.63) 11.39(13.83) 80.06(5.37) 6.31(6.02)
Alt.1 71.90(35.35) 20.45(24.20) 27.06(19.83) 1.94(1.12)
Alt.2 65.20(28.39) 28.75(14.03) 31.69(15.05) 7.94(18.32)
Alt.3 23.15(3.47) 7.45(3.90) 20.35(9.10) 19.85(8.43)
Alt.4 16.80(2.09) 122.20(38.35) 29.85(5.73) 127.40(40.31)
R2 Proposed 97.30(1.75) 5.70(10.99) 80.72(4.64) 20.89(25.90)
Alt.1 86.60(30.13) 13.00(16.06) 47.00(16.82) 6.11(4.92)
Alt.2 85.15(16.11) 39.95(6.87) 33.61(11.44) 19.06(21.78)
Alt.3 23.35(4.18) 7.65(2.89) 21.05(5.77) 25.79(6.27)
Alt.4 16.95(2.86) 126.05(46.47) 16.00(9.56) 71.15(65.52)
R3 Proposed 99.70(0.57) 8.50(14.60) 79.40(3.22) 36.13(38.10)
Alt.1 83.68(27.69) 12.26(18.29) 51.14(25.72) 8.71(11.69)
Alt.2 95.90(8.09) 54.75(12.48) 30.50(14.39) 4.50(7.60)
Alt.3 27.30(1.63) 14.70(17.41) 20.21(7.79) 22.11(8.46)
Alt.4 20.75(2.65) 136.65(37.06) 20.00(8.55) 103.05(63.77)
B2 R1 Proposed 99.80(0.41) 14.25(18.95) 83.90(4.43) 12.60(10.56)
Alt.1 99.80(0.41) 57.80(22.75) 32.00(23.43) 14.35(13.92)
Alt.2 85.80(14.06) 55.55(27.20) 34.75(13.98) 18.25(9.48)
Alt.3 27.17(2.46) 5.28(1.02) 27.15(8.67) 35.15(11.45)
Alt.4 21.45(2.98) 142.05(31.31) 30.30(10.98) 110.10(66.72)
R2 Proposed 99.82(0.39) 4.12(14.69) 77.88(3.67) 20.81(12.93)
Alt.1 90.80 (27.98) 38.65(21.69) 42.69(22.46) 12.06(8.73)
Alt.2 77.85(19.63) 47.05(16.62) 21.75(19.49) 19.05(22.55)
Alt.3 27.37(2.29) 7.79(3.31) 17.45(5.84) 18.95(11.87)
Alt.4 19.60(2.19) 135.35(36.02) 14.95(9.74) 52.40(47.98)
R3 Proposed 99.35(0.67) 12.05(17.72) 77.77(2.95) 9.85(6.67)
Alt.1 96.45(13.77) 50.45(17.38) 35.65(19.45) 21.95(13.06)
Alt.2 86.45(12.17) 46.45(11.91) 16.50(16.99) 10.00(13.13)
Alt.3 28.88(3.14) 7.71(2.52) 14.35(4.89) 16.35(7.19)
Alt.4 21.25(2.71) 140.65(30.84) 14.95(10.79) 65.15(62.45)
4.4.1 Analysis of LUAD data
The response of interest is the reference value for the pre-bronchodilator forced expiratory
volume in one second in percent (FEV1). It is an important biomarker for lung capacity,
with a lower value suggesting the potentially functional disorder of the lung, and has been
shown to be a powerful marker for future morbidity and mortality (Young et al., 2007).
It is continuously distributed and ranges from 1.95 to 156 with mean 80.58 and standard
deviation 23.55. We focus on the primary tumor samples of the Whites. For environmental
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Table 4.2: Summary results for simulation under setting P2 with a total of 70 true positives:
mean (sd) from 200 replicates.
Θ1 Θ2
Approach TP FP TP FP
B1 R1 Proposed 68.85(0.88) 0.40(0.50) 67.30(3.26) 2.30(5.65)
Alt.1 63.30(15.69) 34.80(23.26) 33.95(20.68) 6.68(10.37)
Alt.2 65.25(4.27) 31.85(8.55) 52.15(10.98) 38.30(36.79)
Alt.3 22.25(4.46) 7.85(4.49) 20.95(4.32) 23.85(9.28)
Alt.4 15.30(2.75) 129.45(42.29) 28.10(4.10) 127.65(43.63)
R3 Proposed 57.15(18.43) 10.50(6.36) 53.90(12.49) 2.65(2.21)
Alt.1 42.55(28.65) 18.00(25.46) 38.25(15.21) 4.40(8.18)
Alt.2 42.50(21.19) 24.05(14.57) 28.00(17.26) 3.70(6.14)
Alt.3 24.50(2.50) 10.90(8.42) 18.00(11.31) 23.00(24.04)
Alt.4 14.30(1.95) 107.05(30.44) 16.95(5.31) 83.85(51.99)
R3 Proposed 67.15(6.71) 1.40(3.98) 51.90(13.63) 2.55(2.74)
Alt.1 61.00(19.74) 27.80(17.56) 34.25(6.54) 8.10(14.49)
Alt.2 65.35(5.05) 36.35(11.94) 44.45(15.43) 47.00(43.04)
Alt.3 22.75(2.90) 9.95(7.49) 15.75(4.88) 18.85(12.33)
Alt.4 15.40(2.26) 117.65(30.91) 19.20(5.69) 105.85(61.27)
B2 R2 Proposed 69.75(0.55) 1.70(6.67) 67.05(5.88) 10.50(11.00)
Alt.1 69.75(0.44) 32.30(11.68) 65.40(7.38) 28.65(30.47)
Alt.2 66.40(5.23) 38.15(30.67) 46.00(12.02) 2.30(5.25)
Alt.3 25.79(5.54) 11.05(17.48) 20.95(4.32) 23.85(9.28)
Alt.4 16.65(2.21) 136.00(36.41) 36.25(4.27) 150.50(45.17)
R2 Proposed 67.15(11.35) 1.15(3.77) 57.10(11.11) 4.55(4.08)
Alt.1 69.80(0.52) 33.70(12.69) 41.85(15.79) 16.35(9.42)
Alt.2 58.15(9.91) 36.55(11.76) 43.55(15.74) 11.50(13.61)
Alt.3 26.85(2.89) 6.85(2.13) 18.00(11.31) 23.00(24.04)
Alt.4 17.50(2.65) 148.40(45.18) 18.90(6.21) 91.40(53.36)
R3 Proposed 69.85(0.37) 2.80(7.25) 56.77(8.12) 3.69(6.32)
Alt.1 68.90(4.46) 32.95(9.29) 39.35(12.57) 19.35(18.79)
Alt.2 66.35(6.67) 35.45(7.99) 50.05(11.98) 7.15(14.18)
Alt.3 26.70(3.37) 7.40(3.42) 15.75(4.88) 18.85(12.33)
Alt.4 16.75(1.97) 133.65(32.08) 16.20(6.05) 63.40(43.57)
risk factors, we consider age, American Joint Committee on Cancer (AJCC) tumor patho-
logic stage (Stage), tobacco smoking history indicator (Smoking), and gender, which have
been extensively investigated in the literature. We analyze mRNA gene expression mea-
surements which were collected using the Illumina HiSeq 2000 RNA Sequencing Version 2
analysis platform. For regulators, we include CNV measurements that were collected using
the Genome-Wide Human SNP Array 6.0 platform and DNA methylation measurements
that were collected using the Illumina Infinium HumanMethylation450 platform. A total of
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18,345 gene expression, 23,321 CNV, and 15,288 methylation measurements are available.
In principle, the proposed approach can be directly applied. However, considering that only
a small number of molecular measurements are potentially associated with the outcome and
the analysis may be unstable with the high dimensionality and small sample size, we con-
duct a prescreening. Specifically, we select the top 1,000 molecular measurements with the
smallest p-values using marginal regression. This leads to 164 subjects with 467 gene ex-
pression and 533 regulator (316 CNV and 217 methylation) measurements for downstream
analysis.
The proposed analysis identifies 20 regulatory modules in Step I, and each module on
average contains 11.70 gene expression and 7.35 regulator measurements. The graphical
presentation of the modules is provided in Figure C.1 (Appendix), where some overlappings
between modules are observed. In interaction analysis, the proposed approach identifies
62 main molecular effects and 29 M-E interactions, among which 50 main effects and 27
interactions belong to six regulatory modules. The identified main effects consist of 41
gene expression, 9 CNV, and 12 methylation measurements, and the identified interactions
consist of 20 with gene expressions and 9 with methylations. Detailed estimation results
are presented in Table 4.3, where a “group” corresponds to a module or an individual
measurement. Literature search suggests that the findings are biologically sensible. For
example, Stage and Smoking are shown to be negatively associated with FEV1, which has
also been suggested in previous studies. Gene AFF3 is identified along with its interactions
with Smoking and gender. A decreased methylation of gene AFF3 in non-small cell lung
tumors has been found as one of the key epigenetic changes associated with lung cancer
development. Gene PWRN1 has been reported to be involved in the process of spermato-
genesis, and its expression level has been shown to be related to tumor size in lung cancer
patients. Gene CACNG3 has been identified as an oncogene from a pan-cancer study with
somatic mutation data, suggesting its potentially important role for lung adenocarcinoma.
Gene PRH1 has been identified as one of the candidate exosomal protein biomarkers for the
detection of lung cancer using human saliva and serum. In addition, published studies have
shown that gene CACNG6 is significantly upregulated in lung squamous cell carcinoma
compared to normal lung tissues. Gene PABPC5 has been found to be hypermethylated
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among early-stage non-small cell lung cancer patients compared to controls. Gene MAP4K4
has been demonstrated to be frequently overexpressed in many types of human cancers, re-
lating to transformation, invasiveness, adhesion, and cell migration. Patients with lung
adenocarcinoma and high MAP4K4 expressions have been found to have a shorter overall
survival. The lower expression levels of gene DRD3 have been found among patients with
non-small cell lung cancer.
We take a closer look at the functional and biological connections of genes involved in
each identified regulatory module. Specifically, the gene ontology (GO) enrichment analysis
is conducted using DAVID version 6.8 (Sherman et al., 2009). It is observed that the
identified modules are biologically meaningful with certain significantly enriched GO terms.
For example, in regulatory module #1, genes CACNG6 and RYR3 are enriched with calcium
channel activity (GO:0005262, p-value= 0.0042) and calcium ion transport (GO:0006816,
p-value=0.0072). Biological studies have found calcium controls cell death and proliferation
that are relevant to tumorigenesis, and up or down regulations of specific calcium channels
and pumps are associated with cancers. As another example, genes ATP8A2 and DGUOK
in regulatory module #20 are enriched with purine nucleoside triphosphate (GO:0009144,
p-value=0.0053) and purine nucleoside metabolic process (GO:0006163, p-value=0.008),
suggesting the functional and biological connections within the identified module.
Analysis is also conducted using the alternative approaches. In Table C.1 (Appendix),
we provide the comparison results, including the numbers of identified main effects and
interactions, and numbers of overlapping and RV coefficients between the identifications us-
ing different approaches. The RV coefficient measures the common information of two data
matrices. It lies between 0 and 1, and a larger value indicates a higher degree of overlapping.
We observe that different approaches select significantly different sets of main effects and
interactions, with moderate overlapping as measured by the RV coefficients. In practical
data analysis, it is difficult to objectively evaluate identification performance. To provide
an indirect support, we evaluate prediction performance and selection stability. Specifically,
for prediction evaluation, we consider the prediction mean squared error (PMSE) based on
200 random resamplings (9/10 training and 1/10 testing samples). The proposed approach
demonstrates competitive performance with the average PMSE= 1.02, compared to 1.25
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(Alt.1), 1.16 (Alt.2), 1.05 (Alt.3), and 1.02 (Alt.4). We also assess selection stability using
the observed occurrence index (OOI) (Huang et al., 2006). For each identified main effect
(interaction), OOI computes its selection frequency in the 200 resamplings, and a larger
value suggests higher stability. The proposed approach is observed to have much satisfac-
tory stability with the average OOI value being 0.77, compared to 0.53 (Alt.1), 0.45 (Alt.2),
0.26 (Alt.3), and 0.21 (Alt.4).
4.4.2 Analysis of SKCM data
The response of interest is overall survival, which is subject to censoring. We focus on the
primary tumor samples of the Whites. We consider age, AJCC tumor pathologic stage
(Stage), gender, and Clark level at diagnosis (Clark), all of which have been suggested as
associated with melanoma in the literature. A total of 18,925 gene expression, 23,287 CNV,
and 15,616 methylation measurements are available. With the same prescreening as in the
previous analysis, the data used for downstream analysis contains 314 gene expression and
686 regulator (397 CNV and 289 methylation) measurements on 231 subjects, of which 139
died during follow-up. The observed times range from 2.04 to 357.10 months with median
56.31.
The proposed analysis identifies 17 regulatory modules, which contain on average 7.60
gene expressions and 6.45 regulators. The graphical presentation is provided in Figure C.1
(Appendix). The AFT model is assumed for modeling survival. A total of 28 main effects
and 12 interactions are selected by the proposed approach, among which 14 main effects
belong to one identified regulatory module and the remaining are related to the individual
molecular units. The identified main effects consist of 15 gene expression and 13 methyla-
tion measurements, and the identified interactions consist of 9 with gene expressions and 3
with methylations. The estimated coefficients are presented in Table 4.4. Examining the
estimated coefficients suggests that melanoma patients with higher levels of age, Stage, and
Clark have a shorter survival. Findings on the molecular variables are also sensible. For
instance, gene IMP3 has been found to be associated with cell proliferation and considered
as an oncofetal protein-related gene. Its expression level has been used as a diagnostic
and prognostic marker from surgical pathology in malignant melanoma. TBC1D7 is one
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Table 4.3: Analysis of the LUAD data using the proposed method: identified main effects
and interactions.
Group Type Gene Main Age Stage Smoking Gender
0.010 -0.031 -0.201 -0.067
1 GE VIT 0.006
1 GE PRH1 0.007
1 GE NOXRED1 0.006
1 GE RYR3 0.007
1 GE SERPINB11 0.007
1 GE ZNF273 0.004
1 GE WRAP53 0.003
1 GE SNORA7B 0.006
1 GE GUCY2F 0.007
1 GE STATH 0.007
1 GE CACNG6 0.007
1 DM WIPI2 -0.005
3 GE LINC00922 -0.059 0.009 0.001 0.004
3 GE NDP -0.059 0.008 0.001 0.004
3 GE TNMD -0.055 0.008 0.001 0.004
3 GE IBSP -0.055 0.008 0.001 0.004
3 GE PWRN1 -0.053 0.008 0.001 0.004
3 GE CACNG3 -0.053 0.008 0.001 0.004
3 DM MIS18A -0.045 0.007 0.001 0.003
3 DM RRP1 -0.036 0.005 0.001 0.002
3 DM ZDHHC2 -0.044 0.006 0.001 0.003
9 GE ZXDA -0.014
9 GE EXOSC8 0.022
9 GE EPSTI1 0.020
9 GE UGT2B4 -0.012
9 CNV SLC22A10 0.009
9 CNV PABPC5 0.018
9 DM ATP8A2 0.010
9 DM DHX32 0.013
15 GE KL -0.016
15 CNV MAP4K4 -0.013
15 CNV KCMF1 -0.016
15 DM SATB2 -0.013
16 GE HIST1H2AA -0.009
16 GE KCNIP3 -0.008
16 GE LRRTM3 -0.011
16 GE DCLRE1A -0.012
16 GE PPP1R3D -0.007
16 GE NHLRC2 -0.009
16 GE NPAP1 -0.010
16 CNV MAP4K4 -0.011
Continued on the next page
of the down-regulated genes that are potentially causal for the induction of loss of prolif-
erative capacity and terminal differentiation in human melanoma cells. The lack of gene
A2M expression provides a growth advantage to melanoma cells by interfering with effec-
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Table 4.3: Continued from the previous page.
Group Type Gene Main Age Stage Smoking Gender
20 GE FTSJ1 0.013
20 GE DGUOK 0.012
20 GE SESN3 -0.008
20 GE CAPZB 0.009
20 CNV PABPC5 0.005
20 CNV MRGPRD 0.008
20 DM IL17D 0.008
20 DM ATP8A2 0.006
20 DM DHX32 0.004
21 GE AFF3 -0.106 0.147 -0.013
27 GE SGPP2 -0.009
47 GE FNIP2 -0.027
50 GE C11orf65 0.005
68 GE DRD3 0.012
102 GE DPRX 0.026
124 GE PRIMA1 -0.016
178 GE FAM217B -0.013
304 CNV AK4 0.014
319 CNV MIR582 -0.024
423 DM HOXA1 -0.027
520 DM SDE2 0.014
tive antigen presentation. IL24 is a novel tumor suppressor gene with tumor-apoptotic
and immune-activating properties, and one of several genes that are upregulated during
terminal differentiation of melanoma cells. The high expression level of gene ZDHHC4 has
been observed in NRAS mutant melanoma cell lines. Published studies have also found a
statistically significant overexpression of gene BRF2 in cutaneous melanoma compared to
normal skin, and suggested it as a potential marker for patients at risk for metastasis. Gene
RBP2 has been shown to directly regulate gene transcription in a reporter assay system as
a transcriptional regulator with a tumor suppressive potential in melanoma cells. For the
identified module, we further conduct the GO enrichment analysis. It is observed that the
involved genes share common GO terms. For example, genes A2M, ENOX1, and IL24 are
enriched with extracellular space (GO:0005615, p-value=0.0097), for which published stud-
ies have suggested that extracellular vesicles released to extracellular space are correlated
with genetic tumor progression in human cancer.
We conduct analysis using the alternatives and summarize the comparison results in
Table C.1 (Appendix). Similar patterns as in the previous analysis are observed, where
different approaches have small numbers of overlapping identifications and moderate RV
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coefficients. We also conduct the prediction and selection stability evaluation. With the
censored survival response, we adopt the C statistic to measure prediction accuracy (Uno
et al., 2011). A larger value of C statistic indicates better prediction. The proposed approach
has an average C statistic 0.60, compared to 0.57 (Alt.1), 0.48 (Alt.2), 0.47 (Alt.3), and
0.59 (Alt.4). In addition, it has superior selection stability with an average OOI of 0.74,
compared to 0.56 (Alt.1), 0.50 (Alt.2), 0.38 (Alt.3), and 0.26 (Alt.4). These results provide
a strong support to the proposed M-E interaction analysis.
Table 4.4: Analysis of the SKCM data using the proposed method: identified main effects
and interactions.
Group Type Gene Main Age Stage Gender Clark
-0.176 -0.099 0.150 -0.042
14 GE MYCNOS 0.003
14 GE MRGPRX3 0.004
14 GE MFSD6L 0.005
14 GE IMP3 0.005
14 GE TBC1D7 0.003
14 GE A2M 0.004
14 GE NEURL2 0.005
14 GE IL24 0.004
14 DM MAU2 0.004
14 DM ZDHHC4 0.004
14 DM ENOX1 0.002
14 DM PTPN12 0.005
14 DM BRF2 0.002
14 DM SYT6 0.002
70 GE DSTYK -0.054 0.123 -0.164
71 GE GLDN 0.044 -0.058 0.012
82 GE RBP2 -0.029 -0.026
124 GE SATB2 -0.057 -0.032 0.034
153 GE RPL36AL 0.003
204 GE RNPS1 -0.057 0.112 0.084
214 GE ARL6IP1 -0.014
573 DM DPY19L3 0.006
640 DM RABEP1 -0.080 -0.071 0.010
647 DM SLU7 -0.004
654 DM KLHL31 -0.023
696 DM GLMP -0.016
714 DM BNIP1 -0.025
759 DM MS4A15 0.055 -0.045
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4.5 Discussion
Modeling the outcomes and phenotypes of cancer and other complex diseases is an “old”
but still widely open problem. In this Chapter, we have developed the M-E interaction
analysis, which is the natural next step of the existing literature. In particular, it is built
on but advances from the existing gene-environment interaction analysis by incorporating
multiple types of molecular measurements (which have overlapping but more importantly
independent information in a single analysis). It also advances from the existing multidimen-
sional molecular data analysis by incorporating interactions and respecting the hierarchical
structure. The proposed approach has sound biological and statistical basis. Its working
characteristics are carefully examined, and simulation and data analysis have demonstrated
its satisfactory performance.
It remains an open question how to best accommodate multidimensional molecular data
in modeling. The proposed analysis Step I has been motivated by Wang et al. (2012b), Zhu
et al. (2016a), and several other studies. Similar to the literature, linear modeling and
regularized estimation have been applied for estimating the regulations. Different from
the literature, biclustering has been conducted to identify local regulations, where a small
number of co-expressed genes are regulated by a small number of regulators in a coordinated
manner. It advances from Zhu et al. (2016a) and others by relaxing the rank-one constraint.
The Step II of dimension reduction can be conducted by other techniques such as partial
least squares, can effectively reduce dimensionality and remove collinearity, and has been
shown as effective in numerical study. There are alternative techniques for interaction
analysis in Step III. We have chosen penalization for the consistency of analysis framework.
It will be of interest to extend by adopting other estimation/selection techniques. We have
used gene expressions and their regulators for description. The proposed approach can be




Application of Interaction Analysis
for Histopathological Imaging Data
5.1 Introduction
Cancer is extremely complex. Extensive statistical investigations have been conducted,
modeling various cancer outcomes/phenotypes. A long array of measurements from differ-
ent domains have been used in cancer modeling, including clinical/environmental factors,
socioeconomic factors, omics (genetic, genomic, epigenetic, proteomic, etc.) measurements,
histopathological imaging features, and others. Yet, none of the existing models is com-
pletely satisfactory, and it remains a challenging task to develop new ways of cancer mod-
eling.
Imaging has been playing an irreplaceable role in cancer practice and research (Fass,
2008). It is routine for radiologists to use CT, MRI, PET, and other techniques to gener-
ate radiological images, which can inform the size, location, and other “macro” features of
tumors (Benzaquen et al., 2019). Biopsies are ordered, and pathologists review the slides
of representative sections of tissues to make definitive diagnosis. This procedure generates
histopathological (diagnostic) images (Gurcan et al., 2009). Through microscopically exam-
ining small pieces of tissues, more “micro” features of tumors are obtained. Histopatholog-
ical images have been used as the gold standard for diagnosis. More recently, histopatho-
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logical imaging features have also been used to model other cancer outcomes/phenotypes.
For example, in Yuan et al. (2012), they were used for predicting the prognosis of estrogen
receptor-negative breast cancer, and a multivariate Cox regression was adopted. In Tabesh
et al. (2007), histopathological imaging features were used in a k-nearest neighbor classifier
to assign images into different groups of Gleason tumor grading for prostate cancer patients.
With the complexity of cancer, a single domain of measurement is insufficient, and mea-
surements from multiple sources are needed in modeling (Zhong et al., 2019). In the liter-
ature, histopathological imaging features and clinical/environmental risk factors have been
combined in an additive manner for modeling cancer outcomes. In Wang et al. (2014), for
modeling lung cancer prognosis, clinical factors (including age, gender, cancer type, smok-
ing history, and tumor stage) were combined with imaging features in a multivariate Cox
regression model. This study and those alike have shown that combining the two sources of
information are more informative than a single source. Our literature review suggests that
most if not all of the existing studies have considered the additive effects of histopatho-
logical imaging features and clinical/environmental factors, and studies that accommodate
their interactions (referred to as “I-E” interactions, with “I” and “E” standing for imag-
ing and clinical/environmental factors, in this Chapter) are lacking. Statistically, adding
interactions when the main-effect models are not fully satisfactory is “normal”. Biologi-
cally speaking, incorporating such interactions have been partly motivated by the success
of gene-environment interactions. Specifically, in the literature, the biological rationale and
practical success of G-E interactions have been well established (Hunter, 2005). Cancer is
a genetic disease. Histopathological images reflect essential information on the histological
organization and morphological characteristics of tumor cells and their surrounding tumor
microenvironment, which are heavily regulated by tumors’ molecular features. As such,
from G-E interactions, we may naturally derive I-E interactions. It is noted that I-E and
G-E interaction analyses cannot replace each other. More specifically, not all genetic in-
formation is contained in imaging features, and histopathological features, as reflected in
imaging data, are also affected by factors other than molecular changes.
This study has also been partly motivated by the ineffectiveness of techniques adopted in
the existing studies. Histopathological images contain rich information, and the number of
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extracted features can be quite large, posing analytic challenges. This dimension problem
is “brutally” handled in some studies. For example, in Luo et al. (2017), the univariate
Cox model was fit to each imaging feature, and those with the strongest marginal effects
were selected. Such features were then used along with clinical characteristics, including
age, gender, smoking status, and tumor stage, to construct the final prognostic model.
When joint modeling is the ultimate goal, the aforementioned approach may miss truly
important signals in the first step of screening. To accommodate the high dimensionality
in joint modeling, penalization and other regularization techniques have been adopted. For
example, in Yu et al. (2016), the elastic net approach, which combines the Lasso and ridge
penalties, was used along with Cox regression. With the differences between interactions
and main effects, such methods cannot be directly applied to analysis that accommodates
I-E interactions. There are also studies that use advanced deep learning techniques. For
example, Bychkov et al. (2018) used the CNN (convolutional neural network) technique
to predict colorectal cancer prognosis based on images of tumor tissue samples. Other
examples also include Zhu et al. (2017) and Coudray et al. (2018). Such deep learning
techniques may excel in prediction, however, usually lack interpretations and also suffer
from a lack of stability when sample size is small.
The main objective of this article is to explore accommodating I-E interactions in cancer
modeling. Although the concept may seem simple, such an interaction analysis has not been
conducted in the literature. The adopted statistical methods have been “borrowed” from
G-E interaction analysis. With the connectedness between genetic and histopathological
imaging features and parallelization of G-E and I-E interaction analysis, such a strategy is
sensible. The proposed interaction analysis strategy and methods are demonstrated using
the TCGA lung adenocarcinoma data. Overall, this study may suggest an alternative way
of utilizing histopathological imaging data and modeling cancer more accurately.
5.2 Data
We demonstrate I-E interaction analysis using the TCGA lung cancer data. TCGA is a
collective effort organized by NCI and has published comprehensive data, especially on
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outcomes/phenotypes, clinical/environmental measures, and histopathological images, for
lung and other cancer types. Lung cancer is the leading cause of cancer death globally
(Boolell et al., 2015), and lung adenocarcinoma (LUAD) is the most common histological
subtype and has posed increasing public concerns (Network et al., 2014). The TCGA LUAD
data has been analyzed in multiple published studies, including Wang et al. (2014) and Luo
et al. (2017) that analyzed histopathological images, and Karlsson et al. (2014) and Li et al.
(2014) that conducted analysis on clinical/environmental factors. Thus, it is of interest
to “continue” these studies on main additive effects and further examine potential I-E
interactions with the TCGA LUAD data. It also has the advantage of having a relatively
larger sample size, which is critical to achieve meaningful findings. It is noted that the
proposed analysis can be directly applied to data on other cancer types.
We acquire 541 whole slide histopathology images from the TCGA data portal (https:
//portal.gdc.cancer.gov/projects/TCGA-LUAD). To extract imaging features, we adopt
the following pipeline developed by Luo et al. (2017). First, as the size of the whole slide
images, which is from 300Mb up to 2Gb with 110,000×70,000 pixels, is too huge to be
analyzed directly, each image is cropped into sub-images with 500×500 pixels and saved as
tiff image files using the Openslide Python library. Analyzing all the sub-images (more than
10 million image tiles in total) is still computationally unfeasible. Thus, twenty represen-
tative tiff sub-images that contain mostly (>50%) regions of interest are randomly selected
as input for the following process. It is expected that the randomly selected sub-images
are representative samples for the overall “population” of sub-images. Such cropping and
random selection are common steps in whole slide image processing and widely adopted
in published imaging studies (Sun et al., 2018a; Yu et al., 2017, 2016; Zhu et al., 2016b).
It is noted that randomly selecting sub-images may lead to imaging features with very
small differences (and so affect downstream analysis). However, as our main goal is cancer
model building, as opposed to feature selection, such small differences may not be of major
concern.
Second, we adopt CellProfiler (Soliman, 2015), a platform designed for cell image pro-
cessing and used in quite a few recent publications, to extract quantitative features from
each sub-image. Specifically, image colors are separated based on hematoxylin and eosin
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staining, and converted to grayscale for extracting regional features. Next, cell nuclei are
detected and segmented so that cell-level features can be specifically measured. Other
features such as regional occupation, area fraction, and neighboring architecture are also
captured. Irrelevant features such as file size and execution information are excluded from
analysis. This procedure results in a total of 772 features which are categorized into the
texture, geometry, and holistic groups. Specifically, the texture group contains Haralick,
Gabor “wavelet”, and Granularity features, which are classic image processing features,
measure the texture properties of cells and tissues, and have been examined in a large num-
ber of imaging studies. The geometry group contains features that describe the geometry
properties (such as area, perimeter, and so on), and those extracted by Zernike moments.
The holistic group contains holistic statistics that describe overall information, such as the
total area, perimeter and number of nuclei, and nuclear staining area fraction.
Third, for each patient, the features of images are normalized using sample mean at
the patient level. Missing values (with a missing rate lower than 20%) are imputed using
sample medians.
For clinical/environmental risk factors, we consider age, American Joint Committee
on Cancer tumor pathologic stage, tobacco smoking history indicator, and sex. These
variables have been suggested as associated with multiple lung cancer outcomes/phenotypes,
including those analyzed in this article (Westcott et al., 2015). In particular, Nordquist et al.
(2004) found that the mean age at diagnosis of lung adenocarcinoma among never-smokers
was significantly higher than that among current smokers, and the never-smokers with lung
adenocarcinoma were predominantly female. Studies have shown that tobacco smoking is
responsible for 90% of lung cancer (Bryant and Cerfolio, 2007), and has been identified as a
negative prognostic factor for lung adenocarcinoma (Landi et al., 2008). In addition, these
factors have also been considered in G-E interaction analysis (Wu et al., 2017).
Multiple outcome variables have been analyzed in the literature (Wang et al., 2014).
In this article, we consider two important response variables: (a) FEV1: the reference
value for the pre-bronchodilator forced expiratory volume in one second in percent. It is an
important biomarker for lung capacity. It is continuously distributed, with mean 80.28 and
interquartile range [67.00, 96.25]. Data is available for 132 subjects; and (b) overall survival,
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which is subject to right censoring. Data is available for 271 subjects, among whom 102
died during follow-up. The mean observed time is 27.47 months, with interquartile range
[14.06, 35.00].
Remarks The adopted feature extraction process follows Luo et al. (2017), where the
extracted imaging features were used to predict lung cancer prognosis. Similar processes
have also been adopted in other publications (Yu et al., 2017, 2016). Different from lim-
ited histopathological features recognized visually by pathologists, CellProfiler extracted
features are morphological features of tissue texture, cells, nuclei, and neighboring architec-
ture. These features are extracted and measured by comprehensive computer algorithms,
and are impossible to be assessed by human eyes. As demonstrated in Luo et al. (2017),
quantitative imaging features provide objective and rich information contained in images
that can reveal hidden information to decode tumor development and progression in lung
cancer. Following the literature (Luo et al., 2017; Sun et al., 2018a; Zhu et al., 2016b),
we adopt feature names automatically assigned by CellProfiler, as can be partly seen in
Tables 5.1-5.4. These names provide a brief description of the extracted information with
the general form “Compartment FeatureGroup Feature Channel Parameters”. For exam-
ple, features “AreaShape MedianRadius” and “AreaShape MaximumRadius” measure the
median and maximum radius of the identified tissue, respectively. As in some recent stud-
ies (Luo et al., 2017; Sun et al., 2018a; Zhu et al., 2016b), in this Chapter, our goal is
not to identify specific imaging features as markers and make biological interpretations.
Instead, we aim to conduct better cancer modeling by incorporating I-E interactions. As
such, although they may not have simple, explicit biological interpretations, these features
are sensible for our analysis.
5.3 Methods
In parallel to G-E interaction analysis (Wu and Ma, 2019), we conduct two types of I-E inter-
action analysis, namely marginal and joint analysis. The overall flowchart of analysis is pro-
vided in Figure 5.1. In marginal analysis, one imaging feature, one clinical/environmental
variable (or multiple such variables), and their interaction are analyzed at a time. In joint
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analysis, all imaging features, all clinical/environmental variables, and their interactions are
analyzed in a single model. The two types of analysis have their own pros and cons and
cannot replace each other. We refer to the literature (Witten and Tibshirani, 2010; Zhang
et al., 2011) for more detailed discussions on the two types of analysis.
Figure 5.1: Flowchart of the I-E interaction analysis of TCGA LUAD data.
99
First consider a continuous cancer outcome, which matches the FEV1 analysis. Denote
Y as the length N vector of outcome, where N is the sample size. Denote E = [E1, · · · , EJ ]
as the N × J matrix of clinical/environmental variables, and X = [X1, · · · , XK ] as the
N × K matrix of imaging features. As represented by the LUAD data, usually clini-
cal/environmental variables are pre-selected and low-dimensional, and imaging features are
high-dimensional.
5.3.1 Marginal analysis
Detailed discussions of marginal G-E interaction analysis are available in Xu et al. (2019)
and other recent literature. The marginal I-E interaction analysis proceeds as follows. First
assume that Y , E, and X have been properly centered.
(a) For j = 1, . . . , J and k = 1, . . . ,K, consider the linear regression model
Y = αjEj + βkXk + γjkEjXk + ε, (5.1)
where αj and βk respectively represent the main effects of the j
th clinical/environmental
factor and the kth imaging feature, γjk is the interactive effect, and ε is the random
error. A total of J ×K models are built.
(b) As each model has a low dimension, estimates can be obtained using standard likeli-
hood based approaches and existing software. P-values can be obtained accordingly.
(c) Interactions (and main effects) with small P-values are identified as important. When
more definitive conclusions are needed, the FDR (false discovery rate) or Bonferroni
approach can be applied.
It is noted that in Step (a), one clinical/environmental variable is analyzed in each model,
which follows Xu et al. (2019). It is also possible to accommodate all clinical/environmental
variables in each model. In Step (c), discoveries can be made on interactions only or in-
teractions and main effects combined. Advantages of marginal analysis include its com-
putational simplicity and stability. On the negative side, with the complexity of can-
cer, an outcome/phenotype is usually associated with multiple imaging features and clini-
100
cal/environmental variables. As such, each marginal model can be “mis-specified” or “sub-
optimal”. In addition, there is a lack of attention to the differences between interactions
and main effects.
5.3.2 Joint analysis
Joint analysis can tackle some limitations of marginal analysis, and is getting increasingly
popular in statistical and bioinformatics literature. It proceeds as follows.












ηkθjkEjXk + ε, (5.2)
where τj and ηk are the main effects of the j
th environmental factor and the kth imaging
feature, respectively, and the product of ηk and θjk corresponds to the interaction.
(b) For estimation, consider the Lasso penalization
min
ηk,θjk

















k ηkθjkEjXk, and λ1, λ2 > 0 are tuning
parameters. In numerical study, we select the tuning parameters using the extended
Bayesian information criterion (Chen and Chen, 2008).
(c) Interactions (and main effects) with nonzero estimates are identified as being associ-
ated with the outcome.
5.3.3 Accommodating survival outcomes
Consider cancer survival. Denote T as the N -vector of survival times. Below we describe
joint analysis, and marginal analysis can be conducted accordingly. We adopt the AFT












ηkθjkEjXk + ε, (5.4)
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where notations have similar implications as in the above section. With high-dimensional
data, the AFT model has been widely adopted because of its lucid interpretation and
more importantly computational simplicity (Huang et al., 2006). Under right censor-
ing, denote C as the N -vector of censoring times, Y = log(min(T,C)), and δ = I(T ≤
C), where operations are taken component-wise. To accommodate censoring, a weighted
approach is adopted. Assume that data have been sorted according to Yi’s from the
smallest to the largest. The Kaplan-Meier weights can be computed as w1 =
δ1























where the square root and multiplication are taken component-wise. Interpretations and
other operations are the same as for continuous outcomes.
In joint analysis, the most prominent challenge is the high dimensionality. Here the
penalization technique is adopted, which can simultaneously accommodate high dimension-
ality and identify relevant interactions/main effects. Another feature of this analysis that
is worth highlighting is that it respects the “main effects, interactions” hierarchy. That is,
if an I-E interaction is identified, the corresponding main imaging feature effect is auto-
matically identified. It has been suggested that, statistically and biologically, it is critical
to respect this hierarchy (Choi et al., 2010). We refer to the literature (Bien et al., 2013;
Liu et al., 2013) for alternative penalization and other joint interaction analysis methods.
Compared to marginal analysis, joint analysis can be computationally more challenging,
and well-developed software packages are still limited. In addition, the analysis results can
be less stable.
The proposed analysis can be effectively realized. To facilitate data analysis within and
beyond this study, we have developed R code and made it publicly available at www.github.
com/shuanggema.
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Table 5.1: Marginal analysis of FEV1: identified main effects and interactions, with raw
P-values Pr.
Feature group Feature name Estimate Pr
Geometry AreaShape Zernike 2 2 Main 0.270 0.002
Geometry AreaShape Zernike 5 3 Main -0.319 0.001
Geometry Mean Identifyhemasub2 AreaShape Zernike 9 9 Main -0.259 0.004
Geometry Median Identifyhemasub2 AreaShape Zernike 7 1 Main -0.249 0.005
Geometry Median Identifyhemasub2 AreaShape Zernike 8 6 Main -0.272 0.003
Texture StDev Identifyeosinprimarycytoplasm Texture Correlation maskosingray 3 01 Main 0.280 0.002
Geometry StDev Identifyhemasub2 AreaShape Zernike 8 8 Main -0.251 0.005
Geometry StDev Identifyhemasub2 AreaShape Zernike 9 1 Main -0.259 0.004
Geometry StDev Identifyhemasub2 AreaShape Center Y Sex 0.291 0.002
Geometry StDev Identifyhemasub2 AreaShape Zernike 8 2 Sex 0.304 0.001
Geometry StDev Identifyhemasub2 Location Center Y Sex 0.294 0.002
Table 5.2: Joint analysis of FEV1: identified main effects and interactions.
Feature group Feature name Main Age Stage Smoking Sex
-0.049 -0.052 -0.002 0.006
Geometry AreaShape Zernike 2 2 0.163 0.040 -0.014 -0.185
Geometry AreaShape Zernike 5 3 -0.053
Geometry AreaShape Zernike 6 0 -0.034
Texture Granularity 10 ImageAfterMath 0.137 0.110 -0.020 0.064
Geometry Location Center X 0.002
Geometry Mean Identifyeosinprimarycytoplasm Location Center X 0.005
Geometry Median Identifyhemasub2 AreaShape Zernike 7 1 -0.127 -0.073 0.072 0.003
Geometry StDev Identifyhemasub2 AreaShape Zernike 8 2 -0.170 -0.083 0.188
Texture StDev Identifyhemasub2 Granularity 6 ImageAfterMath -0.029
Texture Texture AngularSecondMoment ImageAfterMath 3 00 -0.044
Texture Texture AngularSecondMoment ImageAfterMath 3 03 -0.010
5.4 Results
5.4.1 Analysis of FEV1
Marginal analysis After the FDR adjustment, none of the main effects or interactions is
statistically significant. In Table 5.1, we present the main effects and interactions with the
smallest (unadjusted) P-values. The top ranked main effects are from the Geometry and
Texture groups, and the top ranked interactions are from the Geometry group and with
sex.
Based on the analysis results, we conduct a power calculation. First assume the current
levels of estimated effects and their variations. Then with a sample size of 224, the top
ranked I-E interactions can be identified as significant with target FDR 0.1. Second, consider
the current sample size and levels of variations. Then an effect of -0.35 can be identified as
significant with target FDR 0.1.
For comparison, we conduct the analysis of main effects (without interactions). The top
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eight main effects (with the smallest P-values) have four overlaps with those in Table 5.1,
suggesting that accommodating interactions can lead to different findings.
Joint analysis The analysis results are provided in Table 5.2. A total of 11 imaging features
are identified, representing the Geometry and Texture groups. A total of 11 interactions
are identified, with all four clinical/environmental variables.
For comparison, we consider the joint model with all clinical/environmental variables
and imaging features but no interactions. Lasso penalization is applied for selection and
estimation. A total of eight imaging features are identified, with one overlapping with those
in Table 5.2. We further compute the RV coefficient, which may more objectively quantify
the amount of “overlapping information” between two analyses. Specifically, it measures
the “correlation” between two data matrices of important effects identified by two different
approaches, with a larger value indicating higher similarity. The RV coefficient is 0.24,
suggesting a mild level of overlapping.
A significant advantage of joint analysis is that it can lead to a predictive model for
the outcome variable. We conduct the evaluation of prediction based on a resampling
procedure, which may provide support to the validity of analysis. Specifically, we split data
into a training and a testing set, generate estimates using the training data, and make
prediction for the testing set subjects. The PMSE (prediction mean squared error) is then
computed. This procedure is repeated 100 times, and the mean PMSE is computed. The
I-E interaction model has a mean PMSE of 0.84, whereas the main-effect-only model has a
mean PMSE of 1.12. This significant improvement suggests the benefit of accommodating
interactions.
5.4.2 Analysis of overall survival
Marginal analysis The analysis results are provided in Table 5.3, where we present estimates,
raw P-values, as well as the FDR adjusted P-values. Three imaging features from the
Holistic group have the FDR adjusted P-values < 0.1. And 36 imaging features from the
Geometry group and 24 features from the Texture group are identified as having interactions
with Smoking, the most important environmental factor for lung cancer. Compared to the
above analysis, more “signals” are identified. Note that the effective sample size is smaller
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Figure 5.2: Kaplan-Meier curves of high and low risk groups identified by the approach that
accommodates interactions (left; logrank test P-value 0.007) and the one with main effects
only (right; logrank test P-value 0.320).
than that above. As such, the smaller P-values are likely to be caused by stronger signals.
For comparison, we conduct the analysis of main effects. One imaging feature is identi-
fied as having FDR adjusted P-value <0.1, which is also identified in Table 5.3. With the
complexity of lung cancer prognosis, the interaction analysis, which identifies more effects,
can be more sensible.
Joint analysis The analysis results are provided in Table 5.4. A total of 31 imaging features
are identified, representing the three feature groups. Two imaging features are identified as
interacting with two and four clinical/environmental variables, respectively.
The analysis of main effects is conducted using the Lasso penalization. A total of two
imaging features are identified, with one overlapping with those in Table 5.4. The RV co-
efficient is computed as 0.40, representing a moderate level of overlapping. As with FEV1,
prediction evaluation is also conducted based on resampling. For the testing set, subjects
are classified into low and high risk groups with equal sizes based on the predicted survival
times, where subjects with predicted survival times larger than the median are classified into
the low risk group. For one resampling of training and testing sets, in Figure 2, we plot the
Kaplan-Meier curves estimated using the observed survival times for the predicted low and
high risk groups, along with those generated under the additive main-effect model. Com-
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Table 5.3: Marginal analysis of overall survival: identified main effects and interactions,
with raw P-values Pr and FDR adjusted P-values Pa.
Feature group Feature name Estimate Pr Pa
Holistic Threshold FinalThreshold Identifyeosinprimarycytoplasm Main -0.301 0 0.095
Holistic Threshold OrigThreshold Identifyeosinprimarycytoplasm Main -0.301 0 0.095
Holistic Threshold WeightedVariance identifyhemaprimarynuclei Main -0.360 0 0.077
Geometry AreaShape Area Smoking 0.253 0.004 0.078
Geometry AreaShape MaximumRadius Smoking 0.266 0.004 0.074
Geometry AreaShape MeanRadius Smoking 0.265 0.005 0.079
Geometry AreaShape MedianRadius Smoking 0.266 0.005 0.079
Geometry AreaShape MinFeretDiameter Smoking 0.257 0.003 0.073
Geometry AreaShape MinorAxisLength Smoking 0.264 0.002 0.07
Geometry AreaShape Zernike 4 4 Smoking -0.241 0.005 0.079
Geometry AreaShape Zernike 7 3 Smoking -0.308 0 0.027
Geometry AreaShape Zernike 8 4 Smoking -0.242 0.007 0.096
Geometry AreaShape Zernike 8 6 Smoking -0.252 0.005 0.079
Geometry AreaShape Zernike 9 1 Smoking -0.303 0 0.027
Texture Granularity 13 ImageAfterMath.1 Smoking -0.317 0.001 0.054
Texture Mean Identifyeosinprimarycytoplasm Texture Correlation maskosingray 3 03 Smoking 0.232 0.005 0.079
Geometry Mean Identifyhemasub2 AreaShape Area Smoking 0.297 0.001 0.049
Geometry Mean Identifyhemasub2 AreaShape MaximumRadius Smoking 0.318 0.001 0.049
Geometry Mean Identifyhemasub2 AreaShape MeanRadius Smoking 0.318 0.001 0.049
Geometry Mean Identifyhemasub2 AreaShape MedianRadius Smoking 0.308 0.002 0.054
Geometry Mean Identifyhemasub2 AreaShape MinFeretDiameter Smoking 0.299 0.001 0.049
Geometry Mean Identifyhemasub2 AreaShape MinorAxisLength Smoking 0.310 0.001 0.045
Geometry Mean Identifyhemasub2 AreaShape Zernike 4 4 Smoking -0.263 0.003 0.07
Geometry Mean Identifyhemasub2 AreaShape Zernike 5 1 Smoking -0.268 0.002 0.07
Geometry Mean Identifyhemasub2 AreaShape Zernike 8 2 Smoking -0.277 0.003 0.073
Geometry Mean Identifyhemasub2 AreaShape Zernike 8 8 Smoking -0.290 0.003 0.073
Geometry Mean Identifyhemasub2 AreaShape Zernike 9 1 Smoking -0.226 0.004 0.074
Texture Mean Identifyhemasub2 Granularity 13 ImageAfterMath Smoking -0.325 0.001 0.054
Texture Mean Identifyhemasub2 Texture Correlation ImageAfterMath 3 01 Smoking 0.330 0 0.039
Texture Mean Identifyhemasub2 Texture Correlation ImageAfterMath 3 02 Smoking 0.297 0.002 0.07
Texture Mean Identifyhemasub2 Texture Correlation ImageAfterMath 3 03 Smoking 0.397 0 0.01
Texture Mean Identifyhemasub2 Texture SumVariance ImageAfterMath 3 02 Smoking 0.258 0.007 0.093
Texture Median Identifyeosinprimarycytoplasm Texture Correlation maskosingray 3 03 Smoking 0.233 0.004 0.079
Geometry Median Identifyhemasub2 AreaShape Area Smoking 0.344 0 0.027
Geometry Median Identifyhemasub2 AreaShape MaxFeretDiameter Smoking 0.242 0.005 0.079
Geometry Median Identifyhemasub2 AreaShape MaximumRadius Smoking 0.323 0.001 0.049
Geometry Median Identifyhemasub2 AreaShape MeanRadius Smoking 0.323 0.001 0.049
Geometry Median Identifyhemasub2 AreaShape MedianRadius Smoking 0.266 0.005 0.079
Geometry Median Identifyhemasub2 AreaShape MinFeretDiameter Smoking 0.346 0 0.027
Geometry Median Identifyhemasub2 AreaShape MinorAxisLength Smoking 0.342 0 0.027
Geometry Median Identifyhemasub2 AreaShape Perimeter Smoking 0.247 0.006 0.085
Geometry Median Identifyhemasub2 AreaShape Zernike 4 4 Smoking -0.242 0.002 0.059
Geometry Median Identifyhemasub2 AreaShape Zernike 5 1 Smoking -0.256 0.003 0.073
Texture Median Identifyhemasub2 Granularity 13 ImageAfterMath Smoking -0.311 0.001 0.049
Texture Median Identifyhemasub2 Texture Correlation ImageAfterMath 3 01 Smoking 0.319 0.001 0.049
Texture Median Identifyhemasub2 Texture Correlation ImageAfterMath 3 02 Smoking 0.274 0.005 0.081
Texture Median Identifyhemasub2 Texture Correlation ImageAfterMath 3 03 Smoking 0.394 0 0.01
Texture StDev Identifyeosinprimarycytoplasm Texture SumAverage maskosingray 3 00 Smoking 0.272 0.003 0.073
Texture StDev Identifyeosinprimarycytoplasm Texture SumAverage maskosingray 3 01 Smoking 0.273 0.003 0.073
Texture StDev Identifyeosinprimarycytoplasm Texture SumAverage maskosingray 3 02 Smoking 0.270 0.004 0.074
Texture StDev Identifyeosinprimarycytoplasm Texture SumAverage maskosingray 3 03 Smoking 0.275 0.003 0.073
Geometry StDev identifyhemaprimarynuclei Location Center Y Smoking -0.245 0.007 0.093
Geometry StDev Identifyhemasub2 AreaShape Zernike 8 4 Smoking -0.280 0.001 0.045
Geometry StDev Identifyhemasub2 AreaShape Zernike 8 8 Smoking -0.236 0.007 0.094
Texture StDev Identifyhemasub2 Texture SumVariance ImageAfterMath 3 01 Smoking 0.266 0.007 0.096
Texture StDev Identifyhemasub2 Texture SumVariance ImageAfterMath 3 02 Smoking 0.283 0.005 0.079
Texture StDev Identifyhemasub2 Texture SumVariance ImageAfterMath 3 03 Smoking 0.283 0.006 0.084
Geometry StDev identifytissueregion Location Center Y Smoking -0.289 0.002 0.059
Texture Texture Correlation ImageAfterMath 3 01 Smoking 0.252 0.004 0.078
Texture Texture Correlation ImageAfterMath 3 03 Smoking 0.329 0 0.027
Texture Texture Correlation maskosingray 3 03 Smoking 0.237 0.004 0.074
Texture Texture Entropy ImageAfterMath 3 01 Smoking 0.220 0.007 0.093
Texture Texture Entropy ImageAfterMath 3 03 Smoking 0.233 0.004 0.074
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pared to the main-effect model, it is obvious that the two risk groups identified by the I-E
interaction model have a much clearer separation of the survival functions, indicating better
prediction performance. To be more rigorous, we further conduct a logrank test, which is a
nonparametric test for comparing the survival distributions of two subject groups. With 100
resamplings, the average logrank statistics are 7.28 (I-E interaction model, P-value=0.007)
and 0.99 (main-effect model, P-value=0.320), respectively. The superior prediction perfor-
mance of the I-E interaction models suggests that incorporating interactions can lead to
clinically more powerful models, justifying the value of the proposed analysis.
Table 5.4: Joint analysis of overall survival: identified main effects and interactions.
Feature group Feature name Main Age Stage Smoking Sex
-0.024 -0.317 -0.038 -0.088
Geometry AreaShape Zernike 6 0 -0.038
Geometry AreaShape Zernike 6 4 -0.019
Geometry AreaShape Zernike 6 6 0.052
Geometry AreaShape Zernike 9 3 0.027
Geometry AreaShape Zernike 9 5 0.153
Texture Granularity 10 ImageAfterMath.1 -0.033
Texture Granularity 9 ImageAfterMath 0.081
Geometry Mean Identifyhemasub2 AreaShape Center X 0.002
Geometry Mean Identifyhemasub2 AreaShape Zernike 5 1 0.013
Geometry Mean Identifyhemasub2 AreaShape Zernike 6 2 -0.002
Geometry Mean Identifyhemasub2 AreaShape Zernike 6 4 -0.010
Geometry Mean Identifyhemasub2 AreaShape Zernike 9 9 -0.146
Geometry Mean Identifyhemasub2 Location Center X 0.002
Geometry Mean identifytissueregion Location Center X 0.056
Geometry Median Identifyeosinprimarycytoplasm Location Center X -0.071
Geometry Median Identifyhemasub2 AreaShape Zernike 4 0 0.023
Geometry Median Identifyhemasub2 AreaShape Zernike 7 3 0.083
Geometry Median Identifyhemasub2 AreaShape Zernike 8 4 -0.120
Geometry Median Identifyhemasub2 AreaShape Zernike 8 6 -0.098
Geometry Median Identifyhemasub2 AreaShape Zernike 9 1 -0.044
Geometry Median identifytissueregion Location Center Y -0.063
Holistic Neighbors SecondClosestDistance Adjacent -0.170 -0.072 0.002
Geometry StDev Identifyeosinprimarycytoplasm Location Center Y 0.095
Texture
StDev Identifyeosinprimarycytoplasm Texture
DifferenceVariance maskosingray 3 00
0.036
Geometry StDev Identifyhemasub2 AreaShape Orientation -0.159
Geometry StDev Identifyhemasub2 AreaShape Zernike 8 8 -0.146
Texture StDev Identifyhemasub2 Granularity 12 ImageAfterMath -0.101
Texture StDev Identifyhemasub2 Granularity 13 ImageAfterMath 0.327 0.130 0.072 -0.189 0.174
Texture StDev Identifyhemasub2 Granularity 9 ImageAfterMath 0.003
Texture
StDev Identifyhemasub2 Texture SumVariance
ImageAfterMath 3 01
-0.034
Geometry StDev identifytissueregion Location Center Y 0.016
5.4.3 Simulation
Comparatively, joint analysis is newer and has been less conducted. To gain more insights
into the validity of findings from our joint interaction analysis, we conduct a set of data-
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based simulation. Specifically, the observed imaging features and clinical/environmental
factors are used. To generate variations across simulation replicates, we use resampling,
with sample sizes set as 200. The “signals” and their levels are set as those in Tables 5.2 and
5.4, respectively. For both the continuous and (log) survival outcomes, we generate random
errors from N(0, 1). For the survival setting, we generate the censoring times from randomly
sampling the observed. The Lasso-based penalization approach is then applied, with tuning
parameters selected using the extended BIC approach. To evaluate identification, TP (true
positive) and FP (false positive) values are computed. Summary statistics are computed
based on 100 replicates. Under the continuous outcome setting, there are 11 true main effects
and 11 I-E interactions. For main effects, the TP and FP values are 9.75 (1.65) and 3.15
(1.39), respectively, where numbers in “()” are standard deviations. For interactions, the
TP and FP values are 7.35 (0.99) and 0.05 (0.22), respectively. Under the censored survival
outcome setting, there are 31 true main effects and 6 I-E interactions. For main effects,
the TP and FP values are 24.41 (3.98) and 13.90 (2.47), respectively. For interactions, the
TP and FP values are 3.24 (0.21) and 0.24 (0.12), respectively. Overall, at the estimated
signal levels and with the observed feature distributions, the joint analysis is capable of
identifying the majority of true interactions and main effects, with a moderate number of
false discoveries. This provides a high level of confidence to the joint interaction analysis.
5.5 Discussion
Histopathological imaging analysis has been routine in cancer diagnosis, and recently, its
application in the analysis of cancer biomarkers, outcomes, and phenotypes has been ex-
plored. This study has taken a natural next step and conducted the imaging-environment
interaction analysis. Statistically and biologically speaking, the analysis has been partly
motivated by G-E interaction analysis. It is noted that the statistical methods themselves
have been almost fully “translated” from G-E interaction analysis. As I-E interaction analy-
sis has not been conducted in published cancer modeling studies, it is sensible to first employ
well-developed methods, and in the future, methods that are more tailored to imaging data
may be developed. We also note that in cancer modeling and other biomedical fields, it
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is not uncommon to apply methods well developed in one field to other new fields. The
proposed I-E interaction analysis, especially joint analysis, may seem considerably more
complex than some cancer modeling approaches. With the complexity of cancer, models
with a few variables and simple statistical analysis are getting increasingly insufficient. Pub-
lished studies have suggested that advanced statistical techniques and complex models are
needed. Recent developments for lung cancer, including the elastic net-Cox analysis (Yu
et al., 2016), deep convolutional neural network (Coudray et al., 2018), and deep network
based on convolutional and recurrent architectures (Bychkov et al., 2018), have comparable
or higher levels of complexity compared to the proposed analysis. Artificial intelligence (AI)
techniques, which have been recently used for cancer modeling in particular including the
radiomics analysis of non-small-cell lung cancer (Hosny et al., 2018; Thrall et al., 2018), have
even higher levels of complexity. We conjecture that such complexity will also be needed
for future developments in cancer modeling using imaging data. The increasing complexity
in cancer modeling seems to be an inevitable trend, and domain specific expertise is a must
for such analysis.
We have analyzed the TCGA LUAD data with a continuous and a censored survival
outcome. This choice has been motivated by the clinical importance of lung adenocarcinoma
as well as data availability (a larger sample size). It is noted that the proposed analysis
and R program will be directly applicable to the analysis of data on other cancer types. I-E
interactions have been identified in both marginal and joint analysis, for both FEV1 and
overall survival. There is one prominent difference between imaging and genetic/clinical
data. With extensive investigations and functional experiments, the biological and biomed-
ical implications of most clinical/environmental factors and genes are at least partially
known. It is thus possible to evaluate whether G-E interactions are biologically sensible.
The circumstance is significantly different for histopathological imaging features. The ra-
tionale and algorithms for feature extraction have been made clear in the developments of
CellProfiler and other software. However, the identified features do not have lucid biological
interpretations. As such, we are not able to objectively assess the biological implications of
the findings in Table 5.1 -5.4. It is noted that this limitation is also shared by recently pub-
lished imaging studies Luo et al. (2017); Sun et al. (2018a); Zhu et al. (2016b), which have
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unambiguously demonstrated the great value of such imaging features in cancer modeling.
It is also noted that imaging features derived from computer-aided pathological analysis
have the unique advantage of being objective and comprehensive, and can reveal hidden
information contained in histopathological images that cannot be recognized or assessed by
pathologists. Our statistical evaluations, including the prediction evaluation and data-based
simulation, can provide support to the analysis results to a great extent. In general, more
investigations into the biological implications of the computer-program-extracted imaging
features will be needed.
This study has suggested a new venue for cancer modeling. Although findings made on
LUAD may not be applicable to other cancers, the analysis technique and R program will be
broadly applicable. Following the flowchart in Figure 5.1 and detailed steps described in this
article, and using the publicly available R program, cancer biostatisticians and clinicians
should be able to carry out the proposed analysis with their own data. More specifically,
with their own clinical/environmental and imaging data, they will be able to construct
models for prognosis and other outcomes/phenotypes. Such models, as other cancer models
(for example those using omics data), can be used to assist clinical decision making. Overall,




In sum, we proposed four statistical methods for analyzing G-E interactions and presented
one application using both marginal and joint models for imaging data. In simulation
studies, improved identification and prediction performance was produced in comparison
with multiple alternatives. Besides numerical studies of the proposed methods, we also
conducted data analyses using TCGA data on multiple cancer types. Sensible findings of
important G-E interactions with superior stability and prediction were made and interpreted
using the published literature. In addition, we developed R code for the proposed methods
and made it publicly available for researchers.
Two generic paradigms of marginal and joint modeling frameworks in G-E interaction
analysis are extensively explored and compared. On the one hand, marginal models en-
joy computational simplicity and are straightforward to understand. Most of the existing
studies are based on a marginal framework, yet marginal models are not able to predict the
outcomes, limited to marker identifications. On the other hand, joint modeling that requires
penalized estimation becomes increasingly popular in the literature. Though computational
cost is relatively higher compared to marginal models, interpretable selection and accurate
prediction can be achieved by the joint modeling. In this dissertation, we do not reach a
definitive conclusion in the competition of marginal and joint modeling frameworks for G-E
interaction analysis.
The first approach in Chapter 2.2 was built on the quantile regression technique, used
weights to easily accommodate censoring, and adopted partial correlation to identify impor-
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tant interactions while properly controlling for the main genetic and environmental effects.
The second approach in Chapter 2.3 employed the trimmed regression under joint modeling,
applied penalization and stability selection to identify important G-E interactions, and re-
spected the “main effects, interactions” hierarchical structure. These two proposed methods
can accommodate prognostic outcomes and demonstrated that robust methods are capable
of improving identification accuracy. The third approach in Chapter 3 utilized penalization
under a marginal analysis framework. We constructed the penalty terms for incorporating
multiple types of additional information and for selecting hierarchal interactions. The hier-
archical structure was enforced by coefficient decomposition and tailored penalization. The
last proposed approach in Chapter 4 integrated multidimensional molecular measurements
and sufficiently accounted for their overlapping as well as independent information. The
proposed joint estimation was based on the penalization technique and had solid statistical
properties, leading to improved estimation and prediction.
6.1 Limitations
Though methodological advancement was made by the proposed novel and useful ap-
proaches, this dissertation of G-E interaction analysis inevitably has limitations. Following
linear regression, the effects of G-E interactions were uniformly described by their coef-
ficients. Many advantages were introduced by this regression framework, including the
coefficient decomposition strategy that enforces the hierarchical structure. Nonetheless,
there exist several other schemes for analyzing interactions. For instance, Ren et al. (2019)
proposed a semiparametric Bayesian model that includes linear and non-linear G-E inter-
actions simultaneously. A partially linear varying coefficient model was adopted where a
smoothing varying coefficient function of the environmental risk factor was used for de-
scribing the non-linear interactions. Other penalization techniques for selecting hierarchical
interactions include the hierarchical Lasso (Bien et al., 2013), the sparse group Lasso (Si-
mon et al., 2013), and many others (Hao and Zhang, 2017). In this study, the simplicity
and interpretability brought by the linear regression framework were well appreciated and
we note its potential for extending to more complex models in future work.
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Another limitation of this dissertation is that statistical inference was not comprehen-
sively discussed. The proposed methods focused more on methodological development and
numerical examinations. Theoretical derivation for the proposed methods under high-
dimensional settings was much limited to draw more definitive conclusions. In the dis-
sertation, theoretical justifications were made in a heuristic manner. In fact, the statistical
techniques that we adopted in these studies have been extensively investigated and the
relevant statistical properties has already been examined in the literature. Although more
rigorous justifications were not readily available for more sophisticated approaches, we note
that the building blocks of the proposed methods have established grounds in statistical
properties to well support this dissertation.
This study is also limited to the TCGA data in real data analysis. As one of the largest
publicly available and high-quality data sources for cancer genomic studies, we chose the
TCGA data and focused mainly on lung adenocarcinoma and cutaneous melanoma datasets.
Additionally, our proposed methods included different sets of environmental risk factors,
for example, Breslow’s depth in Chapter 2.2 as one of the E factors whereas in Chapter 2.3
as the response of interest. Such intensive investigation of the TCGA datasets is widely
accepted and especially common among the publications for demonstrating methodological
advancement. We also note that different results were made across the proposed methods.
Due to the scope of the dissertation, an explicit comparison between those findings was not
discussed.
6.2 Future work
Overall, we recognized the limitations of the existing methodologies for G-E interaction
analysis, conducted comprehensive investigations for novel and useful methods to tackle
practical problems and to advance in methodological development, and analyzed simulated
and real datasets to validate the superiority and applicability of the proposed approaches.
It is challenging to identify important G-E interactions for complex diseases. The proposed
methods presented in this dissertation suggest new venues of interaction analysis and allow
future advancements to build on. For example, one can extend the goodness-of-fit term
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in the proposed objective functions to other loss functions, such as the absolute-value-
based ones. All of the proposed methods assume linear regression models, which can be
replaced by non-linear and nonparametric models. As the most fundamental elements in
G-E interaction analysis were thoroughly addressed in this dissertation, future advancement
in methodology that can be added to the proposed methods becomes natural.
Besides, several analysis strategies, such as coefficient decomposition, which tackled the
essential complications in interaction analysis, can be further adapted and extended to
other research fields. Inspired by our application to histopathological imaging data, the
proposed methods are generally applicable to interaction analysis for high-dimensional data
and can be regarded as statistical methods for interaction selection. In fact, the analysis
of the TCGA data can serve as a prototype and applications to data on complex diseases
other than cancer are desired. Future work in analyzing data on various cancer types and
other complex diseases will potentially contribute to better understanding of the underlying
biological mechanisms of disease development. Extension from genetic factors to other high-




A.1 Censored Quantile Partial Correlation for Cancer Prog-
nosis
Figure A.1: Plot of pROC under setting C1 with ρ = 0.3 and Error 3.




























Table A.1: Simulation results for setting C1 with the AR correlation structure (ρ = 0.3),
Error 1 and various values of sample size. In each cell, mean (sd) based on 200 replicates.
n Method TP20 TP40 pAUC TP.FDR FP.FDR E.FDR
250 AFT 10.8(1.5) 11.8(1.4) 0.83(0.06) 12.6(1.7) 83.0(79.4) 0.78(0.15)
Cox 11.1(1.7) 12.3(1.7) 0.88(0.05) 11.0(1.8) 12.5(18.5) 0.41(0.23)
CQR 3.8(1.5) 5.6(1.6) 0.69(0.04) 9.3(1.8) 125.1(34.1) 0.93(0.02)
KMW-LAD 8.4(1.7) 10.4(2.1) 0.86(0.05) 3.9(2.0) 1.3(1.5) 0.21(0.19)
CQPCorr 10.8(1.6) 12.4(1.7) 0.91(0.04) 8.1(2.4) 1.9(1.8) 0.17(0.14)
300 AFT 11.2(1.4) 12.5(1.5) 0.85(0.05) 13.1(1.6) 67.1(48.0) 0.79(0.11)
Cox 11.5(1.6) 12.8(1.5) 0.89(0.04) 12.0(1.9) 14.9(14.8) 0.46(0.21)
CQR 4.6(1.5) 6.4(1.7) 0.72(0.04) 10.7(1.9) 123.8(29.7) 0.92(0.02)
KMW-LAD 9.8(1.7) 11.5(1.5) 0.88(0.04) 6.4(3.0) 1.6(1.9) 0.19(0.19)
CQPCorr 11.9(1.6) 13.2(1.6) 0.93(0.04) 10.0(2.1) 2.3(2.4) 0.16(0.12)
350 AFT 11.7(1.6) 12.9(1.7) 0.86(0.05) 13.4(1.8) 57.8(37.4) 0.76(0.12)
Cox 11.8(1.4) 13.3(1.6) 0.91(0.04) 12.3(1.9) 13.4(9.9) 0.46(0.16)
CQR 5.8(2.0) 7.7(2.2) 0.75(0.04) 11.6(1.4) 130.5(39.0) 0.91(0.02)
KMW-LAD 11.2(1.4) 12.7(1.4) 0.92(0.04) 8.9(2.1) 2.3(2.6) 0.18(0.15)
CQPCorr 12.9(1.6) 14.1(1.5) 0.95(0.03) 11.5(2.0) 2.3(1.5) 0.16(0.09)
400 AFT 12.4(1.6) 13.7(1.6) 0.88(0.04) 14.2(1.5) 61.4(33.4) 0.78(0.09)
Cox 12.8(1.5) 14.2(1.5) 0.93(0.04) 13.3(1.7) 14.0(10.7) 0.46(0.15)
CQR 6.6(2.0) 8.8(2.2) 0.77(0.05) 12.6(1.9) 130.4(39.9) 0.91(0.03)
KMW-LAD 12.1(1.2) 13.9(1.3) 0.95(0.03) 10.0(2.0) 2.4(2.0) 0.17(0.12)
CQPCorr 13.8(1.3) 14.9(1.0) 0.97(0.02) 12.8(1.7) 2.4(2.0) 0.14(0.11)
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Table A.2: Simulation results for setting C1 with the AR correlation structure (ρ = 0.3),
Error 2 and various values of sample size. In each cell, mean (sd) based on 200 replicates.
n Method TP20 TP40 pAUC TP.FDR FP.FDR E.FDR
250 AFT 6.2(1.9) 7.5(2.0) 0.75(0.06) 4.6(2.6) 6.7(9.8) 0.42(0.25)
Cox 8.1(1.9) 9.4(2.2) 0.82(0.06) 6.0(2.5) 3.7(4.6) 0.30(0.22)
CQR 3.2(1.6) 4.7(1.9) 0.66(0.05) 8.2(2.6) 124.2(36.6) 0.94(0.02)
KMW-LAD 7.3(1.7) 9.2(1.8) 0.82(0.05) 2.4(1.9) 0.8(1.1) 0.20(0.26)
CQPCorr 9.2(2.0) 10.9(2.0) 0.87(0.05) 5.6(2.5) 1.5(1.5) 0.19(0.16)
300 AFT 7.8(1.8) 9.1(1.7) 0.80(0.05) 6.2(2.5) 6.1(8.8) 0.34(0.23)
Cox 9.3(1.9) 10.6(2.0) 0.85(0.06) 8.0(2.3) 3.8(5.4) 0.24(0.19)
CQR 4.3(1.5) 6.1(1.8) 0.71(0.05) 9.3(2.2) 112.5(36.1) 0.92(0.03)
KMW-LAD 8.8(1.8) 10.5(2.2) 0.86(0.05) 4.5(2.8) 0.9(1.2) 0.11(0.13)
CQPCorr 10.7(1.7) 12.0(1.8) 0.90(0.05) 7.6(2.5) 1.2(1.3) 0.11(0.11)
350 AFT 8.1(1.5) 9.2(1.5) 0.80(0.04) 6.4(2.5) 6.6(7.9) 0.38(0.24)
Cox 9.8(1.7) 11.1(1.6) 0.87(0.05) 8.3(1.9) 3.2(3.7) 0.23(0.18)
CQR 4.8(1.3) 6.7(1.4) 0.71(0.04) 10.0(1.8) 119.9(40.3) 0.92(0.03)
KMW-LAD 9.6(1.5) 11.6(1.6) 0.88(0.04) 6.0(2.2) 1.8(2.2) 0.18(0.15)
CQPCorr 11.2(1.4) 12.7(1.7) 0.92(0.04) 8.9(2.2) 1.7(1.7) 0.14(0.11)
400 AFT 8.8(1.6) 10.0(1.7) 0.83(0.05) 7.3(2.4) 6.6(9.4) 0.33(0.22)
Cox 10.9(1.8) 12.3(1.8) 0.89(0.05) 9.6(2.2) 3.5(3.7) 0.23(0.14)
CQR 5.6(2.0) 7.6(2.2) 0.75(0.05) 11.7(2.1) 122.3(39.0) 0.91(0.02)
KMW-LAD 10.7(1.5) 12.4(1.6) 0.91(0.04) 7.1(2.3) 1.7(1.9) 0.16(0.17)
CQPCorr 12.4(1.6) 13.7(1.5) 0.94(0.04) 10.4(2.4) 2.1(1.4) 0.16(0.09)
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Table A.3: Simulation results for setting C1 with the AR correlation structure (ρ = 0.3),
Error 3 and various values of sample size. In each cell, mean (sd) based on 200 replicates.
n Method TP20 TP40 pAUC TP.FDR FP.FDR E.FDR
250 AFT 4.3(2.2) 5.5(2.3) 0.69(0.07) 2.0(2.3) 5.1(9.8) 0.43(0.39)
Cox 7.1(1.9) 8.5(2.1) 0.79(0.06) 4.7(2.2) 2.7(5.0) 0.24(0.23)
CQR 3.0(1.4) 4.5(1.8) 0.65(0.05) 7.1(2.6) 108.4(37.8) 0.93(0.03)
KMW-LAD 6.5(1.8) 8.5(2.0) 0.80(0.06) 2.0(1.6) 0.4(0.6) 0.17(0.28)
CQPCorr 8.3(1.8) 9.9(2.1) 0.84(0.06) 4.3(2.0) 1.1(1.3) 0.16(0.15)
300 AFT 4.5(2.3) 5.7(2.3) 0.70(0.06) 2.5(2.1) 4.9(9.1) 0.39(0.36)
Cox 7.4(2.2) 8.7(1.8) 0.79(0.06) 5.0(2.6) 2.5(4.2) 0.24(0.23)
CQR 3.7(1.5) 5.2(1.5) 0.69(0.04) 8.3(2.1) 104.0(29.9) 0.92(0.02)
KMW-LAD 8.0(1.8) 9.6(2.0) 0.83(0.05) 3.0(2.5) 0.7(1.1) 0.18(0.25)
CQPCorr 9.2(1.8) 10.8(1.9) 0.87(0.05) 6.0(2.2) 1.3(1.9) 0.14(0.16)
350 AFT 5.4(2.0) 6.7(2.2) 0.73(0.06) 3.0(2.7) 4.1(6.8) 0.35(0.33)
Cox 8.7(1.5) 9.9(1.5) 0.83(0.05) 6.1(1.9) 1.7(2.1) 0.17(0.16)
CQR 4.5(1.2) 5.9(1.1) 0.70(0.04) 9.2(2.0) 106.8(27.8) 0.92(0.02)
KMW-LAD 9.9(1.8) 11.3(1.9) 0.88(0.05) 4.4(2.4) 0.6(1.0) 0.10(0.20)
CQPCorr 10.9(1.5) 12.4(1.3) 0.91(0.04) 8.0(2.0) 1.0(0.8) 0.10(0.07)
400 AFT 6.4(1.9) 7.9(2.0) 0.76(0.06) 3.8(2.7) 3.8(6.9) 0.36(0.31)
Cox 9.6(1.5) 10.9(1.6) 0.86(0.05) 7.4(2.3) 2.1(1.9) 0.19(0.14)
CQR 5.1(2.0) 7.1(2.1) 0.74(0.04) 10.7(1.9) 111.6(33.2) 0.91(0.02)
KMW-LAD 10.2(1.8) 11.9(1.7) 0.90(0.05) 5.8(3.2) 0.9(1.1) 0.10(0.11)
CQPCorr 11.7(1.5) 12.9(1.7) 0.92(0.04) 9.2(2.0) 1.2(1.2) 0.10(0.09)
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Table A.4: Simulation results for setting C3 with the AR correlation structure (ρ = 0.5).
In each cell, mean (sd) based on 200 replicates.
Error Method TP20 TP40 pAUC TP.FDR FP.FDR E.FDR
1 AFT 10.8(1.5) 12.0(1.8) 0.86(0.05) 12.0(2.0) 52.5(76.5) 0.64(0.22)
Cox 9.3(1.8) 11.1(1.7) 0.86(0.05) 7.2(3.3) 3.3(3.1) 0.25(0.18)
CQR 4.2(1.8) 6.2(1.9) 0.71(0.06) 10.8(2.0) 141.9(45.9) 0.92(0.02)
KMW-LAD 9.1(1.7) 10.8(1.9) 0.86(0.05) 6.0(3.1) 1.0(1.7) 0.13(0.19)
CQPCorr 9.9(1.8) 11.4(2.0) 0.89(0.04) 6.8(2.8) 1.1(1.0) 0.12(0.09)
2 AFT 5.6(2.5) 7.0(2.6) 0.74(0.07) 3.8(2.7) 8.1(19.9) 0.45(0.29)
Cox 4.7(2.3) 6.1(2.5) 0.71(0.08) 2.5(2.7) 2.0(3.7) 0.18(0.26)
CQR 3.6(1.8) 5.4(1.8) 0.69(0.07) 8.5(2.8) 107.9(25.7) 0.92(0.03)
KMW-LAD 7.5(2.4) 9.0(2.3) 0.81(0.07) 3.2(2.2) 0.4(0.7) 0.10(0.22)
CQPCorr 7.6(2.2) 9.2(2.2) 0.82(0.06) 4.0(2.5) 0.7(0.8) 0.11(0.11)
3 AFT 3.9(2.0) 5.2(2.1) 0.69(0.07) 1.2(2.4) 4.1(12.7) 0.31(0.41)
Cox 3.5(2.0) 4.5(2.3) 0.67(0.08) 0.8(1.3) 1.0(2.6) 0.16(0.28)
CQR 3.0(1.5) 4.5(1.8) 0.66(0.04) 7.5(2.0) 112.0(33.6) 0.93(0.02)
KMW-LAD 6.8(1.9) 8.5(1.8) 0.80(0.05) 2.2(1.8) 0.7(1.5) 0.11(0.23)
CQPCorr 7.1(1.8) 8.8(1.8) 0.80(0.06) 3.5(2.4) 0.7(0.9) 0.12(0.14)
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Table A.5: Simulation results for setting C4 with the AR correlation structure (ρ = 0.5).
In each cell, mean (sd) based on 200 replicates.
Error Method TP20 TP40 pAUC TP.FDR FP.FDR E.FDR
1 AFT 12.1(2.0) 13.8(1.6) 0.90(0.07) 13.6(2.3) 41.6(59.2) 0.61(0.19)
Cox 10.0(2.3) 11.6(2.2) 0.88(0.05) 7.4(4.0) 3.4(3.9) 0.25(0.18)
CQR 4.3(1.7) 6.1(2.0) 0.71(0.06) 9.8(3.0) 130.8(38.4) 0.93(0.02)
KMW-LAD 9.2(1.6) 11.8(1.2) 0.90(0.03) 5.9(2.6) 2.3(2.8) 0.21(0.19)
CQPCorr 10.1(2.3) 12.0(1.8) 0.91(0.05) 7.5(3.7) 2.9(2.9) 0.20(0.15)
2 AFT 1.2(1.6) 1.6(1.7) 0.56(0.06) 0.6(1.1) 1.6(2.4) 0.33(0.43)
Cox 4.2(2.1) 5.7(3.0) 0.70(0.10) 1.6(1.8) 1.2(2.7) 0.21(0.33)
CQR 3.4(1.5) 4.8(2.3) 0.67(0.06) 7.9(2.1) 123.2(30.0) 0.94(0.02)
KMW-LAD 7.2(3.3) 9.8(2.8) 0.83(0.08) 2.8(1.8) 0.8(1.3) 0.15(0.19)
CQPCorr 7.6(1.9) 10.4(2.0) 0.85(0.06) 3.8(2.7) 1.1(0.9) 0.14(0.13)
3 AFT 0.4(1.4) 0.6(1.5) 0.52(0.05) 0.2(1.0) 4.5(14.9) 0.28(0.45)
Cox 2.0(2.1) 2.9(2.7) 0.60(0.09) 0.4(0.7) 0.5(0.8) 0.24(0.38)
CQR 2.6(2.0) 4.4(2.1) 0.65(0.07) 7.2(2.7) 106.5(41.3) 0.93(0.03)
KMW-LAD 6.0(2.3) 7.8(2.4) 0.79(0.06) 1.1(1.1) 0.4(0.7) 0.11(0.21)
CQPCorr 6.2(2.8) 8.2(2.8) 0.83(0.08) 2.0(1.9) 0.5(0.8) 0.10(0.15)
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Table A.6: Simulation results for setting C5 with the AR correlation structure (ρ = 0.5).
In each cell, mean (sd) based on 200 replicates.
Error Method TP20 TP40 pAUC TP.FDR FP.FDR E.FDR
1 AFT 10.0(0.2) 10.0(0.2) 0.77(0.03) 10.0(0.0) 62.2(66.0) 0.76(0.15)
Cox 9.9(0.3) 10.0(0.4) 0.79(0.02) 9.9(0.4) 18.4(16.6) 0.56(0.20)
CQR 5.0(1.7) 6.4(1.9) 0.69(0.04) 8.5(1.7) 112.4(35.3) 0.93(0.02)
KMW-LAD 8.8(0.9) 9.6(0.8) 0.80(0.02) 6.8(2.0) 1.2(1.7) 0.12(0.12)
CQPCorr 9.8(0.5) 10.1(0.7) 0.81(0.02) 8.9(1.0) 1.4(1.0) 0.12(0.08)
2 AFT 7.9(1.6) 8.4(1.7) 0.76(0.04) 7.3(2.1) 9.3(10.2) 0.44(0.24)
Cox 8.6(1.4) 8.9(1.5) 0.77(0.04) 7.5(1.6) 4.3(7.2) 0.26(0.20)
CQR 3.6(1.7) 5.0(1.5) 0.67(0.03) 7.7(1.8) 112.1(35.7) 0.93(0.02)
KMW-LAD 7.8(1.6) 8.5(1.5) 0.77(0.04) 4.4(2.2) 1.0(1.8) 0.11(0.18)
CQPCorr 8.6(1.1) 9.1(1.0) 0.80(0.02) 7.2(1.6) 1.0(1.0) 0.11(0.10)
3 AFT 6.0(2.2) 7.2(2.3) 0.74(0.06) 4.3(3.2) 8.0(18.3) 0.28(0.30)
Cox 7.6(1.9) 8.3(1.8) 0.77(0.05) 5.8(2.5) 2.4(3.0) 0.23(0.20)
CQR 3.4(1.4) 4.9(1.5) 0.67(0.05) 7.0(1.6) 102.6(34.2) 0.93(0.02)
KMW-LAD 6.9(1.4) 8.3(1.5) 0.77(0.05) 3.1(2.2) 0.6(1.0) 0.12(0.16)
CQPCorr 8.2(1.6) 9.2(1.2) 0.80(0.04) 5.4(2.1) 0.9(1.0) 0.11(0.10)
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Settings with banded correlation structure and binary E factors
Under coefficient settings C1 and C2, the following additional scenarios are examined.
For G factors, besides the AR correlation structure, we also consider the banded correlation
structure. Here two scenarios are considered. Under the first scenario (Band 1), the jth and
lth G variables have correlation coefficient 0.5 if |j−l| = 1 and 0 otherwise. Under the second
scenario (Band 2), the jth and lth G variables have correlation coefficient 0.7 if |j − l| = 1,
0.4 if |j − l| = 2, 0.1 if |j − l| = 3, and 0 otherwise. For E factors, the other scenario (E2)
dichotomizes two of the continuous E factors at 0 and create two binary variables. Under
coefficient settings C1 and C2 with the AR correlation structure (ρ = 0.5), we examine
another datasets with a higher censoring rate (35%). Summary results are provided in
Tables A.7-A.14.
122
Table A.7: Simulation results for setting C1 with the AR correlation structure and E2. In
each cell, mean (sd) based on 200 replicates.
Error Method TP20 TP40 pAUC TP.FDR FP.FDR E.FDR
ρ = 0.3 1 AFT 8.5(1.0) 9.4(1.1) 0.74(0.04) 9.5(1.2) 73.0(58.7) 0.83(0.11)
Cox 8.6(1.4) 9.4(1.3) 0.79(0.04) 7.9(1.5) 7.0(5.1) 0.41(0.19)
CQR 3.1(1.5) 4.1(1.5) 0.65(0.04) 6.0(1.7) 81.4(20.7) 0.93(0.02)
KMW-LAD 5.9(1.7) 7.1(1.7) 0.75(0.04) 3.1(1.6) 0.6(0.9) 0.15(0.23)
CQPCorr 7.9(1.3) 8.8(1.5) 0.80(0.04) 5.2(2.0) 1.1(0.9) 0.14(0.11)
2 AFT 5.2(1.9) 5.8(2.0) 0.70(0.05) 3.6(2.5) 6.0(9.0) 0.43(0.32)
Cox 6.5(1.4) 7.6(1.5) 0.75(0.03) 4.2(2.4) 1.5(1.8) 0.20(0.18)
CQR 3.0(1.5) 4.5(1.4) 0.65(0.04) 6.0(1.7) 87.5(26.9) 0.93(0.03)
KMW-LAD 5.8(1.6) 7.1(1.7) 0.74(0.05) 2.5(1.9) 0.4(0.7) 0.09(0.18)
CQPCorr 6.8(1.8) 8.1(2.0) 0.77(0.05) 2.8(1.9) 0.4(0.7) 0.09(0.13)
3 AFT 1.6(1.8) 2.0(2.1) 0.60(0.07) 1.0(1.2) 2.3(4.3) 0.48(0.48)
Cox 4.6(1.8) 6.1(1.2) 0.70(0.04) 1.9(2.0) 1.9(3.0) 0.30(0.41)
CQR 2.3(1.8) 3.0(1.6) 0.62(0.03) 4.6(1.3) 86.4(32.0) 0.94(0.03)
KMW-LAD 4.4(1.7) 6.0(1.5) 0.70(0.03) 1.3(1.7) 0.4(0.5) 0.21(0.37)
CQPCorr 5.7(2.4) 7.0(1.9) 0.74(0.05) 1.7(1.5) 0.7(1.3) 0.20(0.39)
ρ = 0.5 1 AFT 10.0(0.6) 10.3(0.8) 0.78(0.04) 10.4(0.8) 47.2(35.1) 0.75(0.15)
Cox 9.8(0.7) 10.4(0.8) 0.82(0.03) 9.8(0.7) 13.7(16.8) 0.46(0.24)
CQR 5.1(1.8) 6.3(1.9) 0.72(0.05) 8.6(1.7) 81.7(24.6) 0.90(0.03)
KMW-LAD 9.4(1.2) 10.3(1.4) 0.83(0.04) 7.1(2.0) 1.3(1.5) 0.12(0.13)
CQPCorr 9.8(0.9) 10.6(1.0) 0.85(0.03) 8.9(1.0) 1.3(1.4) 0.11(0.11)
2 AFT 8.4(1.2) 9.2(1.1) 0.78(0.03) 7.5(2.4) 13.8(26.8) 0.48(0.20)
Cox 8.6(1.4) 9.4(1.0) 0.79(0.02) 8.0(2.0) 5.6(4.4) 0.34(0.18)
CQR 4.7(1.5) 6.1(1.6) 0.71(0.06) 8.1(2.5) 83.2(30.3) 0.90(0.03)
KMW-LAD 8.0(1.8) 9.3(1.8) 0.81(0.05) 5.1(2.5) 0.9(1.1) 0.15(0.22)
CQPCorr 9.3(1.6) 10.3(1.7) 0.84(0.04) 7.5(2.1) 1.5(1.5) 0.15(0.12)
3 AFT 7.2(1.9) 8.4(1.5) 0.76(0.04) 6.4(3.1) 9.6(14.9) 0.39(0.26)
Cox 8.9(1.1) 9.4(0.9) 0.79(0.03) 7.5(2.2) 3.8(4.9) 0.25(0.20)
CQR 4.6(2.1) 6.2(1.8) 0.70(0.05) 7.2(1.7) 69.5(24.7) 0.89(0.05)
KMW-LAD 7.6(1.5) 8.6(1.6) 0.79(0.05) 3.9(2.3) 0.5(0.7) 0.10(0.15)
CQPCorr 8.6(1.5) 9.7(1.3) 0.82(0.04) 7.0(1.9) 0.9(0.8) 0.10(0.09)
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Table A.8: Simulation results for setting C1 with the banded correlation structure and E1.
In each cell, mean (sd) based on 200 replicates.
Error Method TP20 TP40 pAUC TP.FDR FP.FDR E.FDR
Band1 1 AFT 10.8(1.7) 11.8(2.1) 0.81(0.06) 12.8(1.8) 103.9(96.1) 0.83(0.11)
Cox 11.1(1.8) 12.2(1.8) 0.88(0.05) 11.6(1.8) 14.4(11.8) 0.49(0.16)
CQR 4.0(1.6) 6.0(1.7) 0.70(0.05) 9.8(2.0) 130.0(39.0) 0.93(0.02)
KMW-LAD 9.2(1.6) 10.9(1.9) 0.86(0.05) 5.9(2.7) 1.7(1.9) 0.20(0.17)
CQPCorr 11.0(1.5) 12.3(1.5) 0.91(0.04) 8.6(2.0) 2.0(1.7) 0.16(0.12)
2 AFT 6.8(2.2) 8.2(1.9) 0.76(0.06) 5.9(2.6) 16.4(21.1) 0.52(0.28)
Cox 8.2(2.1) 9.5(1.8) 0.81(0.05) 6.6(2.7) 4.9(4.7) 0.35(0.20)
CQR 3.3(1.9) 4.5(1.9) 0.67(0.05) 8.2(2.0) 125.6(50.2) 0.93(0.02)
KMW-LAD 7.5(1.8) 9.0(2.1) 0.80(0.05) 3.8(2.8) 1.4(1.4) 0.22(0.19)
CQPCorr 9.0(1.8) 10.4(2.1) 0.85(0.05) 5.6(2.3) 1.1(1.2) 0.15(0.15)
3 AFT 4.9(2.6) 6.3(2.4) 0.71(0.07) 3.3(2.7) 11.0(15.9) 0.46(0.39)
Cox 7.4(1.8) 8.6(2.0) 0.79(0.06) 5.0(2.3) 3.8(3.8) 0.34(0.25)
CQR 4.0(1.2) 5.3(1.6) 0.67(0.05) 7.7(2.5) 112.3(43.6) 0.93(0.03)
KMW-LAD 7.2(2.1) 9.2(2.2) 0.82(0.06) 3.7(2.2) 0.5(0.7) 0.11(0.14)
CQPCorr 8.9(2.0) 10.4(2.2) 0.85(0.06) 5.4(2.5) 0.7(0.9) 0.10(0.11)
Band2 1 AFT 12.0(1.0) 14.0(1.7) 0.85(0.08) 15.3(1.2) 109.7(67.6) 0.85(0.08)
Cox 12.3(0.6) 15.0(0.0) 0.95(0.03) 14.7(0.6) 37.0(32.1) 0.65(0.16)
CQR 7.3(3.1) 10.3(2.5) 0.84(0.04) 15.3(1.2) 136.0(9.5) 0.90(0.01)
KMW-LAD 12.7(0.6) 15.0(1.0) 0.97(0.01) 12.0(1.0) 4.0(1.7) 0.25(0.08)
CQPCorr 14.0(1.0) 15.3(1.2) 0.97(0.02) 13.3(0.6) 4.3(1.2) 0.24(0.05)
2 AFT 10.1(1.4) 11.4(1.8) 0.85(0.06) 11.9(2.0) 53.5(55.0) 0.73(0.15)
Cox 11.2(2.0) 12.7(2.0) 0.90(0.05) 11.9(2.3) 16.0(10.3) 0.52(0.16)
CQR 6.2(1.8) 8.5(2.1) 0.77(0.06) 11.7(2.1) 126.3(53.0) 0.90(0.05)
KMW-LAD 11.1(1.6) 12.8(2.0) 0.92(0.05) 9.3(2.7) 3.9(3.3) 0.25(0.15)
CQPCorr 12.5(1.9) 14.0(1.7) 0.94(0.05) 11.5(2.5) 4.0(2.2) 0.24(0.10)
3 AFT 9.1(1.2) 10.5(1.8) 0.82(0.07) 10.0(1.9) 38.5(61.8) 0.63(0.21)
Cox 11.2(1.8) 12.4(2.1) 0.89(0.07) 11.1(1.7) 11.5(9.3) 0.45(0.18)
CQR 6.0(1.8) 8.1(1.9) 0.77(0.04) 11.8(1.4) 120.1(36.9) 0.90(0.03)
KMW-LAD 10.4(1.5) 12.2(2.1) 0.90(0.06) 8.1(2.2) 3.0(2.2) 0.25(0.13)
CQPCorr 11.8(1.7) 13.4(1.8) 0.93(0.05) 10.4(2.2) 3.4(1.8) 0.24(0.09)
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Table A.9: Simulation results for setting C1 with the banded correlation structure and E2.
In each cell, mean (sd) based on 200 replicates.
Error Method TP20 TP40 pAUC TP.FDR FP.FDR E.FDR
Band1 1 AFT 9.5(0.5) 9.8(0.4) 0.75(0.03) 9.9(0.5) 96.3(84.4) 0.85(0.10)
Cox 9.4(0.7) 9.9(0.7) 0.79(0.02) 9.4(0.9) 14.8(12.2) 0.54(0.16)
CQR 4.2(1.7) 6.1(1.8) 0.70(0.05) 7.5(1.9) 69.9(18.8) 0.90(0.03)
KMW-LAD 8.1(1.2) 9.1(1.1) 0.80(0.04) 4.8(1.7) 1.2(1.6) 0.15(0.16)
CQPCorr 9.1(1.2) 10.2(1.0) 0.83(0.03) 7.6(1.7) 1.4(1.0) 0.14(0.08)
2 AFT 6.5(1.8) 7.8(1.8) 0.74(0.05) 5.6(2.8) 10.5(12.1) 0.50(0.28)
Cox 7.4(1.4) 8.4(1.5) 0.76(0.03) 6.3(1.8) 4.0(4.4) 0.30(0.24)
CQR 3.5(1.2) 4.8(1.3) 0.66(0.04) 6.2(2.3) 79.8(30.2) 0.92(0.02)
KMW-LAD 7.1(1.7) 8.2(1.6) 0.78(0.04) 3.2(1.8) 0.9(0.9) 0.20(0.23)
CQPCorr 8.1(1.5) 9.2(1.4) 0.80(0.04) 5.6(2.3) 1.4(1.6) 0.17(0.17)
3 AFT 4.4(2.2) 5.1(2.5) 0.68(0.07) 2.2(2.4) 4.9(9.3) 0.42(0.40)
Cox 6.8(2.0) 7.4(2.1) 0.74(0.05) 4.0(2.9) 1.5(2.9) 0.16(0.22)
CQR 3.4(1.4) 4.3(1.1) 0.65(0.04) 5.8(2.1) 79.8(22.5) 0.93(0.02)
KMW-LAD 5.5(1.4) 6.7(1.3) 0.73(0.05) 2.1(2.0) 0.4(1.3) 0.04(0.12)
CQPCorr 7.4(1.1) 8.3(1.2) 0.78(0.03) 4.1(2.0) 0.3(0.5) 0.04(0.07)
Band2 1 AFT 10.1(0.5) 10.4(1.0) 0.76(0.07) 10.9(1.0) 126.6(113.8) 0.86(0.12)
Cox 10.2(0.6) 10.5(0.8) 0.82(0.04) 10.4(0.7) 24.9(16.6) 0.64(0.17)
CQR 6.6(1.7) 8.4(1.7) 0.77(0.05) 10.5(1.6) 99.4(25.3) 0.90(0.02)
KMW-LAD 10.1(1.6) 10.9(1.5) 0.85(0.05) 8.5(1.2) 2.4(1.8) 0.21(0.13)
CQPCorr 10.8(1.5) 11.3(1.5) 0.86(0.04) 10.1(1.3) 2.8(1.7) 0.20(0.10)
2 AFT 9.5(0.8) 9.8(0.7) 0.79(0.03) 9.6(0.8) 23.2(21.1) 0.60(0.23)
Cox 9.8(0.6) 10.5(1.1) 0.82(0.04) 9.4(0.7) 10.7(13.7) 0.42(0.22)
CQR 6.4(1.1) 8.2(1.5) 0.77(0.04) 10.2(1.8) 79.1(26.2) 0.88(0.05)
KMW-LAD 9.5(1.2) 10.0(1.1) 0.84(0.04) 7.7(2.0) 1.5(1.3) 0.15(0.12)
CQPCorr 10.2(1.0) 10.8(0.9) 0.86(0.04) 9.1(0.9) 1.6(1.3) 0.14(0.10)
3 AFT 8.5(1.1) 9.1(0.9) 0.76(0.02) 8.2(1.5) 26.9(37.1) 0.52(0.30)
Cox 9.4(0.8) 9.8(0.4) 0.80(0.02) 9.3(0.9) 9.1(14.4) 0.30(0.29)
CQR 5.9(1.6) 7.4(1.6) 0.75(0.03) 9.4(1.3) 69.9(15.7) 0.88(0.03)
KMW-LAD 9.6(1.3) 10.6(1.2) 0.84(0.05) 7.0(1.6) 0.8(1.1) 0.08(0.10)
CQPCorr 9.8(0.8) 10.8(1.2) 0.84(0.03) 8.4(1.1) 0.6(0.5) 0.07(0.06)
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Table A.10: Simulation results for setting C2 with the AR correlation structure and E2. In
each cell, mean (sd) based on 200 replicates.
Error Method TP20 TP40 pAUC TP.FDR FP.FDR E.FDR
ρ = 0.3 1 AFT 8.5(1.4) 9.5(1.4) 0.78(0.04) 8.6(2.2) 31.9(37.2) 0.61(0.24)
Cox 7.6(1.6) 8.5(1.6) 0.77(0.05) 5.7(2.6) 3.2(3.5) 0.25(0.20)
CQR 3.0(1.5) 4.1(1.6) 0.65(0.04) 5.9(1.9) 82.2(33.0) 0.93(0.02)
KMW-LAD 5.7(1.8) 7.0(1.8) 0.74(0.05) 2.5(2.0) 0.9(1.3) 0.20(0.25)
CQPCorr 6.8(1.5) 8.0(1.6) 0.77(0.04) 3.8(2.2) 1.2(1.4) 0.19(0.18)
2 AFT 2.6(1.2) 3.6(1.3) 0.62(0.04) 0.5(0.7) 1.7(3.0) 0.42(0.43)
Cox 4.0(1.7) 5.0(2.0) 0.68(0.06) 1.6(2.0) 0.8(1.4) 0.15(0.24)
CQR 2.1(1.0) 3.3(1.6) 0.62(0.05) 4.4(2.3) 72.9(20.7) 0.94(0.03)
KMW-LAD 4.4(1.4) 5.7(1.4) 0.71(0.04) 1.0(1.1) 0.1(0.3) 0.03(0.08)
CQPCorr 5.1(1.5) 6.5(1.3) 0.73(0.04) 1.6(1.3) 0.1(0.4) 0.04(0.09)
3 AFT 1.4(1.5) 1.9(1.5) 0.57(0.05) 0.2(0.5) 1.1(2.0) 0.37(0.47)
Cox 3.1(2.1) 3.7(2.6) 0.63(0.08) 0.8(1.4) 0.3(0.7) 0.12(0.28)
CQR 2.1(1.3) 3.3(1.7) 0.62(0.05) 4.4(1.7) 62.7(27.1) 0.93(0.03)
KMW-LAD 3.9(1.4) 5.0(1.9) 0.67(0.06) 0.3(0.6) 0.1(0.2) 0.03(0.11)
CQPCorr 3.8(1.8) 5.2(2.1) 0.69(0.07) 1.3(1.4) 0.2(0.4) 0.07(0.15)
ρ = 0.5 1 AFT 9.7(0.8) 10.4(1.0) 0.78(0.06) 10.3(1.3) 55.8(65.9) 0.69(0.25)
Cox 9.4(0.9) 10.0(1.1) 0.81(0.04) 8.8(1.3) 7.9(13.9) 0.28(0.26)
CQR 5.1(1.8) 6.5(2.1) 0.72(0.06) 8.8(1.7) 91.3(24.0) 0.91(0.03)
KMW-LAD 8.8(1.7) 10.0(1.9) 0.84(0.06) 6.4(1.8) 1.0(1.3) 0.11(0.13)
CQPCorr 9.7(2.1) 10.4(2.1) 0.84(0.06) 7.3(2.7) 1.1(1.1) 0.10(0.09)
2 AFT 6.5(2.0) 7.9(1.8) 0.75(0.05) 4.1(3.2) 3.9(6.8) 0.29(0.28)
Cox 7.9(2.1) 8.6(2.0) 0.78(0.06) 5.7(3.3) 2.7(3.5) 0.22(0.22)
CQR 4.5(2.3) 6.5(2.2) 0.73(0.06) 8.0(2.1) 69.2(29.3) 0.88(0.05)
KMW-LAD 8.7(1.3) 9.9(1.9) 0.82(0.06) 3.9(2.0) 0.3(0.5) 0.08(0.12)
CQPCorr 9.4(1.7) 10.5(1.9) 0.85(0.05) 6.8(2.4) 0.7(0.8) 0.07(0.08)
3 AFT 5.5(3.0) 6.2(3.2) 0.71(0.09) 3.4(3.5) 3.5(7.1) 0.30(0.37)
Cox 6.3(3.0) 7.0(2.9) 0.73(0.09) 4.7(3.8) 2.0(2.8) 0.25(0.28)
CQR 4.3(1.6) 6.0(1.8) 0.71(0.05) 7.8(2.4) 67.0(20.3) 0.89(0.03)
KMW-LAD 8.6(1.8) 9.5(1.5) 0.82(0.05) 3.1(2.1) 0.2(0.4) 0.05(0.11)
CQPCorr 8.8(1.8) 9.6(1.7) 0.83(0.05) 5.5(2.3) 0.3(0.5) 0.04(0.06)
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Table A.11: Simulation results for setting C2 with the banded correlation structure and E1.
In each cell, mean (sd) based on 200 replicates.
Error Method TP20 TP40 pAUC TP.FDR FP.FDR E.FDR
Band1 1 AFT 10.9(1.5) 12.2(1.9) 0.85(0.06) 12.8(2.1) 62.8(58.3) 0.74(0.17)
Cox 10.8(2.1) 11.8(2.0) 0.88(0.06) 10.1(2.8) 8.9(9.0) 0.38(0.20)
CQR 4.3(1.9) 5.9(2.0) 0.70(0.05) 10.4(2.4) 142.5(38.4) 0.93(0.02)
KMW-LAD 8.7(2.1) 10.5(2.2) 0.86(0.05) 5.1(2.4) 1.3(1.3) 0.18(0.15)
CQPCorr 10.2(2.2) 11.8(1.9) 0.89(0.05) 6.6(2.5) 1.7(1.7) 0.17(0.14)
2 AFT 4.7(2.0) 6.0(2.0) 0.71(0.06) 3.4(3.0) 16.2(32.7) 0.55(0.35)
Cox 7.3(2.1) 8.6(2.3) 0.79(0.08) 5.2(2.5) 4.2(5.3) 0.32(0.26)
CQR 3.8(1.8) 5.0(1.9) 0.68(0.05) 8.6(2.3) 120.0(32.0) 0.93(0.02)
KMW-LAD 7.7(1.4) 9.4(1.7) 0.83(0.05) 3.5(2.0) 0.8(1.3) 0.15(0.23)
CQPCorr 8.5(1.7) 10.6(2.0) 0.86(0.06) 5.1(2.1) 1.0(1.1) 0.15(0.14)
3 AFT 2.7(1.4) 3.8(2.0) 0.65(0.07) 1.1(1.2) 5.2(9.7) 0.50(0.44)
Cox 5.5(2.1) 6.9(2.7) 0.73(0.09) 3.0(2.7) 1.7(2.4) 0.27(0.30)
CQR 3.0(1.6) 4.3(1.5) 0.65(0.05) 7.5(2.0) 119.5(32.4) 0.94(0.03)
KMW-LAD 6.9(1.8) 8.4(1.9) 0.80(0.05) 2.2(2.2) 0.6(1.4) 0.10(0.16)
CQPCorr 7.5(1.9) 8.8(2.2) 0.81(0.07) 3.3(2.2) 0.5(0.7) 0.09(0.12)
Band2 1 AFT 12.7(1.2) 14.3(1.5) 0.87(0.07) 15.2(1.2) 106.3(97.0) 0.80(0.12)
Cox 13.1(1.3) 14.7(1.2) 0.94(0.04) 14.5(1.7) 36.0(43.7) 0.60(0.17)
CQR 6.8(2.0) 9.2(2.3) 0.80(0.04) 13.3(1.8) 151.4(55.7) 0.91(0.03)
KMW-LAD 12.5(1.1) 14.1(1.2) 0.95(0.03) 11.5(1.6) 5.5(3.4) 0.29(0.15)
CQPCorr 13.4(1.1) 14.9(1.3) 0.97(0.02) 13.1(1.6) 5.3(2.3) 0.28(0.09)
2 AFT 10.4(1.6) 11.9(1.3) 0.87(0.04) 11.0(2.5) 26.1(31.7) 0.60(0.17)
Cox 11.6(1.9) 13.1(2.2) 0.91(0.06) 11.6(2.4) 16.8(22.6) 0.43(0.24)
CQR 6.7(1.4) 8.6(1.3) 0.76(0.05) 12.7(1.8) 142.9(40.0) 0.91(0.03)
KMW-LAD 11.2(1.3) 13.2(1.3) 0.92(0.04) 8.7(2.5) 3.2(2.7) 0.22(0.15)
CQPCorr 12.8(1.3) 14.2(1.2) 0.96(0.03) 11.1(2.2) 3.1(1.9) 0.20(0.10)
3 AFT 8.2(2.7) 9.6(2.7) 0.82(0.09) 6.3(4.4) 11.9(17.9) 0.45(0.32)
Cox 9.5(2.7) 11.4(2.8) 0.88(0.08) 7.8(3.7) 5.3(5.6) 0.38(0.25)
CQR 5.4(1.9) 7.4(2.3) 0.74(0.06) 11.4(2.6) 132.8(35.5) 0.92(0.02)
KMW-LAD 10.9(2.0) 12.9(2.4) 0.92(0.05) 8.3(2.9) 3.0(2.7) 0.23(0.14)
CQPCorr 11.8(1.5) 13.3(1.7) 0.94(0.05) 9.9(2.9) 3.1(1.8) 0.22(0.09)
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Table A.12: Simulation results for setting C2 with the banded correlation structure and E2.
In each cell, mean (sd) based on 200 replicates.
Error Method TP20 TP40 pAUC TP.FDR FP.FDR E.FDR
Band1 1 AFT 9.0(1.2) 9.4(1.3) 0.76(0.04) 9.4(1.6) 45.8(52.2) 0.69(0.23)
Cox 8.7(1.6) 9.4(1.4) 0.78(0.04) 8.2(2.0) 8.9(21.2) 0.30(0.26)
CQR 4.5(1.7) 5.8(2.0) 0.69(0.06) 7.9(2.3) 83.6(29.5) 0.91(0.04)
KMW-LAD 7.4(2.0) 8.6(2.1) 0.79(0.07) 4.5(2.3) 1.0(1.1) 0.15(0.15)
CQPCorr 8.1(1.9) 9.2(2.2) 0.81(0.07) 5.8(2.0) 1.1(1.0) 0.14(0.12)
2 AFT 4.7(1.8) 5.6(1.9) 0.69(0.05) 2.6(2.6) 13.7(33.9) 0.49(0.40)
Cox 5.7(2.1) 6.6(2.2) 0.71(0.06) 3.7(2.6) 2.3(3.5) 0.27(0.22)
CQR 3.3(1.9) 4.8(2.1) 0.67(0.06) 6.5(2.3) 77.3(22.1) 0.92(0.03)
KMW-LAD 6.2(2.0) 7.7(2.3) 0.76(0.07) 2.9(1.8) 0.8(1.4) 0.15(0.24)
CQPCorr 7.2(2.2) 7.9(2.4) 0.78(0.07) 4.2(2.4) 0.8(1.0) 0.14(0.16)
3 AFT 2.9(2.0) 3.6(2.1) 0.63(0.07) 0.9(1.4) 2.6(5.9) 0.44(0.44)
Cox 5.1(1.7) 5.9(1.7) 0.70(0.05) 2.4(2.3) 1.3(2.4) 0.14(0.24)
CQR 2.8(1.4) 4.1(1.7) 0.64(0.04) 5.3(1.4) 75.1(28.9) 0.93(0.03)
KMW-LAD 5.6(1.7) 7.1(2.1) 0.74(0.06) 1.6(1.4) 0.3(0.5) 0.09(0.18)
CQPCorr 6.0(1.6) 7.1(1.8) 0.75(0.05) 2.9(1.6) 0.4(1.1) 0.08(0.15)
Band2 1 AFT 10.1(0.6) 10.3(0.5) 0.80(0.05) 10.2(0.4) 35.7(31.5) 0.64(0.29)
Cox 10.0(0.9) 10.4(1.0) 0.81(0.04) 10.1(0.3) 31.7(53.5) 0.52(0.25)
CQR 6.7(1.7) 8.2(1.8) 0.75(0.05) 10.0(1.8) 101.8(37.0) 0.90(0.03)
KMW-LAD 9.7(1.2) 10.8(1.4) 0.86(0.05) 8.6(1.6) 2.5(1.9) 0.21(0.11)
CQPCorr 9.9(0.6) 11.2(0.8) 0.88(0.04) 9.2(1.4) 2.4(1.0) 0.20(0.05)
2 AFT 9.3(0.9) 9.9(0.6) 0.80(0.02) 8.6(1.7) 8.0(9.3) 0.33(0.27)
Cox 9.4(1.3) 10.2(1.3) 0.82(0.04) 8.9(1.4) 4.9(4.9) 0.29(0.19)
CQR 6.3(1.6) 7.6(1.5) 0.75(0.05) 9.4(1.7) 78.2(26.2) 0.88(0.04)
KMW-LAD 9.9(1.4) 11.4(1.9) 0.87(0.05) 7.7(1.4) 1.2(2.1) 0.09(0.14)
CQPCorr 10.2(1.2) 11.2(1.6) 0.87(0.04) 8.4(1.6) 1.8(1.1) 0.17(0.10)
3 AFT 7.0(2.2) 8.2(2.3) 0.77(0.07) 5.0(3.5) 5.2(8.1) 0.29(0.26)
Cox 8.9(1.4) 9.8(1.4) 0.80(0.05) 6.9(2.7) 4.0(3.9) 0.32(0.25)
CQR 5.5(1.4) 7.4(1.4) 0.74(0.05) 9.2(1.9) 77.8(35.2) 0.88(0.04)
KMW-LAD 9.0(1.5) 10.5(1.5) 0.85(0.05) 6.4(2.5) 1.5(2.2) 0.12(0.14)
CQPCorr 9.8(1.3) 10.9(1.4) 0.86(0.04) 7.4(2.2) 1.2(1.2) 0.12(0.10)
128
Table A.13: Simulation results for setting C1 with the AR correlation structure (ρ = 0.5)
and 35% censoring rate. In each cell, mean (sd) based on 200 replicates.
Error Method TP20 TP40 pAUC TP.FDR FP.FDR E.FDR
1 AFT 10.0(0.2) 10.0(0.2) 0.77(0.03) 10.0(0.0) 62.2(66.0) 0.76(0.15)
Cox 9.9(0.3) 10.0(0.4) 0.79(0.02) 9.9(0.4) 18.4(16.6) 0.56(0.20)
CQR 5.0(1.7) 6.4(1.9) 0.69(0.04) 8.5(1.7) 112.4(35.3) 0.93(0.02)
KMW-LAD 8.8(0.9) 9.6(0.8) 0.80(0.02) 6.8(2.0) 1.2(1.7) 0.12(0.12)
CQPCorr 9.8(0.5) 10.1(0.7) 0.81(0.02) 8.9(1.0) 1.4(1.0) 0.12(0.08)
2 AFT 7.9(1.6) 8.4(1.7) 0.76(0.04) 7.3(2.1) 9.3(10.2) 0.44(0.24)
Cox 8.6(1.4) 8.9(1.5) 0.77(0.04) 7.5(1.6) 4.3(7.2) 0.26(0.20)
CQR 3.6(1.7) 5.0(1.5) 0.67(0.03) 7.7(1.8) 112.1(35.7) 0.93(0.02)
KMW-LAD 7.8(1.6) 8.5(1.5) 0.77(0.04) 4.4(2.2) 1.0(1.8) 0.11(0.18)
CQPCorr 8.6(1.1) 9.1(1.0) 0.80(0.02) 7.2(1.6) 1.0(1.0) 0.11(0.10)
3 AFT 6.0(2.2) 7.2(2.3) 0.74(0.06) 4.3(3.2) 8.0(18.3) 0.28(0.30)
Cox 7.6(1.9) 8.3(1.8) 0.77(0.05) 5.8(2.5) 2.4(3.0) 0.23(0.20)
CQR 3.4(1.4) 4.9(1.5) 0.67(0.05) 7.0(1.6) 102.6(34.2) 0.93(0.02)
KMW-LAD 6.9(1.4) 8.3(1.5) 0.77(0.05) 3.1(2.2) 0.6(1.0) 0.12(0.16)
CQPCorr 8.2(1.6) 9.2(1.2) 0.80(0.04) 5.4(2.1) 0.9(1.0) 0.11(0.10)
129
Table A.14: Simulation results for setting C2 with the AR correlation structure (ρ = 0.5)
and 35% censoring rate. In each cell, mean (sd) based on 200 replicates.
Error Method TP20 TP40 pAUC TP.FDR FP.FDR E.FDR
1 AFT 9.7(1.0) 10.2(1.2) 0.79(0.05) 10.6(1.7) 64.6(82.3) 0.72(0.20)
Cox 9.6(1.3) 10.3(1.4) 0.82(0.04) 9.2(1.6) 7.3(7.3) 0.37(0.17)
CQR 4.0(1.8) 5.6(2.1) 0.69(0.06) 8.7(2.0) 121.3(36.7) 0.93(0.03)
KMW-LAD 7.9(1.7) 9.3(2.1) 0.80(0.06) 3.7(2.0) 0.9(1.0) 0.19(0.22)
CQPCorr 8.8(1.2) 9.7(1.4) 0.82(0.04) 7.3(1.8) 2.0(2.0) 0.18(0.15)
2 AFT 5.1(2.8) 6.1(2.8) 0.71(0.08) 2.8(3.1) 4.7(8.3) 0.46(0.41)
Cox 6.6(2.2) 7.5(1.8) 0.75(0.06) 4.0(2.0) 2.2(2.5) 0.25(0.21)
CQR 3.0(1.1) 4.6(1.4) 0.67(0.04) 7.2(1.6) 102.7(37.7) 0.93(0.03)
KMW-LAD 5.8(1.6) 6.6(2.3) 0.73(0.07) 1.6(1.6) 0.1(0.3) 0.03(0.09)
CQPCorr 6.8(2.1) 7.8(2.4) 0.76(0.07) 2.9(2.6) 0.4(0.8) 0.04(0.08)
3 AFT 2.6(2.1) 3.7(2.4) 0.63(0.06) 0.9(1.7) 2.0(3.8) 0.47(0.47)
Cox 4.8(2.0) 6.2(2.0) 0.71(0.07) 2.4(2.2) 1.3(1.9) 0.33(0.35)
CQR 2.1(1.1) 3.1(1.5) 0.62(0.04) 5.5(1.7) 110.7(28.8) 0.95(0.02)
KMW-LAD 5.2(1.6) 6.0(1.4) 0.70(0.05) 0.8(1.2) 0.2(0.6) 0.13(0.29)
CQPCorr 6.3(2.1) 7.2(1.9) 0.75(0.06) 3.1(2.1) 0.9(1.3) 0.15(0.16)
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Table A.15: Simulation results for setting C1 with the AR correlation structure (ρ = 0.5)
and various values of τ . In each cell, mean (sd) based on 200 replicates.
Error Method τ TP20 TP40 pAUC TP.FDR FP.FDR E.FDR
1 CQR 0.2 4.9(1.7) 7.1(2.0) 0.73(0.04) 11.5(2.0) 140.9(48.5) 0.92(0.03)
0.35 4.9(1.6) 6.8(1.9) 0.72(0.05) 11.2(2.0) 141.1(44.8) 0.92(0.03)
0.5 4.7(1.6) 6.9(1.8) 0.74(0.06) 11.5(2.0) 133.0(33.1) 0.92(0.02)
0.65 5.3(1.9) 7.2(1.9) 0.72(0.04) 11.1(1.9) 137.8(43.0) 0.92(0.02)
0.8 4.7(1.6) 6.8(1.9) 0.72(0.04) 11.2(1.8) 140.2(44.8) 0.92(0.02)
CQPCorr 0.2 9.6(1.7) 10.8(1.8) 0.86(0.05) 11.5(2.5) 4.3(2.7) 0.30(0.13)
0.35 11.4(2.0) 12.8(1.6) 0.92(0.04) 9.8(2.1) 3.6(2.7) 0.24(0.15)
0.5 12.2(1.6) 13.8(1.5) 0.94(0.03) 10.9(2.0) 3.3(2.5) 0.21(0.12)
0.65 10.5(1.5) 12.4(1.5) 0.91(0.03) 8.9(1.8) 3.3(2.4) 0.24(0.15)
0.8 9.2(1.4) 10.3(1.4) 0.85(0.05) 8.4(1.7) 4.0(3.3) 0.28(0.17)
2 CQR 0.2 5.6(1.7) 7.1(1.9) 0.73(0.06) 9.7(1.9) 110.1(39.9) 0.91(0.03)
0.35 5.3(1.4) 7.3(1.8) 0.72(0.06) 9.5(1.8) 107.3(42.3) 0.91(0.04)
0.5 5.2(1.4) 7.1(1.5) 0.73(0.04) 9.6(2.1) 108.4(23.8) 0.91(0.02)
0.65 5.3(1.7) 7.3(1.9) 0.73(0.05) 9.9(2.0) 108.4(40.6) 0.91(0.03)
0.8 5.1(1.8) 7.1(2.2) 0.73(0.06) 10.2(1.6) 110.2(40.3) 0.91(0.03)
CQPCorr 0.2 7.2(1.5) 8.0(1.6) 0.77(0.03) 9.7(1.9) 2.6(1.7) 0.32(0.15)
0.35 10.3(1.4) 11.4(1.8) 0.88(0.05) 8.3(1.7) 1.7(1.8) 0.15(0.13)
0.5 10.4(1.7) 12.0(2.0) 0.89(0.05) 8.0(2.4) 1.6(1.2) 0.16(0.09)
0.65 10.1(1.9) 11.6(1.6) 0.88(0.04) 8.0(2.8) 2.1(2.1) 0.18(0.14)
0.8 7.9(1.8) 9.2(2.0) 0.81(0.05) 5.9(2.5) 2.3(2.1) 0.24(0.15)
3 CQR 0.2 4.8(1.6) 6.4(1.8) 0.71(0.04) 9.0(2.0) 99.6(36.7) 0.91(0.03)
0.35 4.6(1.6) 6.3(1.5) 0.71(0.05) 8.8(2.4) 97.7(37.3) 0.91(0.04)
0.5 4.5(1.6) 6.3(1.7) 0.70(0.05) 9.0(1.9) 105.8(44.7) 0.92(0.03)
0.65 4.8(1.6) 6.1(2.0) 0.70(0.05) 8.6(2.2) 97.6(36.3) 0.91(0.03)
0.8 4.9(1.6) 6.3(1.8) 0.71(0.05) 9.0(2.2) 101.6(38.1) 0.91(0.03)
CQPCorr 0.2 6.1(2.1) 7.5(2.2) 0.75(0.06) 9.0(2.5) 1.3(1.6) 0.19(0.18)
0.35 9.2(1.8) 10.6(1.6) 0.85(0.05) 6.8(2.1) 1.4(1.3) 0.16(0.12)
0.5 10.7(1.7) 12.2(1.9) 0.90(0.06) 7.5(2.4) 1.3(1.4) 0.14(0.11)
0.65 9.6(1.5) 11.0(1.6) 0.87(0.04) 6.4(2.2) 1.4(1.3) 0.16(0.13)
0.8 6.8(1.7) 8.1(2.0) 0.77(0.06) 3.7(2.0) 1.5(1.9) 0.22(0.20)
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Table A.16: Data analysis: numbers of overlapping interactions (RV-coefficients) identified
by different methods. Upper panel: results based on FDR control. Lower panel: results
based on (roughly) top forty lists.
LUAD AFT Cox CQR KMW-LAD CQPCorr
AFT 8(1.00) 2(0.71) 4(0.77) 0(0.41) 2(0.85)
Cox 29(1.00) 16(0.87) 0(0.47) 13(0.84)
CQR 620(1.00) 2(0.64) 15(0.89)
KMW-LAD 4(1.00) 0(0.50)
CQPCorr 48(1.00)
SKCM AFT Cox CQR KMW-LAD CQPCorr
AFT 17(1.00) 16(0.74) 11(0.60) 0(0.00) 6(0.77)
Cox 573(1.00) 101(0.53) 1(0.00) 44(0.72)
CQR 741(1.00) 5(0.02) 20(0.81)
KMW-LAD 20(1.00) 0(0.00)
CQPCorr 80(1.00)
LUAD AFT Cox CQR KMW-LAD CQPCorr
AFT 40(1.00) 14(1.00) 1(0.40) 1(0.27) 4(0.20)
Cox 40(1.00) 1(0.39) 0(0.25) 5(0.19)
CQR 40(1.00) 1(0.71) 1(0.44)
KMW-LAD 40(1.00) 3(0.40)
CQPCorr 46(1.00)
SKCM AFT Cox CQR KMW-LAD CQPCorr
AFT 40(1.00) 12(0.87) 5(0.14) 0(0.01) 7(0.53)
Cox 40(1.00) 0(0.10) 0(0.00) 7(0.48)
CQR 47(1.00) 2(0.02) 3(0.14)
KMW-LAD 45(1.00) 0(0.01)
CQPCorr 43(1.00)



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table A.18: Summary results under simulation scenarios with continuous G factors and
Band structure under linear model. In each cell, mean (sd) based on 200 replicates.
M:TP M:FP I:TP I:FP RSSE PMSE
D1: N(0, 1)
LTS-MCP-Hier 7.8(0.4) 0.8(1.9) 12.0(2.0) 1.0(1.1) 2.34(0.53) 0.99(0.53)
LS-MCP 5.5(0.9) 3.9(4.4) 10.9(0.9) 12.9(11.1) 2.92(0.45) 1.31(0.62)
LAD-Lasso 8.0(0.1) 11.4(5.6) 13.1(1.5) 30.4(11.6) 1.78(0.39) 1.47(0.56)
RLARS 7.4(0.7) 0.7(1.1) 7.5(1.8) 11.4(7.2) 3.25(0.44) 2.29(0.80)
LTS-MCP 6.0(1.0) 6.5(3.3) 10.7(1.0) 25.8(8.9) 2.63(0.49) 1.34(0.25)
LS-MCP-Hier 8.0(0.1) 0.5(1.7) 12.7(1.1) 0.5(0.7) 1.79(0.35) 0.81(0.19)
D2: 0.9N(0, 1) + 0.1Cauchy(0, 5)
LTS-MCP-Hier 7.8(0.4) 0.9(2.9) 11.4(2.0) 1.1(1.0) 2.28(0.50) 1.14(0.60)
LS-MCP 2.1(1.8) 18.2(8.0) 2.3(2.4) 71.9(11.6) 30.32(40.12) 547.58(2145.90)
LAD-Lasso 7.5(0.6) 2.8(2.2) 7.0(2.4) 7.5(3.4) 3.13(0.35) 4.11(1.22)
RLARS 7.1(0.8) 0.8(1.1) 6.0(1.8) 11.4(6.8) 3.67(0.50) 3.33(1.23)
LTS-MCP 5.8(0.9) 8.4(3.9) 10.4(1.1) 29.5(10.3) 2.80(0.43) 1.37(0.36)
LS-MCP-Hier 5.8(1.4) 150.7(118.1) 2.4(3.2) 27.2(74.9) 28.76(42.09) 1181.23(5245.02)
D3: 0.9N(0, 1) + 0.1N(20, 1)
LTS-MCP-Hier 7.8(0.4) 0.9(2.3) 11.7(1.8) 1.0(1.1) 2.15(0.47) 1.05(0.50)
LS-MCP 2.7(1.0) 24.1(5.2) 2.7(1.4) 67.9(5.2) 9.96(0.68) 33.43(7.57)
LAD-Lasso 7.3(0.8) 3.0(1.8) 5.4(2.1) 8.0(2.7) 3.39(0.34) 5.09(1.51)
RLARS 5.8(1.2) 1.4(1.4) 3.7(1.8) 11.4(4.9) 4.31(0.48) 5.55(2.15)
LTS-MCP 6.0(0.9) 7.3(3.7) 10.7(1.0) 26.4(8.9) 2.67(0.49) 1.20(0.28)
LS-MCP-Hier 6.1(0.9) 94.6(7.1) 2.4(1.5) 5.3(5.2) 8.79(0.62) 33.32(6.65)
D4: N(0, 1) and with leverage points
LTS-MCP-Hier 7.0(1.3) 6.8(13.7) 9.9(3.5) 2.8(2.2) 2.91(0.90) 1.26(2.64)
LS-MCP 1.3(0.9) 22.2(5.2) 3.1(1.9) 69.0(6.5) 7.21(0.86) 18.85(6.15)
LAD-Lasso 3.9(1.2) 4.1(2.3) 4.0(1.6) 12.8(3.5) 4.05(0.33) 9.23(2.16)
RLARS 7.1(0.8) 0.8(1.1) 6.9(1.9) 12.1(7.9) 3.42(0.43) 2.88(0.96)
LTS-MCP 5.8(1.2) 8.9(4.4) 10.4(1.3) 31.7(11.1) 2.78(0.58) 3.12(0.68)
LS-MCP-Hier 5.2(1.2) 56.4(35.5) 3.4(2.7) 5.0(3.3) 5.44(1.27) 14.17(8.50)
D5: 0.9N(0, 1) + 0.1Cauchy(0, 5) and with leverage points
LTS-MCP-Hier 7.2(1.2) 5.6(12.7) 9.8(2.9) 2.7(2.2) 2.75(0.87) 1.09(2.28)
LS-MCP 0.5(0.7) 18.0(9.6) 1.5(1.5) 69.0(16.7) 25.10(32.12) 258.07(680.53)
LAD-Lasso 3.6(1.4) 4.4(2.1) 4.0(2.1) 12.4(3.4) 4.06(0.36) 9.17(2.26)
RLARS 6.7(0.9) 1.1(1.3) 5.9(1.6) 13.3(7.4) 3.77(0.43) 3.65(1.24)
LTS-MCP 6.0(1.0) 9.3(4.0) 10.7(1.2) 32.7(8.5) 2.67(0.52) 2.55(0.35)
LS-MCP-Hier 4.3(1.6) 154.0(110.7) 1.0(1.8) 26.0(61.5) 27.86(39.79) 1019.76(4540.05)
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Table A.19: Summary results under simulation scenarios with continuous G factors and
Band structure under AFT model. In each cell, mean (sd) based on 200 replicates.
M:TP M:FP I:TP I:FP RSSE Cstat
D1: N(0, 1)
LTS-MCP-Hier 7.8(0.5) 8.0(9.5) 10.1(2.7) 0.8(1.0) 2.67(0.50) 0.90(0.03)
LS-MCP 6.2(1.0) 13.0(5.4) 11.0(0.9) 38.9(10.2) 2.59(0.54) 0.92(0.02)
LAD-Lasso 7.4(0.9) 13.8(7.9) 6.6(4.0) 31.1(16.6) 3.32(0.61) 0.83(0.06)
RLARS 7.2(0.8) 10.5(2.8) 3.1(1.4) 22.2(4.4) 4.22(0.35) 0.78(0.05)
LTS-MCP 5.8(1.0) 14.8(4.6) 6.6(1.7) 57.8(7.4) 3.36(0.31) 0.85(0.03)
LS-MCP-Hier 8.0(0.2) 2.6(4.4) 11.7(1.3) 0.8(1.1) 2.04(0.35) 0.92(0.02)
D2: 0.9N(0, 1) + 0.1Cauchy(0, 5)
LTS-MCP-Hier 7.7(0.6) 7.5(7.6) 9.2(2.7) 1.2(1.1) 2.88(0.58) 0.88(0.03)
LS-MCP 1.1(1.2) 12.9(7.8) 1.2(1.5) 61.1(8.9) 46.82(93.14) 0.56(0.07)
LAD-Lasso 5.8(1.5) 4.9(2.4) 1.8(1.5) 12.4(3.4) 4.08(0.35) 0.74(0.06)
RLARS 6.1(1.6) 7.3(3.9) 1.5(1.1) 24.1(5.9) 5.42(5.41) 0.72(0.06)
LTS-MCP 5.7(1.2) 16.0(4.1) 5.7(1.7) 58.5(6.1) 3.66(0.35) 0.83(0.03)
LS-MCP-Hier 5.5(1.4) 193.2(160.4) 2.1(2.4) 73.5(236.8) 57.08(118.64) 0.58(0.07)
D3: 0.9N(0, 1) + 0.1N(20, 1)
LTS-MCP-Hier 8.0(0.1) 3.8(6.7) 11.4(1.7) 0.9(1.0) 2.12(0.42) 0.92(0.01)
LS-MCP 2.5(1.0) 26.6(5.4) 2.6(1.3) 70.5(6.3) 10.76(0.69) 0.63(0.04)
LAD-Lasso 6.6(1.1) 4.3(2.2) 2.9(1.9) 11.0(3.0) 3.77(0.33) 0.78(0.05)
RLARS 6.3(1.1) 4.2(2.9) 1.4(1.2) 12.0(5.7) 4.40(0.39) 0.77(0.04)
LTS-MCP 6.0(1.1) 11.2(4.0) 9.2(1.8) 47.4(9.4) 2.93(0.50) 0.89(0.02)
LS-MCP-Hier 5.9(1.1) 101.8(7.3) 2.5(1.6) 7.0(6.3) 9.68(0.59) 0.66(0.04)
D4: N(0, 1) and with leverage points
LTS-MCP-Hier 6.8(1.2) 10.3(9.7) 9.1(3.4) 1.7(1.5) 3.46(0.71) 0.84(0.07)
LS-MCP 3.1(1.1) 15.2(4.5) 4.9(2.1) 53.2(6.0) 4.98(0.62) 0.74(0.05)
LAD-Lasso 6.0(1.3) 7.2(5.8) 3.4(2.5) 18.8(10.2) 3.92(0.38) 0.76(0.05)
RLARS 6.8(1.0) 12.1(4.0) 2.8(1.6) 21.8(4.7) 4.41(0.39) 0.76(0.04)
LTS-MCP 5.4(1.3) 15.8(3.9) 5.5(1.9) 61.7(5.9) 3.73(0.41) 0.81(0.04)
LS-MCP-Hier 5.8(1.1) 42.5(23.6) 4.5(2.4) 2.9(2.1) 4.18(0.64) 0.77(0.05)
D5: 0.9N(0, 1) + 0.1Cauchy(0, 5) and with leverage points
LTS-MCP-Hier 7.1(1.1) 10.1(12.0) 9.5(3.2) 1.8(1.3) 3.30(0.75) 0.84(0.06)
LS-MCP 0.9(1.0) 13.1(7.1) 1.1(1.3) 57.1(10.2) 36.77(71.77) 0.56(0.06)
LAD-Lasso 5.2(1.7) 4.6(2.3) 1.8(1.5) 12.9(3.7) 4.16(0.33) 0.73(0.06)
RLARS 6.2(1.3) 8.5(4.6) 2.5(1.5) 22.6(6.7) 6.82(16.01) 0.73(0.06)
LTS-MCP 5.8(1.1) 15.9(4.3) 5.1(1.6) 61.1(5.2) 3.74(0.42) 0.81(0.04)
LS-MCP-Hier 5.0(1.7) 173.4(152.1) 2.0(2.3) 66.5(240.4) 52.85(129.70) 0.57(0.06)
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Table A.20: Summary results under simulation scenarios with categorical G factors and AR
structure under linear model. In each cell, mean (sd) based on 200 replicates.
M:TP M:FP I:TP I:FP RSSE PMSE
D1: N(0, 1)
LTS-MCP-Hier 7.9(0.3) 0.3(1.0) 12.3(1.5) 0.6(0.9) 2.03(0.42) 0.95(0.44)
LS-MCP 6.2(1.1) 4.5(4.2) 11.3(1.3) 14.3(11.5) 2.48(0.54) 1.13(0.37)
LAD-Lasso 8.0(0.0) 10.7(5.7) 13.4(1.0) 27.9(10.1) 1.68(0.31) 1.37(0.41)
RLARS 4.1(1.2) 13.2(5.8) 2.3(1.6) 8.4(5.0) 4.73(0.44) 8.87(3.01)
LTS-MCP 6.7(0.9) 7.0(3.3) 11.3(1.1) 27.6(8.1) 2.19(0.49) 1.19(0.25)
LS-MCP-Hier 8.0(0.0) 0.3(0.8) 13.1(0.9) 0.5(0.7) 1.66(0.27) 0.80(0.17)
D2: 0.9N(0, 1) + 0.1Cauchy(0, 5)
LTS-MCP-Hier 8.0(0.2) 1.0(2.8) 11.8(2.0) 0.9(1.1) 2.13(0.47) 1.07(0.45)
LS-MCP 1.9(1.8) 21.1(8.4) 2.2(2.4) 74.7(11.4) 35.47(49.17) 712.17(2635.35)
LAD-Lasso 7.8(0.4) 2.4(1.7) 7.8(2.3) 7.2(3.5) 3.02(0.34) 4.05(1.16)
RLARS 4.0(1.1) 11.4(5.3) 1.9(1.4) 7.8(4.4) 4.85(0.41) 9.86(3.38)
LTS-MCP 6.5(1.0) 8.5(3.5) 11.1(1.2) 32.1(7.9) 2.35(0.52) 1.24(0.28)
LS-MCP-Hier 6.0(1.5) 153.5(116.8) 2.4(3.2) 24.5(72.4) 28.86(41.92) 1214.97(5318.06)
D3: 0.9N(0, 1) + 0.1N(20, 1)
LTS-MCP-Hier 8.0(0.2) 0.5(1.4) 12.3(1.6) 0.8(0.9) 1.94(0.41) 0.93(0.41)
LS-MCP 2.8(1.1) 25.0(5.4) 2.7(1.4) 67.2(6.0) 9.90(0.71) 34.37(7.31)
LAD-Lasso 7.5(0.6) 2.8(1.9) 5.6(2.2) 8.4(2.6) 3.33(0.33) 5.04(1.54)
RLARS 3.8(1.1) 10.1(3.8) 0.9(0.9) 6.3(3.2) 5.14(0.50) 11.87(3.95)
LTS-MCP 6.7(1.1) 7.6(3.5) 11.4(1.1) 28.0(7.5) 2.21(0.52) 1.03(0.22)
LS-MCP-Hier 6.4(1.0) 94.4(7.5) 2.2(1.5) 5.1(5.6) 8.64(0.53) 31.64(6.01)
D4: N(0, 1) and with leverage points
LTS-MCP-Hier 7.7(0.6) 7.7(12.3) 10.1(3.0) 1.3(1.1) 2.50(0.61) 1.71(1.08)
LS-MCP 4.4(1.3) 21.5(5.7) 6.8(1.9) 55.4(7.3) 4.95(0.79) 6.95(2.98)
LAD-Lasso 7.0(0.9) 7.6(4.0) 4.7(2.4) 9.0(4.1) 3.51(0.37) 6.35(1.97)
RLARS 5.7(1.1) 13.7(6.6) 2.7(1.7) 8.7(4.8) 4.46(0.42) 7.11(2.26)
LTS-MCP 6.2(1.1) 11.9(5.1) 10.5(1.6) 34.4(7.0) 2.67(0.59) 2.17(0.56)
LS-MCP-Hier 7.7(0.6) 52.4(20.8) 6.5(2.2) 2.4(2.4) 3.61(0.67) 4.38(1.90)
D5: 0.9N(0, 1) + 0.1Cauchy(0, 5) and with leverage points
LTS-MCP-Hier 7.9(0.4) 1.7(4.7) 11.2(2.3) 1.0(1.1) 2.27(0.53) 1.56(0.78)
LS-MCP 1.4(1.4) 22.2(7.7) 1.6(2.0) 76.1(10.6) 39.92(54.72) 771.74(2428.31)
LAD-Lasso 7.2(0.9) 4.5(2.6) 4.6(2.2) 8.0(2.9) 3.51(0.31) 6.12(1.65)
RLARS 5.6(1.1) 11.0(5.6) 2.7(1.8) 9.3(5.8) 4.50(0.40) 7.18(2.21)
LTS-MCP 6.4(0.9) 10.1(4.2) 11.1(1.4) 32.8(7.5) 2.43(0.55) 1.86(0.38)
LS-MCP-Hier 5.4(1.5) 164.5(117.5) 1.7(2.4) 29.5(75.9) 31.75(42.57) 1196.18(4354.42)
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Table A.21: Summary results under simulation scenarios with categorical G factors and AR
structure under AFT model. In each cell, mean (sd) based on 200 replicates.
M:TP M:FP I:TP I:FP RSSE Cstat
D1: N(0, 1)
LTS-MCP-Hier 7.8(0.4) 6.4(10.0) 10.1(2.7) 0.8(1.0) 2.43(0.53) 0.90(0.03)
LS-MCP 7.0(1.0) 12.3(4.6) 12.1(1.2) 38.1(8.7) 1.92(0.67) 0.92(0.01)
LAD-Lasso 7.5(0.7) 14.6(8.2) 8.0(4.1) 33.2(16.6) 3.16(0.60) 0.85(0.05)
RLARS 2.6(1.3) 3.5(2.8) 0.7(0.9) 34.4(6.8) 5.65(0.54) 0.61(0.07)
LTS-MCP 6.1(1.0) 15.2(4.3) 6.7(1.7) 57.4(8.5) 3.27(0.32) 0.85(0.03)
LS-MCP-Hier 7.9(0.3) 1.3(3.0) 12.3(1.2) 0.5(0.8) 1.89(0.36) 0.92(0.02)
D2: 0.9N(0, 1) + 0.1Cauchy(0, 5)
LTS-MCP-Hier 7.8(0.4) 6.2(5.4) 9.3(3.3) 1.1(1.1) 2.64(0.59) 0.88(0.04)
LS-MCP 1.1(1.4) 16.5(8.8) 1.2(1.5) 63.9(9.9) 58.01(114.22) 0.55(0.07)
LAD-Lasso 5.8(1.6) 4.7(2.4) 1.9(1.3) 12.1(3.4) 4.09(0.33) 0.74(0.06)
RLARS 1.0(1.1) 2.8(2.3) 0.5(0.8) 32.4(8.8) 232.54(898.65) 0.55(0.05)
LTS-MCP 6.2(0.9) 15.5(4.3) 5.6(1.7) 59.7(4.9) 3.57(0.33) 0.83(0.03)
LS-MCP-Hier 5.4(1.5) 198.8(160.5) 2.0(2.7) 70.5(239.0) 59.85(123.92) 0.58(0.08)
D3: 0.9N(0, 1) + 0.1N(20, 1)
LTS-MCP-Hier 8.0(0.2) 1.2(3.0) 12.4(1.3) 0.6(0.8) 1.90(0.34) 0.92(0.01)
LS-MCP 2.5(1.1) 26.5(5.0) 2.5(1.5) 71.4(5.6) 10.67(0.75) 0.63(0.04)
LAD-Lasso 6.5(1.1) 4.3(2.5) 2.8(1.7) 10.8(3.5) 3.79(0.29) 0.78(0.04)
RLARS 1.2(1.0) 1.6(1.7) 0.5(0.7) 25.7(9.8) 5.75(0.75) 0.60(0.06)
LTS-MCP 6.3(0.8) 12.2(4.0) 9.4(1.7) 48.6(9.6) 2.77(0.52) 0.90(0.02)
LS-MCP-Hier 5.9(1.2) 101.6(7.2) 2.2(1.7) 7.6(6.1) 9.60(0.61) 0.66(0.04)
D4: N(0, 1) and with leverage points
LTS-MCP-Hier 7.2(0.8) 15.4(10.4) 8.7(2.4) 1.2(1.1) 3.67(0.44) 0.85(0.05)
LS-MCP 3.3(1.3) 18.8(4.1) 3.0(1.7) 53.8(5.1) 6.07(0.70) 0.67(0.05)
LAD-Lasso 2.3(1.6) 11.5(4.9) 0.3(0.7) 14.5(6.7) 4.48(0.29) 0.63(0.05)
RLARS 3.9(1.2) 21.4(6.0) 0.3(0.5) 17.4(6.3) 5.38(0.40) 0.64(0.04)
LTS-MCP 5.6(1.1) 19.2(5.3) 4.2(1.6) 59.4(5.9) 4.00(0.35) 0.78(0.04)
LS-MCP-Hier 5.9(1.1) 66.0(8.2) 1.7(1.3) 2.9(2.7) 5.03(0.67) 0.71(0.05)
D5: 0.9N(0, 1) + 0.1Cauchy(0, 5) and with leverage points
LTS-MCP-Hier 7.5(0.7) 13.6(19.0) 9.1(3.4) 1.0(1.1) 3.28(0.62) 0.84(0.05)
LS-MCP 0.5(0.8) 16.2(7.7) 0.4(0.7) 64.4(9.4) 63.10(119.35) 0.52(0.03)
LAD-Lasso 1.6(1.6) 12.9(5.6) 0.2(0.5) 10.1(5.0) 4.60(0.27) 0.60(0.05)
RLARS 3.4(1.6) 15.4(8.1) 0.4(0.7) 18.8(6.2) 63.57(153.77) 0.61(0.06)
LTS-MCP 6.0(1.0) 16.8(4.2) 5.0(2.0) 59.0(5.1) 3.82(0.37) 0.81(0.03)
LS-MCP-Hier 4.6(2.2) 201.0(155.2) 1.6(2.8) 87.9(263.4) 63.33(132.06) 0.51(0.05)
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Table A.22: Summary results under simulation scenarios with categorical G factors and
Band structure under linear model. In each cell, mean (sd) based on 200 replicates.
M:TP M:FP I:TP I:FP RSSE PMSE
D1: N(0, 1)
LTS-MCP-Hier 7.9(0.3) 0.4(1.1) 11.6(1.9) 0.8(1.0) 2.18(0.49) 0.98(0.45)
LS-MCP 5.9(1.2) 4.8(5.0) 11.1(1.0) 15.4(13.4) 2.64(0.59) 1.19(0.52)
LAD-Lasso 8.0(0.1) 12.7(5.5) 13.2(1.3) 31.8(11.8) 1.72(0.34) 1.42(0.48)
RLARS 4.1(1.4) 13.4(6.1) 2.3(1.4) 9.0(4.8) 4.72(0.46) 9.01(3.04)
LTS-MCP 6.2(1.1) 6.5(3.9) 11.0(1.1) 25.7(8.3) 2.40(0.59) 1.26(0.26)
LS-MCP-Hier 8.0(0.0) 0.4(1.1) 13.1(1.0) 0.5(0.7) 1.67(0.33) 0.79(0.18)
D2: 0.9N(0, 1) + 0.1Cauchy(0, 5)
LTS-MCP-Hier 7.9(0.3) 0.6(1.8) 11.8(1.5) 0.9(1.0) 2.14(0.40) 1.10(0.43)
LS-MCP 1.8(1.8) 21.8(8.9) 2.2(2.4) 74.2(10.9) 35.32(48.40) 673.99(2547.57)
LAD-Lasso 7.6(0.6) 2.7(2.0) 7.2(2.3) 7.3(3.2) 3.12(0.40) 4.32(1.44)
RLARS 4.0(1.4) 11.5(5.4) 1.8(1.4) 8.2(4.0) 4.81(0.41) 9.70(3.17)
LTS-MCP 6.3(1.0) 8.4(3.7) 10.8(1.3) 31.8(8.1) 2.52(0.51) 1.28(0.29)
LS-MCP-Hier 5.9(1.6) 152.2(118.4) 2.4(3.3) 25.3(74.6) 28.95(42.00) 1126.17(4531.24)
D3: 0.9N(0, 1) + 0.1N(20, 1)
LTS-MCP-Hier 7.9(0.2) 0.6(1.5) 12.0(1.4) 0.7(0.8) 2.07(0.41) 0.99(0.43)
LS-MCP 2.6(1.1) 25.3(5.3) 2.6(1.5) 68.3(5.4) 9.98(0.74) 33.57(6.78)
LAD-Lasso 7.2(0.8) 2.9(1.8) 5.6(2.2) 8.3(2.9) 3.41(0.33) 5.31(1.51)
RLARS 3.7(1.3) 9.6(3.9) 0.9(1.0) 6.4(3.0) 5.06(0.52) 11.42(4.16)
LTS-MCP 6.4(1.1) 7.8(3.3) 11.0(1.1) 27.5(7.3) 2.41(0.58) 1.16(0.23)
LS-MCP-Hier 6.1(1.1) 93.7(6.3) 2.4(1.4) 5.7(5.4) 8.57(0.49) 30.92(5.83)
D4: N(0, 1) and with leverage points
LTS-MCP-Hier 7.5(0.6) 7.5(8.7) 9.3(2.8) 1.2(1.2) 2.72(0.56) 1.82(1.11)
LS-MCP 4.1(1.2) 21.6(4.9) 6.7(1.7) 55.9(5.9) 5.00(0.69) 7.12(2.55)
LAD-Lasso 6.6(0.9) 7.0(3.9) 4.5(2.2) 9.1(3.5) 3.61(0.36) 6.63(1.89)
RLARS 5.3(1.3) 13.1(7.1) 2.7(1.6) 8.7(5.4) 4.52(0.37) 7.49(1.89)
LTS-MCP 6.0(1.1) 13.3(6.4) 10.0(2.0) 34.8(8.3) 2.85(0.55) 2.54(0.79)
LS-MCP-Hier 7.3(0.6) 49.5(21.6) 6.2(2.1) 2.1(2.2) 3.66(0.67) 4.63(1.97)
D5: 0.9N(0, 1) + 0.1Cauchy(0, 5) and with leverage points
LTS-MCP-Hier 7.7(0.6) 2.3(6.9) 10.9(2.6) 0.9(1.0) 2.33(0.57) 1.55(0.81)
LS-MCP 1.4(1.5) 22.0(7.8) 1.6(1.8) 77.6(10.0) 39.63(52.58) 743.55(2252.92)
LAD-Lasso 6.8(0.9) 4.4(2.9) 4.5(1.9) 8.9(3.3) 3.60(0.31) 6.35(1.59)
RLARS 5.3(1.3) 10.0(5.2) 2.6(1.6) 9.3(5.7) 4.50(0.37) 7.29(2.12)
LTS-MCP 6.2(1.1) 9.6(3.8) 10.8(1.0) 32.7(7.3) 2.64(0.49) 1.93(0.37)
LS-MCP-Hier 5.3(1.6) 160.8(108.0) 1.6(1.6) 32.8(78.2) 31.77(42.35) 1097.13(4234.09)
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Table A.23: Summary results under simulation scenarios with categorical G factors and
Band structure under AFT model. In each cell, mean (sd) based on 200 replicates.
M:TP M:FP I:TP I:FP RSSE Cstat
D1: N(0, 1)
LTS-MCP-Hier 7.9(0.4) 7.0(11.8) 11.8(2.8) 0.9(1.2) 2.52(0.56) 0.89(0.03)
LS-MCP 6.8(1.1) 14.4(5.1) 11.7(1.2) 41.4(7.5) 2.15(0.66) 0.92(0.02)
LAD-Lasso 7.3(1.0) 14.1(7.8) 6.8(4.2) 32.0(15.9) 3.36(0.58) 0.82(0.06)
RLARS 2.3(1.3) 2.9(1.9) 0.7(0.8) 34.7(7.6) 5.51(0.55) 0.61(0.06)
LTS-MCP 6.2(1.0) 14.8(4.0) 7.0(2.0) 56.1(7.2) 3.24(0.36) 0.85(0.04)
LS-MCP-Hier 7.9(0.2) 1.5(3.6) 12.2(1.3) 0.6(0.8) 1.92(0.36) 0.92(0.02)
D2: 0.9N(0, 1) + 0.1Cauchy(0, 5)
LTS-MCP-Hier 7.7(0.5) 8.9(7.4) 9.6(3.1) 1.1(1.1) 2.75(0.58) 0.88(0.04)
LS-MCP 1.0(1.3) 16.5(8.9) 0.8(1.1) 64.9(10.7) 56.73(108.19) 0.54(0.06)
LAD-Lasso 5.8(1.3) 4.9(2.4) 1.7(1.3) 12.9(3.5) 4.11(0.32) 0.74(0.05)
RLARS 0.9(0.9) 2.7(2.4) 0.4(0.6) 32.2(8.6) 198.16(1027.54) 0.54(0.05)
LTS-MCP 6.1(1.1) 15.9(3.9) 5.9(1.9) 59.1(5.8) 3.58(0.39) 0.82(0.03)
LS-MCP-Hier 5.5(1.6) 196.3(157.2) 1.9(2.4) 66.8(224.0) 57.70(118.80) 0.58(0.08)
D3: 0.9N(0, 1) + 0.1N(20, 1)
LTS-MCP-Hier 8.0(0.1) 1.8(3.4) 12.2(1.2) 0.6(0.7) 1.96(0.36) 0.92(0.01)
LS-MCP 2.5(1.0) 26.4(5.9) 2.2(1.2) 72.3(5.5) 10.74(0.70) 0.62(0.04)
LAD-Lasso 6.5(1.0) 4.6(1.8) 2.7(1.8) 11.1(3.0) 3.78(0.31) 0.77(0.04)
RLARS 1.2(0.9) 1.4(1.2) 0.4(0.6) 25.3(9.1) 81.94(762.49) 0.59(0.06)
LTS-MCP 6.2(1.1) 11.4(4.0) 9.5(1.6) 47.3(8.5) 2.81(0.41) 0.90(0.02)
LS-MCP-Hier 5.9(1.1) 101.8(8.3) 2.3(1.5) 7.4(6.8) 9.60(0.58) 0.66(0.04)
D4: N(0, 1) and with leverage points
LTS-MCP-Hier 7.0(1.0) 18.7(9.7) 8.5(2.3) 0.9(1.0) 3.85(0.42) 0.85(0.05)
LS-MCP 3.0(1.3) 18.7(4.0) 2.6(1.5) 54.4(4.6) 6.12(0.59) 0.65(0.04)
LAD-Lasso 2.2(1.4) 11.9(4.9) 0.3(0.5) 15.4(7.8) 4.52(0.25) 0.62(0.04)
RLARS 3.6(1.2) 21.3(4.4) 0.4(0.6) 18.0(5.5) 5.34(0.43) 0.63(0.05)
LTS-MCP 5.4(1.1) 20.1(4.8) 4.3(1.7) 58.0(4.9) 4.04(0.39) 0.78(0.04)
LS-MCP-Hier 5.5(1.2) 67.6(9.0) 1.7(1.4) 2.5(2.1) 5.06(0.60) 0.70(0.06)
D5: 0.9N(0, 1) + 0.1Cauchy(0, 5) and with leverage points
LTS-MCP-Hier 7.4(0.7) 12.1(10.4) 9.0(3.0) 1.2(1.1) 3.35(0.59) 0.84(0.05)
LS-MCP 0.5(0.9) 15.3(7.7) 0.5(0.7) 65.6(9.7) 64.24(125.79) 0.52(0.03)
LAD-Lasso 1.6(1.7) 12.9(5.4) 0.3(0.5) 9.7(4.9) 4.62(0.30) 0.60(0.05)
RLARS 3.0(1.6) 15.2(8.2) 0.4(0.7) 19.5(6.6) 104.31(331.36) 0.60(0.06)
LTS-MCP 5.8(1.1) 18.0(4.9) 5.3(1.9) 57.6(5.9) 3.76(0.39) 0.81(0.04)
LS-MCP-Hier 4.3(2.2) 204.0(159.3) 1.4(2.6) 81.3(250.6) 60.77(122.85) 0.51(0.05)
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Table A.24: Summary results under simulation scenarios with some weak signals. In each
cell, mean (sd) based on 200 replicates.
M:TP M:FP I:TP I:FP RSSE PMSE
D1: N(0, 1)
LTS-MCP-Hier 8.0(0.2) 0.4(1.2) 8.0(1.4) 0.6(0.7) 1.54(0.32) 0.92(0.25)
LS-MCP 6.7(0.9) 2.3(3.0) 7.7(1.3) 9.5(10.2) 2.14(0.45) 1.07(0.39)
LAD-Lasso 8.0(0.0) 5.7(3.2) 8.6(1.3) 16.5(8.3) 1.44(0.26) 1.21(0.32)
RLARS 7.8(0.4) 0.2(0.6) 5.0(1.5) 8.2(5.6) 2.43(0.41) 1.45(0.41)
LTS-MCP 6.8(0.8) 6.9(3.7) 7.2(1.4) 25.3(9.1) 2.03(0.46) 0.97(0.22)
LS-MCP-Hier 8.0(0.0) 0.5(1.0) 9.0(1.2) 0.7(0.7) 1.38(0.21) 0.76(0.14)
D2: 0.9N(0, 1) + 0.1Cauchy(0, 5)
LTS-MCP-Hier 8.0(0.1) 0.6(1.4) 8.3(1.4) 0.8(0.9) 1.56(0.26) 0.89(0.20)
LS-MCP 1.8(1.7) 18.9(8.0) 1.5(1.5) 73.9(10.1) 38.28(56.15) 761.65(2767.61)
LAD-Lasso 8.0(0.2) 2.3(1.5) 5.8(1.6) 7.3(2.4) 2.03(0.30) 1.96(0.58)
RLARS 7.6(0.6) 0.8(1.1) 4.3(1.4) 10.3(6.8) 2.71(0.39) 1.82(0.58)
LTS-MCP 6.7(0.9) 8.2(3.8) 7.1(1.4) 31.1(10.3) 2.12(0.49) 1.00(0.27)
LS-MCP-Hier 5.5(1.5) 166.6(124.1) 1.3(1.6) 31.3(79.7) 32.79(45.78) 1446.11(5735.58)
D3: 0.9N(0, 1) + 0.1N(20, 1)
LTS-MCP-Hier 8.0(0.1) 0.4(1.2) 8.6(1.4) 0.7(0.9) 1.48(0.24) 0.82(0.18)
LS-MCP 2.9(1.1) 25.2(5.4) 2.0(1.0) 67.4(5.0) 9.44(0.63) 31.63(6.25)
LAD-Lasso 7.9(0.3) 2.6(1.7) 5.1(1.7) 7.8(2.4) 2.18(0.36) 2.29(0.77)
RLARS 6.5(1.1) 1.4(1.4) 3.0(1.4) 11.6(5.7) 3.31(0.40) 3.04(1.08)
LTS-MCP 6.8(0.9) 6.5(3.2) 7.4(1.2) 28.2(9.1) 2.01(0.48) 0.93(0.20)
LS-MCP-Hier 5.9(1.0) 93.1(6.0) 1.7(1.4) 5.4(4.6) 8.07(0.52) 28.15(5.19)
D4: N(0, 1) and with leverage points
LTS-MCP-Hier 7.8(0.6) 1.4(2.7) 7.7(2.0) 1.4(1.8) 1.75(0.54) 1.01(0.93)
LS-MCP 1.5(0.9) 22.1(4.8) 2.3(1.4) 69.4(6.4) 6.41(0.85) 14.50(4.92)
LAD-Lasso 4.5(1.2) 4.0(2.2) 3.2(1.8) 14.2(3.5) 3.27(0.32) 6.70(1.77)
RLARS 7.6(0.6) 0.5(0.7) 5.0(1.4) 10.1(6.3) 2.53(0.38) 1.65(0.59)
LTS-MCP 6.5(1.2) 6.7(4.3) 7.2(1.4) 27.0(12.7) 2.12(0.58) 1.30(0.35)
LS-MCP-Hier 5.5(1.3) 27.1(29.1) 3.7(2.4) 5.1(2.7) 3.99(0.85) 7.47(4.51)
D5: 0.9N(0, 1) + 0.1Cauchy(0, 5) and with leverage points
LTS-MCP-Hier 7.7(0.9) 1.5(2.8) 8.0(2.1) 1.3(1.3) 1.76(0.53) 1.04(1.04)
LS-MCP 0.5(0.8) 17.1(8.9) 1.1(1.1) 69.2(18.5) 32.48(44.17) 600.83(2389.98)
LAD-Lasso 4.5(1.4) 4.0(2.1) 3.5(1.8) 12.6(3.4) 3.28(0.32) 6.54(1.70)
RLARS 7.3(0.7) 1.0(1.1) 4.3(1.7) 11.3(6.7) 2.81(0.39) 1.98(0.63)
LTS-MCP 6.7(0.9) 8.4(3.9) 7.0(1.4) 32.0(10.5) 2.17(0.51) 1.31(0.29)
LS-MCP-Hier 4.4(1.5) 168.7(117.3) 1.0(1.5) 27.6(71.1) 31.14(43.24) 1186.95(4305.08)
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Table A.25: Summary results under simulation scenarios where the hierarchy is violated for
some interactions. In each cell, mean (sd) based on 200 replicates.
M:TP M:FP I:TP I:FP RSSE PMSE
D1: N(0, 1)
LTS-MCP-Hier 7.8(0.4) 4.0(4.4) 10.5(2.0) 2.5(1.7) 3.46(0.35) 3.90(0.95)
LS-MCP 5.5(1.0) 5.0(4.4) 16.8(1.0) 17.8(9.8) 2.95(0.44) 1.51(0.60)
LAD-Lasso 7.9(0.4) 15.0(7.4) 17.9(2.9) 36.0(12.1) 2.23(0.59) 2.25(1.17)
RLARS 7.3(0.7) 1.0(1.5) 8.9(2.2) 14.4(7.9) 4.02(0.38) 4.29(1.08)
LTS-MCP 6.2(1.1) 7.0(3.0) 16.8(1.3) 26.8(6.9) 2.48(0.57) 1.11(0.35)
LS-MCP-Hier 7.8(0.4) 6.0(5.9) 11.3(1.9) 2.9(1.6) 3.40(0.45) 3.78(1.28)
D2: 0.9N(0, 1) + 0.1Cauchy(0, 5)
LTS-MCP-Hier 7.7(0.5) 6.0(5.9) 10.1(2.0) 2.9(1.6) 3.58(0.34) 4.19(1.02)
LS-MCP 2.2(1.8) 17.0(7.4) 3.5(3.2) 71.4(10.6) 38.37(84.37) 2057.01(11618.56)
LAD-Lasso 7.2(0.7) 2.0(1.5) 8.2(2.7) 7.7(3.1) 3.88(0.36) 6.93(1.99)
RLARS 7.0(0.9) 1.0(1.5) 7.1(2.3) 12.4(7.2) 4.44(0.43) 5.43(1.59)
LTS-MCP 6.1(1.0) 8.0(3.0) 16.2(1.6) 33.2(6.8) 2.78(0.53) 1.39(0.48)
LS-MCP-Hier 5.8(1.4) 110.0(32.6) 2.4(2.6) 34.2(95.9) 29.73(50.07) 1510.65(6857.39)
D3: 0.9N(0, 1) + 0.1N(20, 1)
LTS-MCP-Hier 7.6(0.6) 5.0(4.4) 10.2(2.2) 2.8(1.6) 3.60(0.47) 4.32(1.49)
LS-MCP 2.6(1.1) 22.0(5.2) 4.0(1.6) 66.9(5.3) 10.47(0.68) 38.04(6.53)
LAD-Lasso 6.9(0.9) 2.5(2.2) 6.4(2.2) 8.7(3.1) 4.13(0.34) 8.07(2.19)
RLARS 5.8(1.1) 1.0(1.5) 4.4(1.9) 11.9(5.8) 5.12(0.49) 8.10(2.43)
LTS-MCP 6.2(1.0) 8.0(3.0) 16.6(1.4) 29.2(6.1) 2.61(0.54) 1.18(0.37)
LS-MCP-Hier 6.2(1.0) 96.5(8.2) 2.7(1.6) 7.3(5.7) 9.76(0.64) 42.01(9.31)
D4: N(0, 1) and with leverage points
LTS-MCP-Hier 7.3(1.1) 7.5(8.2) 9.4(3.2) 2.8(1.8) 3.78(0.76) 5.35(3.54)
LS-MCP 1.1(0.9) 21.0(4.4) 4.9(2.5) 67.0(6.2) 7.90(0.91) 22.21(7.30)
LAD-Lasso 3.8(1.2) 4.0(3.0) 6.0(2.4) 13.0(4.3) 4.56(0.35) 11.86(2.85)
RLARS 6.8(1.0) 0.0(0.0) 8.1(1.9) 12.8(6.6) 4.27(0.42) 4.78(1.44)
LTS-MCP 6.2(1.1) 9.0(3.0) 16.5(1.5) 32.4(6.6) 2.64(0.57) 1.24(0.43)
LS-MCP-Hier 4.8(1.3) 91.0(7.4) 2.2(2.1) 5.0(4.1) 7.55(1.16) 28.00(10.44)
D5: 0.9N(0, 1) + 0.1Cauchy(0, 5) and with leverage points
LTS-MCP-Hier 7.5(0.9) 8.0(4.4) 9.5(2.5) 3.0(2.0) 3.77(0.71) 5.32(3.72)
LS-MCP 0.6(0.7) 19.0(5.9) 2.0(1.8) 68.5(17.0) 32.80(78.33) 1370.28(8180.45)
LAD-Lasso 3.9(1.3) 4.0(1.5) 5.5(2.1) 12.2(3.5) 4.57(0.33) 12.16(3.24)
RLARS 6.6(1.0) 1.0(1.5) 6.8(2.2) 12.2(6.5) 4.57(0.40) 5.88(1.67)
LTS-MCP 6.2(1.1) 10.0(3.0) 16.4(1.5) 34.4(7.1) 2.68(0.57) 1.28(0.44)
LS-MCP-Hier 4.4(1.6) 113.0(25.2) 1.4(2.1) 31.8(88.0) 28.25(46.51) 1477.08(7265.55)
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Table A.26: Analysis of SKCM data: numbers of overlapping interactions (RV-coefficients)
identified by different approaches.
Main: G LTS-MCP-Hier LS-MCP LAD-Lasso RLARS LTS-MCP LS-MCP-Hier
LTS-MCP-Hier 43 0(0.58) 1(0.00) 0(0.00) 12(0.33) 22(0.48)
LS-MCP 13 0(0.00) 0(0.00) 0(0.03) 0(0.03)
LAD-Lasso 1 0(0.00) 0(0.00) 1(0.00)
RLARS 0 0(0.00) 0(0.00)
LTS-MCP 50 15(0.98)
LS-MCP-Hier 47
Interaction LTS-MCP-Hier LS-MCP LAD-Lasso RLARS LTS-MCP LS-MCP-Hier
LTS-MCP-Hier 26 0(0.02) 0(0.73) 0(0.28) 3(0.00) 4(0.58)
LS-MCP 72 0(0.02) 1(0.03) 6(0.00) 1(0.02)
LAD-Lasso 25 0(0.48) 2(0.01) 3(0.41)
RLARS 31 1(0.00) 0(0.20)
LTS-MCP 110 4(0.03)
LS-MCP-Hier 24
Table A.27: Analysis of BRCA data: numbers of overlapping interactions (RV-coefficients)
identified by different approaches.
Main: G LTS-MCP-Hier LS-MCP LAD-Lasso RLARS LTS-MCP LS-MCP-Hier
LTS-MCP-Hier 32 1(0.27) 5(0.41) 0(0.22) 2(0.37) 14(0.73)
LS-MCP 6 1(0.27) 0(0.16) 0(0.11) 1(0.23)
LAD-Lasso 27 0(0.21) 0(0.33) 3(0.43)
RLARS 12 1(0.22) 0(0.27)
LTS-MCP 17 2(0.47)
LS-MCP-Hier 51
Interaction LTS-MCP-Hier LS-MCP LAD-Lasso RLARS LTS-MCP LS-MCP-Hier
LTS-MCP-Hier 39 1(0.09) 0(0.20) 0(0.15) 0(0.20) 6(0.33)
LS-MCP 17 2(0.19) 0(0.17) 0(0.12) 1(0.15)
LAD-Lasso 36 3(0.26) 0(0.21) 1(0.32)






Table B.1: Simulation results of S2 under correlation setting C1 and additional information
J2. In each cell, mean(sd) based on 200 replicates.
M:TP M:FP I:TP I:FP TP60
AR(0.3)
Proposed 19.3(1.1) 1.3(1.4) 36.3(2.7) 6.5(7.5) 58.7(2.2)
HierMCP 15.2(1.7) 2.7(2.4) 18.8(2.0) 29.6(2.6) 34.4(1.2)
MCP-LP 7.5(1.8) 0.1(0.3) 17.3(2.8) 28.3(7) 28.2(3.6)
Lasso 1.2(1.6) 0(0) 7.7(3.4) 2.9(2.7) 8.8(3.5)
MA 0(0) 0(0) 0.5(1.1) 3.3(4.5) 4.1(3.0)
AR(0.5)
Proposed 19.7(0.7) 0.4(1.3) 37.7(2.7) 4(5) 58.3(3.7)
HierMCP 15(1.6) 0.1(0.2) 20.7(2.4) 30.8(3.8) 34.7(1.2)
MCP-LP 11.4(4) 0(0) 20.3(0.7) 16.7(5.2) 37.3(3.8)
Lasso 0.9(1.3) 0(0) 8.7(3.7) 1.3(1.5) 9.6(3.7)
MA 0(0) 0(0) 0.9(2) 3.2(6.2) 4.0(3.7)
Band1
Proposed 18.7(1.1) 2.4(3.9) 34.3(1.4) 9.1(7.3) 56.2(3.9)
HierMCP 14.7(2.1) 4.6(2.5) 17.3(2.8) 29.6(3.3) 31.9(2.1)
MCP-LP 6.5(1.8) 0.1(0.2) 16.4(3.1) 27.5(5.0) 25(4.4)
Lasso 0.9(1.4) 0(0) 5.9(2.9) 2.6(3.2) 6.8(3.2)
MA 0(0) 0(0) 0.9(1.4) 4.5(5.6) 3.1(2.3)
Band2
Proposed 19.6(0.8) 0.4(1.0) 37.2(2.6) 5(6.8) 58.6(2.8)
HierMCP 15.5(1.5) 0.4(0.8) 20.8(1.8) 30.8(2.2) 35.3(1.8)
MCP-LP 11.6(3.9) 0(0) 19.9(1.2) 19.1(5.4) 36(4.0)
Lasso 0.9(1.3) 0(0) 8.9(3.1) 1.0(1.0) 9.7(3.6)
MA 0(0) 0.1(0.2) 0.8(1.3) 4.6(8.2) 4.2(3.6)
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Table B.2: Simulation results of S2 under correlation setting C2 and additional information
J2. In each cell, mean(sd) based on 200 replicates.
M:TP M:FP I:TP I:FP TP60
AR(0.3)
Proposed 19.1(0.9) 1.4(2.0) 36(2.2) 10.1(12.9) 55.8(5.9)
HierMCP 15.8(1.7) 2(2.2) 19.1(2.7) 30.3(3.3) 34.8(1.9)
MCP-LP 7.3(2.7) 0(0) 18.7(1.6) 26.2(7.1) 30.4(3.1)
Lasso 0.9(1.2) 0(0) 7.9(3.8) 2.6(1.9) 8.8(4.0)
MA 0(0) 0.1(0.3) 0.7(1.4) 3.9(5.1) 4(3.3)
AR(0.5)
Proposed 19.8(1.0) 0.3(0.7) 36.5(2.3) 8.4(8.8) 57.1(4.9)
HierMCP 15.1(1.1) 0.2(0.4) 20.5(1.9) 30.4(3.1) 35.5(1.5)
MCP-LP 10(4.6) 0(0) 20.4(0.9) 17.6(4) 37.9(2.5)
Lasso 1.4(1.8) 0(0) 9.7(3.4) 2.4(2.2) 11.1(3.9)
MA 0(0) 0.2(0.7) 1.1(2) 3.5(4.1) 5.3(4.5)
Band1
Proposed 18.4(1.1) 1.9(2) 34.6(1.5) 14.4(9.9) 52.5(4.0)
HierMCP 14.7(1.8) 7(4.3) 16.4(3.1) 28.7(3.7) 30.8(3.1)
MCP-LP 5.8(2.4) 0.1(0.3) 14.9(3.4) 32.9(8.3) 25.5(3.8)
Lasso 1.5(1.3) 0(0) 5.5(2.9) 3.7(2.7) 7(3.4)
MA 0(0) 0(0) 0.7(1.1) 3.4(7.1) 3.3(2.6)
Band2
Proposed 19.5(1.0) 0.6(1.3) 36.7(2.4) 6.9(6.2) 57.6(3.4)
HierMCP 15.2(1.6) 0.2(0.5) 20.5(1.9) 30.6(2.7) 35.8(1.8)
MCP-LP 8.6(3.2) 0(0) 19.5(1.3) 19.6(4.0) 34.7(2.8)
Lasso 1.3(1.5) 0(0) 6.1(2.5) 1.8(2.4) 7.4(2.7)






































































Figure C.1: Data analysis: identified regulatory modules.
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Detailed simulation settings
In Step (e) of simulation, the important main molecular effects and M-E interactions are
set as follows.
• P1 with a total of 100 important effects under the regulation pattern Θ1: The impor-
tant main molecular effects consist of 15 gene expressions and 20 regulators, among
which 30 are involved in one regulatory module and the remaining five are molecular
units with individual effects. There are 25 interactions with gene expressions and
40 interactions with regulators, relating to one regulatory module and five individual
molecular units.
• P1 with a total of 100 important effects under the regulation pattern Θ2: The impor-
tant main molecular effects consist of 25 gene expressions and 21 regulators, among
which 33 are involved in two regulatory modules and the remaining 13 are molecular
units with individual effects. There are 36 interactions with gene expressions and 18
interactions with regulators, relating to one regulatory module and nine individual
molecular units.
• P2 with a total of 70 important effects under the regulation pattern Θ1: The impor-
tant main molecular effects consist of 15 gene expressions and 20 regulators, among
which 30 are involved in one regulatory module and the remaining five are molecular
units with individual effects. There are 15 interactions with gene expressions and
20 interactions with regulators, relating to one regulatory module and five individual
molecular units.
• P2 with a total of 70 important effects under the regulation pattern Θ2: The impor-
tant main molecular effects consist of 17 gene expressions and 21 regulators, among
which 33 are involved in two regulatory modules and the remaining five are molecular
units with individual effects. There are 20 interactions with gene expressions and 12
interactions with regulators, relating to one regulatory module and four individual
molecular units.
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Table C.1: Data analysis: numbers of overlapping main molecular effects and M-E interac-
tions (RV-coefficients) identified by different methods.
LUAD Proposed Alt.1 Alt.2 Alt.3 Alt.4
Proposed 62(1) 7(0.32) 57(0.65) 4(0.24) 9(0.3)
Alt.1 90(1) 3(0.31) 2(0.08) 33(0.58)
Main effects Alt.2 140(1) 6(0.24) 11(0.36)
Alt.3 11(1) 2(0.08)
Alt.4 66(1)
Proposed Alt.1 Alt.2 Alt.3 Alt.4
Proposed 35(1) 0(0) 4(0.10) 1(0.11) 3(0.08)
Alt.1 8(1) 1(0.03) 2(0.28) 1(0.12)
Interactions Alt.2 30(1) 1(0.1) 1(0.07)
Alt.3 11(1) 6(0.27)
Alt.4 122(1)
SKCM Proposed Alt.1 Alt.2 Alt.3 Alt.4
Proposed 28(1) 9(0.47) 18(0.62) 9(0.52) 4(0.39)
Alt.1 22(1) 7(0.39) 12(0.72) 6(0.53)
Main effects Alt.2 35(1) 7(0.39) 4(0.37)
Alt.3 13(1) 4(0.51)
Alt.4 10(1)
Proposed Alt.1 Alt.2 Alt.3 Alt.4
Proposed 12(1) 2(0.36) 0(0.00) 2(0.32) 1(0.11)
Alt.1 4(1) 0(0.01) 3(0.66) 1(0.19)




Algorithm 1 Identifying regulatory module
1. Estimate Θ̂ with objective function (4.1) using R package glmnet.
2. Initialize s = 0 U (s) as the normalized matrix of Θ̂, where U (s) denotes the remaining
regulation relationships at iteration s.
3. s = s + 1. Apply the sparse 2-means clustering to U (s) based on objective function
(4.2), and obtain two clusters Cs and C̄s for regulators as well as the weight vector ws
for gene expressions, using R package sparcl.






















, under the null
hypothesis of no clusters.







the jth order statistic of the weights at iteration k of Step 4.
6. Conduct a two-sample Kolmogorov-Smirnov test to compare ws and w
0
s.
7. If the test at Step 6 rejects the null hypothesis at significance level 0.05,









. Denote the corresponding in-

































8. Repeat Steps 3-7 until the test at Step 6 fails to reject the null hypothesis, and return
the final regulatory modules {C1,D1} , · · · , {CS ,DS} with S+ 1 being the termination
iteration.
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Algorithm 2 M-E interaction analysis with integrated molecular data
1. Initialize t = 0, Φ(0) = 0, and res(0) = Y , where Φ(t) and res(t) denote the estimates
of Φ and residual res at iteration t.
2. Update t = t+ 1. Optimize Q(Φ) by cycling through α, βs, γ, ηsm and τm.
(a) Update α with the least squared solution. Let Ỹ = res(t−1) + Eα(t−1), then
α(t) = (E′E)−1E′Ỹ . Update res(t−1) = Ỹ −Eα(t).

























s = 0; Other-
wise, update β
(t)












j = 1, . . . , ps, using the R function optimize. Update res
(t−1) = Ỹ − W̃ sβ(t)s .

































, where ST (a, b) = sign(a)(|a|−b)+
is the soft-thresholding operator. Update res(t−1) = Ỹ − W̃ dγ
(t)
d .
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, update ηsm se-
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sm = 0; otherwise, update η
(t)
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√








d 6= 0, d = 1, . . . , pz
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, update τ̂md sequentially.
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